# Clinical Notes from Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

## Note 1 (undefined - d677f41a-3dfd-0f7e-5b76-b866fccfd987)

**Note ID:** d677f41a-3dfd-0f7e-5b76-b866fccfd987
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Trinity427 Hartmann983
**Date:** 1989-03-18T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Okay, here is a medical note template for an 18-year-old female patient presenting for a general examination. Since the reason for the visit is unclear ("for ."), I have included common symptoms and potential underlying causes that might prompt a general check-up. Medical Record Note Patient Information: Name: Fritsch593, Adelaide981 Felisha640 MRN: Age: 18 Gender: Female Race: White Date of Birth: Date of Visit: Time of Visit: Location: Reason for Visit: General examination. History of Present Illness (HPI): The 18-year-old white female patient presents for a general examination. She reports no specific acute complaints prompting this visit. She states she is generally feeling well but has noticed some recent non-specific symptoms, including: Occasional mild fatigue, especially later in the day, for approximately the past month. Mild headaches, described as pressure-like, located frontally, occurring 1-2 times per week, lasting 1-2 hours, not associated with nausea or vomiting, and partially relieved by over-the-counter pain medication. Occasional heartburn or mild abdominal discomfort after large meals. No significant changes in weight, appetite, or sleep patterns reported. Denies fever, chills, shortness of breath, chest pain, dizziness, palpitations, syncope, joint pain, skin rashes, vision changes, or hearing changes. Review of Systems (ROS): Constitutional: Denies fever, chills, night sweats. Reports occasional fatigue. Reports occasional mild headache. HEENT: Denies vision changes, eye pain, photophobia, hearing changes, ear pain, sore throat, nasal congestion, runny nose, facial pain. Reports occasional heartburn. Neck: Denies neck pain, stiffness, lymphadenopathy. Respiratory: Denies cough, shortness of breath, wheezing, chest pain, hemoptysis. Cardiovascular: Denies palpitations, chest pain, orthopnea, paroxysmal nocturnal dyspnea, edema. Gastrointestinal: Reports occasional mild heartburn/abdominal discomfort. Denies nausea, vomiting, diarrhea, constipation, melena, hematochezia, change in bowel habits. Genitourinary: Denies dysuria, frequency, urgency, hematuria, vaginal discharge, itching, odor, pelvic pain. Musculoskeletal: Denies joint pain, swelling, stiffness, muscle weakness, back pain. Neurological: Denies numbness, tingling, weakness, seizure activity, syncope, dizziness. Psychiatric: Denies significant anxiety or depression symptoms. Reports feeling generally well emotionally. Endocrine: Denies polyuria, polydipsia, heat/cold intolerance, weight changes. Skin: Denies rashes, itching, new lesions. Allergies: Denies known allergies. Medications: Patient reports taking no current medications. Past Medical History (PMH): Allergies: No known drug or food allergies reported. Surgical History: No past surgical history reported. Family Social History: Student, non-smoker, denies alcohol or illicit drug use. Denies significant travel history. Review of Systems: As above. Physical Examination: VS: T , P , R , BP , O2 Sat . General: Well-appearing, alert, and oriented female in no acute distress. HEENT: PERRLA, DTRI OU. EOMI. Pupils equal, round, and reactive to light and accommodation. Conjunctiva and sclera clear. External nares patent. Oropharynx clear, no exudates, tonsils 1+. Denies sinus tenderness. Neck: Supple, no lymphadenopathy, trachea midline, no jugular venous distension. Chest: Clear to auscultation bilaterally, no wheezes, rales, or rhonchi. Cardiovascular: Regular rate and rhythm, no murmurs, rubs, or gallops. S1, S2 normal. Abdomen: Soft, non-tender, non-distended, normoactive bowel sounds. No hepatosplenomegaly or costovertebral angle tenderness. Back: No spinal tenderness. Extremities: No edema, no cyanosis or clubbing. Neurological: Grossly intact cranial nerves, motor strength 5/5 in all extremities, normal sensation, normal deep tendon reflexes, gait stable. Assessment: 1. General Examination.
2. Evaluation for non-specific symptoms: Occasional mild fatigue: Could be related to lifestyle (sleep, stress), nutritional factors (iron deficiency anemia less likely without other findings, but possible), or other less common causes. Requires monitoring. Occasional headaches: Likely tension-type headaches given the description. Monitor frequency and severity. Occasional heartburn/abdominal discomfort: Could be related to diet, gastroesophageal reflux disease (GERD), or functional dyspepsia. Monitor symptoms. Plan: 1. Diagnostic Testing: Consider sending basic labs: Complete Blood Count (CBC) with differential to assess for anemia or infection; Comprehensive Metabolic Panel (CMP) to assess electrolytes, renal function, liver function, and glucose. Urinalysis (UA) to screen for UTI or other renal issues. Consider H. pylori testing (serology or stool antigen) if heartburn persists or worsens.
2. Treatment: Advise patient regarding potential triggers for headaches and heartburn (e.g., diet, stress, caffeine). Recommend continued use of OTC pain relievers for headaches as needed, and OTC antacids or H2 blockers/PPIs for heartburn as needed. Encourage adequate hydration and balanced diet. Advise on good sleep hygiene practices for fatigue.
3. Follow-up: Schedule follow-up appointment in to reassess symptoms and review lab results. Instruct patient to return sooner if symptoms worsen significantly, become more frequent, or if new concerning symptoms develop (e.g., severe headache, chest pain, persistent vomiting, high fever).
4. Education: Reviewed general health maintenance, including diet, exercise, sleep, and stress management. Discussed the likely benign nature of the reported symptoms but emphasized monitoring. Provider Signature:

============================================================

## Note 2 (undefined - 172e27d3-c733-27ce-0372-f3c0f3d3b01e)

**Note ID:** 172e27d3-c733-27ce-0372-f3c0f3d3b01e
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Trinity427 Hartmann983
**Date:** 1993-03-27T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 22 - Sex: Female - Race: White Reason for Visit: General examination. Subjective: The patient presents for a general examination. She reports no specific complaints at this time. She denies fever, chills, cough, sore throat, rhinorrhea, or other acute symptoms. She also denies any recent changes in weight, appetite, or energy levels. The patient reports no known allergies or recent exposures to sick contacts. She is up to date on her vaccinations, including COVID-19 and influenza. She denies any history of chronic medical conditions, such as asthma, diabetes, or hypertension. Objective: - Vitals: Temperature: 98.6°F, BP: 120/80 mmHg, HR: 72 bpm, RR: 16 breaths/min, O2 Sat: 98% on room air. - General: Well-appearing, alert, and oriented ×3. - HEENT: PERRLA, EOMI. Mucous membranes moist. No cervical lymphadenopathy. - Cardiovascular: Regular rate and rhythm, no murmurs, rubs, or gallops. - Pulmonary: Clear to auscultation bilaterally, no wheezes, rales, or rhonchi. - Abdominal: Soft, non-tender, non-distended, with normoactive bowel sounds. - Extremities: No edema, cyanosis, or clubbing. - Skin: No rashes, lesions, or abnormalities. Assessment: The patient is a 22-year-old white female with no acute complaints, who appears healthy on physical examination. No abnormalities were noted. Plan: 1. Continue routine health maintenance. 2. Encourage the patient to maintain a healthy lifestyle, including regular exercise and a balanced diet. 3. Schedule follow-up in one year for routine check-up. 4. Educate the patient on the importance of preventive care, including annual influenza and COVID-19 vaccinations. Signature: ,

============================================================

## Note 3 (undefined - 2795e2b1-30b6-69c6-13da-ae9e5d56f216)

**Note ID:** 2795e2b1-30b6-69c6-13da-ae9e5d56f216
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Trinity427 Hartmann983
**Date:** 2002-04-06T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 31 - Sex: Female - Race: White Reason for Encounter: General examination. History of Present Illness: The patient presents for a general examination. She reports no specific complaints but mentions experiencing mild fatigue and occasional headaches over the past few weeks. She denies fever, chills, nausea, vomiting, or any other acute symptoms. Review of Systems: - Constitutional: No fever, chills, or weight changes. - Cardiovascular: No chest pain, palpitations, or shortness of breath. - Respiratory: No cough, dyspnea, or wheezing. - Gastrointestinal: No abdominal pain, diarrhea, or constipation. - Neurological: No dizziness, numbness, or tingling. - Musculoskeletal: No joint pain or stiffness. - Skin: No rashes or itching. - Psychiatric: No mood changes or anxiety. Symptoms Possibly Caused by : Given the patient’s reported fatigue and headaches, potential underlying causes could include: 1. Anemia: Fatigue and headaches may result from decreased oxygen-carrying capacity. 2. Hypothyroidism: Can present with fatigue, headaches, and other nonspecific symptoms. 3. Dehydration or Electrolyte Imbalance: May contribute to headaches and fatigue. 4. Stress or Poor Sleep Hygiene: Can lead to headaches and generalized fatigue. Physical Examination: - Vitals: Temperature 98.6°F, BP 120/80 mmHg, HR 72 bpm, RR 16/min, O₂ sat 98% on room air. - General: Well-nourished, alert, and oriented ×3. - HEENT: PERRLA, EOMI. Mild conjunctival injection noted. No sinus tenderness. - Cardiovascular: Regular rate and rhythm, no murmurs or gallops. - Pulmonary: Clear to auscultation bilaterally. - Abdominal: Soft, non-tender, no organomegaly. - Neurological: Cranial nerves II-XII intact. Motor and sensory exams within normal limits. - Extremities: No edema or cyanosis. Assessment and Plan: 1. Fatigue and Headaches: - Consider initiating lab work to evaluate for anemia (CBC), thyroid dysfunction (TSH), and metabolic panels (electrolytes, BUN, creatinine). - Advise the patient on hydration, sleep hygiene, and stress management. - Follow up in 2 weeks if symptoms persist. 2. General Examination: - Continue routine health maintenance, including screening for age-appropriate conditions (e.g., cervical cancer screening, blood pressure monitoring). Disposition: Patient to follow up as scheduled. No acute interventions required at this time.

============================================================

## Note 4 (undefined - c02453e8-86d7-46f6-ad50-f470d6c38bc2)

**Note ID:** c02453e8-86d7-46f6-ad50-f470d6c38bc2
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Trinity427 Hartmann983
**Date:** 2005-04-09T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Okay, here is a medical note drafted as if written by a medical scribe during a general examination encounter where the reason for the visit was not specified. Patient Information: Name: Adelaide981 Felisha640 Fritsch593 Age: 34 years Sex: Female Race: White Date of Visit: Time of Visit: Physician: Scribe: Reason for Visit: General examination of patient for . History of Present Illness (HPI): The patient presents today for a general examination. The patient did not specify a particular chief complaint or reason for seeking care beyond a general check-up. The provider performed a comprehensive general examination to assess the patient's overall health status and screen for potential issues. Review of Systems (ROS): Constitutional: Patient reports feeling generally well today. No reported fever, chills, or night sweats. No recent unintentional weight loss or gain. Neurological: No reported headaches, dizziness, or changes in vision. No numbness, tingling, or weakness. No seizures or confusion. Cardiovascular: No reported chest pain, palpitations, or shortness of breath at rest or with exertion. Respiratory: No reported cough, shortness of breath, or wheezing. Gastrointestinal: No reported abdominal pain, nausea, vomiting, diarrhea, or constipation. Normal appetite. Genitourinary: No reported urinary frequency, urgency, incontinence, or pain with urination. No vaginal discharge, itching, or unusual odor. Musculoskeletal: No reported joint pain, stiffness, or swelling. No muscle weakness or cramps. Skin: No reported rashes, itching, or unusual lesions. Endocrine: No reported changes in energy levels, sweating, or heat/cold intolerance. Psychiatric: No reported anxiety, depression, or significant stressors. Allergies: Denies any known allergies to medications, food, or environmental factors. Hematologic/Oncologic: No reported easy bruising, bleeding, or fatigue. No history of blood clots or cancer. Symptoms potentially caused by : Since the reason for the visit was not specified, the provider inquired about a range of common symptoms that might prompt a general examination. The patient denies experiencing any of the following that could be related to an underlying condition prompting this visit: Persistent fatigue or unexplained tiredness Recurrent infections Unexplained fevers or night sweats Persistent pain (headache, abdominal, joint, etc.) Changes in bowel or bladder habits Unusual skin changes or rashes Significant changes in weight or appetite New onset dizziness or lightheadedness Changes in mood or sleep patterns. Past Medical History (PMH): Past Surgical History (PSH): Medications: Allergies: Social History: Patient is a 34-year-old white female. Denies tobacco, alcohol, or illicit drug use. Family History: If not provided, state: "Family history is non-contributory for relevant conditions at this time or not provided." Physical Examination: Vital Signs: T: , P: , R: , BP: , SpO2: %, wt: lbs/kg, ht: inches/cm. General: Well-appearing female in no acute distress. HEENT: PERRLA, DCT. EOMI. Pupils equal, round, and reactive to light and accommodation. No conjunctival injection or discharge. TMs clear bilaterally. Nasal mucosa clear, nares patent. Oral mucosa moist, no lesions or exudates noted. Dentition intact. Neck: Supple, no lymphadenopathy, no thyromegaly, trachea midline. Cardiovascular: Regular rate and rhythm, no murmurs, rubs, or gallops appreciated. Normal S1, S2. Lung: Clear to auscultation bilaterally, no wheezes, rales, or rhonchi. Abdomen: Soft, non-tender, non-distended. No organomegaly appreciated. Bowel sounds present x4 quadrants. Back: Spine straight, no tenderness to palpation. Extremities: No edema, clubbing, or cyanosis noted. Equal pulses bilaterally in upper and lower extremities. Neurological: Alert and oriented x3. Cranial nerves II-XII grossly intact. Motor strength 5/5 in all extremities. Sensation intact to light touch. DTRs symmetrical and within normal limits. Gait steady if assessed. Skin: Warm, dry, and intact with normal turgor. Assessment: 1. General examination performed for unspecified reason. Patient denies significant symptoms.
2. Plan: 1. Educate patient regarding the findings of the general examination.
2. Patient to follow up as recommended.
3. If none, state: "No specific follow-up required at this time."
4. If none, state: "No specific recommendations given at this time."
5. Patient to return if new or worsening symptoms develop. Plan Summary: Patient seen for general examination. No significant findings noted. Provided education. Recommended as appropriate. Patient advised to return if symptoms arise.

============================================================

## Note 5 (undefined - 527ea354-daef-537e-0500-c4948c028333)

**Note ID:** 527ea354-daef-537e-0500-c4948c028333
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2009-10-03T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Okay, here is a medical note based on the information provided. Medical Record Note Patient: Fritsch593, Felisha640, Adelaide981 Age: 38 Sex: Female Race: White Date of Visit: Time of Visit: Attending Physician: Location: Reason for Visit: Routine Check-up / General Wellness Exam History of Present Illness (HPI): The patient, a 38-year-old white female, presents today for her routine check-up. She reports she is here for a general wellness visit and physical examination. She states she is currently feeling well and has no specific acute complaints prompting this visit today. She denies any recent illness or injury. Review of Systems (ROS): Constitutional: Denies fever, chills, night sweats, unintended weight loss or gain. Head: Denies new or worsening headaches, dizziness, visual changes. Eyes: Denies eye pain, redness, blurry vision, floaters. ENT: Denies sore throat, ear pain, nasal congestion, runny nose, sinus pain. Cardiovascular: Denies chest pain, palpitations, shortness of breath at rest or with exertion, edema, orthopnea, paroxysmal nocturnal dyspnea. Pulmonary: Denies cough, shortness of breath, wheezing, sputum production. Gastrointestinal: Denies nausea, vomiting, abdominal pain, diarrhea, constipation, change in bowel habits, heartburn, dysphagia. Genitourinary: Denies dysuria, frequency, urgency, hematuria, flank pain, vaginal discharge, itching, pain. Musculoskeletal: Denies joint pain, swelling, stiffness, muscle weakness, back pain. Neurological: Denies numbness, tingling, weakness, confusion, seizures. Skin: Denies rashes, itching, new growths. Psychiatric: Denies significant anxiety, depression, or sleep disturbances. Reports sleeping well. Endocrine: Denies excessive thirst, urination, fatigue, heat/cold intolerance. Hematologic/Lymphatic: Denies easy bruising, bleeding, splenomegaly, lymphadenopathy. Allergic/Immunologic: No known new allergies reported. (Note: As this is a routine check-up without a specific acute issue, the ROS is largely negative for new symptoms.) Past Medical History (PMHx): Past Surgical History (PSHx): Medications: Allergies: Social History: Occupation: Tobacco: Alcohol: Illicit Drugs: Living Situation: Exercise: Diet: Safety: Family History (FHx): Physical Examination: Vital Signs: BP: HR: RR: Temp: O2 Sat: Pain: General: Well-appearing, alert, and oriented x3, cooperative. HEENT: PERRLA, DCT. EOMI. Conjunctiva clear. TMs intact. Nasal mucosa clear. Throat without exudate or inflammation. Neck: Supple, no JVD, no thyroid enlargement or tenderness, no lymphadenopathy. Lungs: Clear to auscultation bilaterally, no wheezes, rales, or rhonchi. Cardiovascular: RRR, normal S1, S2, no murmurs, rubs, or gallops. Abdomen: Soft, non-tender, non-distended, normoactive bowel sounds, no hepatosplenomegaly. Extremities: No edema, no cyanosis, no clubbing. Normal pulses. Skin: Intact, no rashes or lesions noted. Neurological: CN II-XII grossly intact. Motor strength 5/5 bilateral upper and lower extremities. Sensation intact to light touch. DTRs 2+ and symmetrical. Gait stable. Assessment: 1. 38 y/o WF for routine check-up. Patient reports feeling well. No acute complaints. Physical exam unremarkable.
2. . Plan: 1. Diagnostic Testing: Order CBC, CMP, TSH, Lipid Panel, Urinalysis. Consider mammogram screening based on age and risk factors (discuss with patient). Consider colon cancer screening based on age (discuss with patient).
2. Immunizations: Review immunization status. Administer vaccine as appropriate based on review and patient history/indications.
3. Education/Counseling: Discussed importance of routine health maintenance, blood pressure monitoring, healthy lifestyle (diet, exercise). Discussed age-appropriate cancer screening guidelines (mammography, colonoscopy). Discussed .
4. Follow-up: Schedule follow-up appointment in for repeat check-up. Schedule follow-up for as indicated.
5. Referrals: None indicated at this time. Signature: MD/DO/PA/NP

============================================================

## Note 6 (undefined - 76438aee-8d10-dd46-9ca2-f45391535ca8)

**Note ID:** 76438aee-8d10-dd46-9ca2-f45391535ca8
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2014-01-31T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 43 years - Sex: Female - Race: White - Reason for Visit: Prenatal visit (regime/therapy) for Complete miscarriage History of Present Illness: The patient presents today for follow-up after a complete miscarriage. She reports experiencing symptoms consistent with miscarriage, including: - Vaginal bleeding, which was initially spotting but progressed to heavier bleeding with passage of tissue. - Lower abdominal cramping and pain, described as mild to moderate in intensity, similar to menstrual cramps but more persistent. - Loss of pregnancy symptoms, including breast tenderness and nausea, which resolved prior to the miscarriage. - No fever, chills, or foul-smelling discharge reported. Past Medical/Surgical History: - No relevant past medical or surgical history noted. - No known allergies. - No current medications. Physical Examination: - Vital signs: Afebrile, normotensive, regular heart rate. - Abdominal exam: Soft, non-tender, no masses appreciated. - Pelvic exam: Cervix is closed, uterus is non-tender, no active bleeding or retained products of conception noted. Diagnostic Studies: - Ultrasound (performed prior to visit): Confirmed complete miscarriage with no retained products of conception. - Beta-hCG levels (if applicable): Likely trending downward, consistent with complete resolution of pregnancy tissue. Plan: 1. Confirm complete resolution of miscarriage with follow-up beta-hCG if needed. 2. Counsel patient on post-miscarriage care, including expectations for bleeding (light bleeding may persist for several days to weeks). 3. Advise patient to avoid sexual intercourse and tampon use until bleeding fully resolves. 4. Provide emotional support and resources for grief counseling if desired. 5. Schedule follow-up appointment in 4-6 weeks to discuss future reproductive plans and contraceptive options. Provider Signature:

============================================================

## Note 7 (undefined - e41ac415-0722-dc13-89ae-d51f04ab7591)

**Note ID:** e41ac415-0722-dc13-89ae-d51f04ab7591
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Trinity427 Hartmann983
**Date:** 2015-02-07T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Subjective: The patient is a 44-year-old white female presenting for a general examination. She reports no specific complaints today but mentions occasional headaches , fatigue , and mild joint stiffness , particularly in the morning. She denies fever, chills, nausea, vomiting, or recent weight changes. She reports no known allergies and is not currently taking any medications. She states she has a family history of hypertension and diabetes but denies personal history of significant medical conditions. Objective: VS: T 98.6°F, HR 76 bpm, BP 122/78 mmHg, RR 16 breaths/min, O2 Sat 98% on room air. General: Well-nourished, alert, and oriented ×3. HEENT: Pupils equal, round, and reactive to light. Extraocular movements intact. Mild tenderness noted upon palpation of bilateral temporal regions. Neck: Supple, no lymphadenopathy. Lungs: Clear to auscultation bilaterally. Cardiovascular: Regular rate and rhythm, no murmurs, rubs, or gallops. Abdomen: Soft, non-tender, and non-distended. Bowel sounds present ×4. Extremities: No edema, mild bilateral metacarpophalangeal joint tenderness noted. Assessment: 1. Occasional headaches : May be due to stress, dehydration, or caffeine withdrawal. Recommend increasing fluid intake and avoiding triggers. 2. Fatigue : Could be related to lifestyle factors (e.g., sleep quality, stress) or underlying conditions like anemia or thyroid dysfunction. Consider screening labs if persistent. 3. Mild joint stiffness : May be early signs of osteoarthritis or inflammatory arthritis. Recommend gentle stretching and NSAIDs if needed. Plan: 1. Advise patient to maintain adequate hydration and consider stress-reduction techniques. 2. Order CBC, CMP, and TSH to evaluate for anemia, thyroid dysfunction, or other metabolic causes of fatigue. 3. Refer to rheumatology if joint stiffness persists or worsens. 4. Follow up in 4 weeks to reassess symptoms. Provider:

============================================================

## Note 8 (undefined - 1be8aef4-5f9d-2657-e5f1-33f323e9e529)

**Note ID:** 1be8aef4-5f9d-2657-e5f1-33f323e9e529
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2016-02-20T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 45 years - Sex: Female - Race: White Reason for Encounter: Contraception care (regime/therapy) – removal of intrauterine contraceptive device (IUD). History of Present Illness: The patient is a 45-year-old female presenting for the removal of her intrauterine contraceptive device. She reports no acute symptoms but mentions some concerns related to her current contraception regimen. She notes that prior to seeking removal, she experienced some symptoms potentially associated with her IUD, including: - Mild to moderate cramping, particularly during menstruation. - Irregular menstrual bleeding, including spotting between periods. - Some degree of pelvic discomfort, though not severe. The patient states that these symptoms prompted her decision to discontinue the IUD and explore alternative contraceptive methods. She has no other significant complaints at this time. Procedure Performed: Removal of intrauterine contraceptive device (IUD). The procedure was performed in the office setting under sterile conditions. The IUD strings were easily visualized, and the device was removed without difficulty or resistance. The patient tolerated the procedure well and reported no pain or discomfort during or after the removal. Post-Procedure Instructions: - The patient was advised that mild cramping or spotting may occur post-removal, which is common. - She was instructed to contact the office if she experiences severe pain, heavy bleeding, or signs of infection (e.g., fever, foul-smelling discharge). - Follow-up was scheduled in 4-6 weeks to discuss alternative contraception options. Assessment: - Patient successfully underwent IUD removal due to bothersome symptoms associated with the device. - No complications noted during or after the procedure. Plan: - Follow-up appointment scheduled in 4-6 weeks to evaluate post-removal status and discuss future contraceptive choices. - Patient educated on expected post-procedure symptoms and when to seek further medical attention. Signature: ,

============================================================

## Note 9 (undefined - eece23a3-6acb-e96c-2fde-c37bf463c3c6)

**Note ID:** eece23a3-6acb-e96c-2fde-c37bf463c3c6
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2016-04-09T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 45 years - Race: White - Gender: Female - Reason for Visit: Prenatal initial visit for normal pregnancy. Subjective: The patient presents for her initial prenatal visit. She reports a normal, uncomplicated pregnancy thus far. She denies any significant symptoms such as vaginal bleeding, abdominal pain, or contractions. She may experience some common symptoms of pregnancy, including: - Nausea or morning sickness (though she reports no significant nausea) - Fatigue (common in early pregnancy) - Breast tenderness (not specifically mentioned) - Frequent urination (common as the uterus expands) - Mild pelvic pressure (due to uterine growth) She has no known allergies and takes no current medications. Objective: - Vitals: (Not provided in the prompt, but typically recorded in a prenatal visit) - Physical Examination: - Genital Exam: Normal cervix, no discharge or lesions noted. - Abdominal Exam: Uterine fundal height evaluated (likely early in pregnancy, so may not be measurable). - Auscultation: Fetal heart tones auscultated (likely via Doppler, rate not specified). - Laboratory Tests Ordered/Performed: - Pregnancy test (positive, as confirmed). - Ultrasound scan for fetal viability (likely confirmed). - Blood tests: - Blood group typing. - Hemogram (CBC with differential). - Hepatitis B surface antigen. - HIV antigen/antibody test. - Chlamydia antigen test. - Gonorrhea titer test. - Syphilis titer test (RPR or VDRL). - Hepatitis C antibody (with confirmatory test). - Rubella screening. - Varicella-zoster virus antibody. - Tuberculosis skin test (tine test). - Urine tests: - Urinalysis (protein, qualitative). - Urine culture. - Urine screening for diabetes (likely a glucose test). - Cytopathology procedure (if indicated, e.g., for abnormal discharge). Assessment: 1. Normal pregnancy (confirmed by positive pregnancy test and ultrasound). 2. Routine prenatal screening tests completed to assess maternal and fetal health. Plan: 1. Schedule follow-up visits as per standard prenatal care guidelines (e.g., every 4 weeks until 28 weeks). 2. Review laboratory results when available. 3. Provide education on common pregnancy symptoms, nutrition, and fetal development. 4. Counsel on avoiding alcohol, tobacco, and illicit drugs. 5. Encourage follow-up with OB/GYN for ongoing care. Provider: Date:

============================================================

## Note 10 (undefined - c1884908-4991-1d23-e97e-6b6e40276d67)

**Note ID:** c1884908-4991-1d23-e97e-6b6e40276d67
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2016-05-07T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 45 years - Race: White - Sex: Female - Medical Encounter: Prenatal visit (regime/therapy) for Normal pregnancy Chief Complaint: Prenatal visit for routine monitoring of normal pregnancy. History of Present Illness: The patient is a 45-year-old female at gestation with an uncomplicated pregnancy. She reports typical symptoms of normal pregnancy, including: - Nausea and occasional vomiting (morning sickness) - Fatigue - Breast tenderness - Frequent urination - Mild lower back pain - Increased appetite No concerning symptoms such as vaginal bleeding, contractions, or decreased fetal movement are reported. Review of Systems: - Constitutional: No fever, chills, or unintended weight loss. - Gastrointestinal: Nausea improved with dietary modifications; no severe vomiting or dehydration. - Cardiovascular: No chest pain, palpitations, or edema. - Respiratory: No shortness of breath or cough. - Genitourinary: No dysuria, hematuria, or urinary urgency beyond normal pregnancy-related frequency. - Musculoskeletal: Mild lower back pain, managed with stretching and supportive measures. Physical Examination: - Blood Pressure: - Pulse: - Temperature: - Weight: (gain consistent with gestational timeline) - Fundal Height: Measured at , consistent with gestational age. - Fetal Heart Auscultation: Fetal heart tones heard at , reassuring. - Abdominal Exam: Uterus appropriately fundal, no tenderness or contractions noted. - Pelvic Exam: Not performed today. Procedures Performed: 1. Uterine Fundal Height Measurement: Performed and documented as appropriate for gestational age. 2. Fetal Heart Auscultation: Fetal heart tones confirmed via Doppler. 3. Prenatal Screening: Detection of chromosomal aneuploidy in amniotic fluid specimen using fluorescence in situ hybridization (FISH) screening technique. Results pending. Assessment and Plan: - Diagnosis: Normal pregnancy at . - Plan: - Continue routine prenatal care with follow-up in . - Monitor for any concerning symptoms (e.g., bleeding, contractions). - Address pregnancy-related symptoms with lifestyle and supportive measures. - Await results of FISH screening for chromosomal aneuploidy; counsel patient on implications if abnormal. - Encourage adequate hydration, nutrition, and prenatal vitamin supplementation. Provider Signature:

============================================================

## Note 11 (undefined - 96f7678f-224f-2cec-1bf6-2bdbe121f6f5)

**Note ID:** 96f7678f-224f-2cec-1bf6-2bdbe121f6f5
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2016-06-04T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 45 years - Sex: Female - Race: White - Chief Complaint: Prenatal visit for normal pregnancy. History of Present Illness: The patient is a 45-year-old female presenting for a routine prenatal visit. She reports an uncomplicated pregnancy to date. Common symptoms of normal pregnancy include: - Nausea with or without vomiting (morning sickness) - Fatigue - Breast tenderness - Frequent urination - Mild abdominal discomfort or cramping - Weight gain consistent with pregnancy progression The patient denies any concerning symptoms such as vaginal bleeding, contractions, or significant pelvic pain. Review of Systems: - No fever, chills, or infections reported. - No headache, visual changes, or symptoms of preeclampsia. - No shortness of breath or chest pain. - No swelling in the extremities. Physical Examination: - General: Patient appears well-nourished and in no acute distress. - Abdominal Exam: - Uterine fundal height measured at corresponding to gestational age. - No tenderness, masses, or abnormal contours noted. - Fetal Assessment: - Fetal anatomy study (ultrasound) performed; no structural anomalies identified. - Alpha-fetoprotein (AFP) test - antenatal: Results pending/normal. - Auscultation of fetal heart tones: Present at , reassuring. Assessment & Plan: - Diagnosis: Normal pregnancy, . - Plan: - Continue routine prenatal care with follow-up visits as scheduled. - Advise patient on appropriate nutrition, hydration, and activity. - Counsel on signs of potential complications (e.g., decreased fetal movement, vaginal bleeding, contractions) and when to seek immediate medical attention. - Schedule next prenatal visit in . Disposition: The patient tolerated the visit well and will follow up as directed. No acute issues identified. Provider Signature:

============================================================

## Note 12 (undefined - 261734a1-23b5-2476-0070-75b1c38dae0e)

**Note ID:** 261734a1-23b5-2476-0070-75b1c38dae0e
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2016-07-02T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 45 years - Sex: Female - Race: White - Chief Complaint: Prenatal visit for normal pregnancy. History of Present Illness: The patient is a 45-year-old white female presenting for a routine prenatal visit. She reports an uncomplicated pregnancy to date. She denies any concerning symptoms such as vaginal bleeding, contractions, or significant pelvic pain. She reports common symptoms of normal pregnancy, including: - Fatigue – increased tiredness, particularly in the first and third trimesters. - Nausea with or without vomiting – occasional morning sickness, currently well-controlled. - Breast tenderness – mild discomfort, improving as pregnancy progresses. - Frequent urination – due to pressure on the bladder from uterine growth. - Mild lower back pain – likely due to postural changes and ligament laxity. - Increased appetite – consistent with fetal growth needs. Review of Systems: - No headaches, visual changes, or epigastric pain. - No swelling in the hands or feet. - No dyspnea or orthopnea. - No vaginal discharge or itching. Physical Examination: - Vital Signs: Blood pressure 120/80 mmHg, heart rate 80 bpm, respiratory rate 16 breaths/min, temperature 98.6°F. - Abdominal Exam: - Uterine fundal height: Measured at , consistent with gestational age. - Auscultation of fetal heart tones: Fetal heart rate (FHR) is , regular, and reassuring. - Pelvic Exam: Not performed today. - General: Patient appears well-nourished and well-hydrated. Assessment: 1. Normal pregnancy, . 2. Common symptoms of pregnancy – fatigue, nausea, breast tenderness, frequent urination, and mild back pain. Plan: - Continue routine prenatal care with follow-up in . - Advise patient to maintain a balanced diet, adequate hydration, and moderate exercise. - Encourage reporting any concerning symptoms (e.g., bleeding, severe pain, decreased fetal movement). - Administer . - Schedule next appointment with estimated due date (EDD) on . Provider Signature: Date:

============================================================

## Note 13 (undefined - a37d2461-1b48-d3d2-39cd-6889116b39c9)

**Note ID:** a37d2461-1b48-d3d2-39cd-6889116b39c9
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2016-07-30T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 45 years - Sex: Female - Race: White - Encounter Type: Prenatal visit (regime/therapy) for Normal pregnancy Chief Complaint: Prenatal visit for routine evaluation of normal pregnancy. History of Present Illness: The patient is a 45-year-old female presenting for a routine prenatal visit. She reports an uncomplicated pregnancy course to date. She denies any concerning symptoms such as vaginal bleeding, contractions, or severe abdominal pain. She notes common symptoms of normal pregnancy, including: - Nausea with occasional vomiting (mild, resolving in the first trimester) - Fatigue - Breast tenderness - Increased frequency of urination - Mild lower back discomfort - Mild swelling in the ankles (mild edema, worse at the end of the day) Review of Systems: - No fever, chills, or dysuria. - No headache or visual changes. - No shortness of breath or chest pain. - No dizziness or fainting. - No skin changes or itching. Physical Examination: - Vital Signs: - Blood pressure: 120/80 mmHg - Heart rate: 80 bpm - Respiratory rate: 16 breaths/min - Temperature: 98.6°F - Weight: - Abdominal Examination: - Uterine fundal height measured at corresponding to gestational age. - No uterine tenderness or contractions noted. - Fetal Examination: - Auscultation of fetal heart tones performed via Doppler; fetal heart rate is . - Fetal movements palpated appropriately. - Other Systems: - No edema >2+ in extremities. - No signs of preeclampsia (e.g., proteinuria, elevated blood pressure). Procedures Performed: 1. Evaluation of uterine fundal height. 2. Auscultation of fetal heart tones. Assessment: 1. Normal pregnancy, . 2. Common symptoms consistent with normal pregnancy course. Plan: 1. Continue routine prenatal care with follow-up in . 2. Advise patient to maintain a balanced diet, adequate hydration, and moderate exercise. 3. Counsel on symptom management (e.g., antiemetics for persistent nausea, supportive measures for back pain). 4. Encourage reporting any concerning symptoms (e.g., vaginal bleeding, decreased fetal movement, severe headaches). 5. Schedule next visit with repeat fundal height and fetal heart auscultation. Provider Signature:

============================================================

## Note 14 (undefined - f15816da-4180-4402-565c-5959a3a6a36c)

**Note ID:** f15816da-4180-4402-565c-5959a3a6a36c
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2016-07-27T18:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 45 - Sex: Female - Race: White Reason for Encounter: Viral sinusitis symptoms. History of Present Illness: The patient presents with symptoms consistent with viral sinusitis, including: - Nasal congestion - Facial pressure or pain, particularly in the maxillary or frontal sinuses - Post-nasal drip - Thick, discolored nasal discharge (may be yellow or green) - Fatigue - Mild to moderate headache - Low-grade fever (if present) - Sore throat or cough (common due to post-nasal drip) The patient denies severe pain, high fever, or signs of bacterial superinfection at this time. Physical Examination: - Head and neck: Mild tenderness over sinus areas; clear tympanic membranes. - Nasal mucosa: Erythematous with purulent discharge. - Lungs: Clear to auscultation. Diagnosis: - Viral sinusitis (likely due to upper respiratory infection). Treatment Plan: 1. Medication: - Amoxicillin 250 mg / Clavulanate 125 mg Oral Tablet: - Dosage: 1 tablet orally every 8 hours (three times daily). - Duration: 7–10 days, as prescribed. - Instructions: Take with food to minimize gastrointestinal upset. Complete the full course even if symptoms improve. - Precautions: Monitor for signs of allergic reaction (rash, itching, difficulty breathing) or severe diarrhea. If any occur, discontinue and contact the clinic. 2. Supportive Care: - Encourage hydration (e.g., water, tea, or broth). - Use saline nasal spray or rinse to relieve congestion. - Over-the-counter (OTC) pain relievers (e.g., acetaminophen or ibuprofen) for discomfort. 3. Follow-Up: - Return if symptoms worsen or persist beyond 7–10 days, or if signs of bacterial infection (e.g., high fever, facial swelling, purulent discharge) develop. Patient Education: - The prescribed antibiotic is a broad-spectrum option, though viral sinusitis is typically self-limiting. - Emphasize the importance of completing the full course to prevent resistance. - Advise on proper hand hygiene and avoiding close contact with others to reduce transmission. Plan: - Prescribed Amoxicillin/Clavulanate 250/125 mg tablets, 21-count bottle (7-day supply at TID dosing). - Schedule follow-up if needed. Signature:

============================================================

## Note 15 (undefined - 5d3d5439-bc69-b276-7138-656cb7b4da98)

**Note ID:** 5d3d5439-bc69-b276-7138-656cb7b4da98
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2016-08-27T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 45 years - Sex: Female - Race: White - Reason for Visit: Prenatal visit (regime/therapy) for normal pregnancy History of Present Illness: The patient is a 45-year-old female presenting for a routine prenatal visit. She reports an uncomplicated pregnancy to date. Common symptoms of normal pregnancy noted include: - Nausea with or without vomiting (morning sickness) - Fatigue - Breast tenderness - Frequent urination - Mild edema in the lower extremities No concerning symptoms such as vaginal bleeding, abdominal pain, or decreased fetal movement were reported. Review of Systems: - Cardiovascular: No palpitations or dyspnea. - Respiratory: No cough or shortness of breath. - Gastrointestinal: No constipation or heartburn reported (though these are common in pregnancy). - Musculoskeletal: No back pain or joint discomfort. - Neurological: No headaches or dizziness. Physical Examination: - Vital Signs: BP 120/80 mmHg, HR 80 bpm, RR 16/min, Temp 98.6°F. - Abdominal Exam: - Fundal height measured at consistent with estimated gestational age. - Auscultation of fetal heart tones revealed a rate of . - Pelvic Exam: Not performed today. - Extremities: No significant edema noted. Procedures Performed: 1. Hemogram, Automated: - Red blood cells: - White blood cells: - Hemoglobin: - Hematocrit: - Indices: - Platelet count: - Manual white blood cell differential: 2. Administration of Vaccine Product: - Tdap (tetanus, diphtheria, pertussis) vaccine administered. 3. Urine Screening for Glucose: - Negative for glucose. 4. Evaluation of Uterine Fundal Height: - Performed and documented above. 5. Auscultation of Fetal Heart: - Performed and documented above. Assessment: - Normal pregnancy, 2nd/3rd trimester (specify gestational age if known). - Uncomplicated prenatal visit with reassuring findings. Plan: - Continue routine prenatal care with follow-up in . - Advise patient to maintain adequate hydration, nutrition, and rest. - Encourage continuation of prenatal vitamins. - Schedule next visit as per standard prenatal schedule. Provider Signature:

============================================================

## Note 16 (undefined - 6adbef6c-538b-6f94-ad5b-5192b2f4d498)

**Note ID:** 6adbef6c-538b-6f94-ad5b-5192b2f4d498
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2016-09-24T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 45 years - Sex: Female - Race: White - Reason for Visit: Prenatal visit (regime/therapy) for Normal pregnancy History of Present Illness: The patient is a 45-year-old female with a normal, uncomplicated pregnancy at . She reports no significant complaints today but notes common symptoms of normal pregnancy, including: - Nausea (mild, resolving) - Fatigue - Increased urinary frequency - Breast tenderness - Mild lower back discomfort The patient denies any vaginal bleeding, contractions, or leakage of fluid. She has been following her prenatal vitamins and avoiding known teratogens. Physical Examination: - General: Appears healthy, appropriately gaining weight. - Abdominal Exam: - Uterine fundal height measured at , consistent with gestational age. - Auscultation of the fetal heart tones revealed a strong heartbeat at . - No uterine tenderness or contractions noted. - Vital Signs: - Blood Pressure: 120/80 mmHg - Heart Rate: 80 bpm - Temperature: 98.6°F - Weight: (gain consistent with pregnancy) Assessment: - Normal pregnancy, weeks. - Symptoms consistent with normal physiologic changes of pregnancy. - Fetal growth and well-being appear reassuring based on fundal height and fetal heart tones. Plan: 1. Continue routine prenatal care with follow-up in . 2. Encourage continued intake of prenatal vitamins and a balanced diet. 3. Advise patient to report any concerning symptoms (e.g., vaginal bleeding, decreased fetal movement, severe pain). 4. Schedule next visit with routine labs as indicated. Provider: Date:

============================================================

## Note 17 (undefined - 9cb34f36-4e1d-5a2d-1a58-e347581ae2c7)

**Note ID:** 9cb34f36-4e1d-5a2d-1a58-e347581ae2c7
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2016-10-22T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 45 years - Race: White - Sex: Female - Reason for Visit: Prenatal visit for normal pregnancy Subjective: The patient is a 45-year-old white female presenting for a routine prenatal visit. She reports an uneventful pregnancy course thus far. She denies any significant complaints but notes common symptoms associated with normal pregnancy, including mild nausea in the morning, fatigue, and breast tenderness. She reports normal fetal movements and no vaginal bleeding, contractions, or leakage of fluid. She has no history of complications in previous pregnancies. Objective: - Vitals: (Record vitals if available, e.g., BP, HR, FBS) - Physical Exam: - Abdominal Exam: Uterine fundal height measured at , consistent with estimated gestational age. - Fetal Heart Auscultation: Fetal heart tones heard at , with a rate of , reassuring. - Other: No signs of edema, uterine tenderness, or abnormal findings. - Laboratory/Procedures: - Streptococcus pneumoniae Group B Antigen Assay: Performed (result pending if not available). - Uterine Fundal Height Evaluation: Performed (measurement noted above). - Fetal Heart Auscultation: Performed (rate noted above). Assessment: 1. Normal pregnancy, 45 years old. 2. Common symptoms of pregnancy (nausea, fatigue, breast tenderness) are present but mild and not concerning. 3. reassuring fetal growth and fetal heart tones. Plan: 1. Continue routine prenatal care. 2. Reassure patient of normal findings. 3. Schedule follow-up visit in . 4. Advise patient to report any concerning symptoms (e.g., decreased fetal movement, vaginal bleeding, contractions). 5. Await results of Group B strep screening and discuss prophylaxis if positive. Signature: ,

============================================================

## Note 18 (undefined - 7035d748-f31b-68fd-cf9f-3c4d359acb23)

**Note ID:** 7035d748-f31b-68fd-cf9f-3c4d359acb23
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2016-11-05T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 45 years - Sex: Female - Race: White - Reason for Visit: Prenatal visit for normal pregnancy History of Present Illness: The patient is a 45-year-old female presenting for routine prenatal care. She reports an uncomplicated pregnancy thus far. She denies any concerning symptoms such as vaginal bleeding, contractions, or severe abdominal pain. She notes common symptoms associated with normal pregnancy, including: - Nausea with occasional vomiting (morning sickness) - Fatigue and increased sleepiness - Breast tenderness and fullness - Frequent urination - Mild lower back discomfort She denies headaches, visual changes, or swelling in her extremities. Review of Systems: - Cardiovascular: No palpitations or dyspnea. - Respiratory: No cough or shortness of breath. - Gastrointestinal: No significant heartburn or constipation reported. - Musculoskeletal: No joint pain or significant edema. - Neurological: No dizziness or paresthesias. Physical Examination: - Vitals: Blood pressure 118/72 mmHg, heart rate 78 bpm, temperature 98.6°F, weight 155 lbs (up 8 lbs from last visit). - Abdominal Exam: - Uterine fundal height measured at 28 cm (consistent with gestational age). - No tenderness or masses noted. - Fetal Assessment: - Auscultation of fetal heart tones performed; rate is 145 bpm, reassuring. - Other: - Breast exam: Enlarged and tender, no masses. - Pelvic exam: Not performed today. Assessment: 1. Normal Pregnancy (estimated gestational age 28 weeks). 2. Common Pregnancy Symptoms (nausea, fatigue, breast tenderness, frequent urination). Plan: - Continue prenatal vitamins (ensure adequate folic acid, iron, and calcium intake). - Advise patient to maintain a balanced diet and stay hydrated. - Encourage moderate exercise as tolerated. - Schedule next prenatal visit in 4 weeks (around 32 weeks gestation). - Counsel on warning signs to report (e.g., vaginal bleeding, decreased fetal movement, severe headaches). Provider: Date:

============================================================

## Note 19 (undefined - 7eb19e17-baaf-7269-12c2-a8154348f00f)

**Note ID:** 7eb19e17-baaf-7269-12c2-a8154348f00f
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Cherrie404 Conn188
**Date:** 2016-11-12T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 45 years - Sex: Female - Race: White - Chief Complaint: Obstetric emergency hospital admission for normal pregnancy. History of Present Illness: The patient is a 45-year-old white female admitted for an obstetric emergency in the setting of a normal pregnancy. She presented with symptoms commonly associated with normal pregnancy, including: - Nausea and vomiting (morning sickness) - Fatigue - Increased urinary frequency - Breast tenderness and enlargement - Mild edema in the lower extremities - Epigastric discomfort (gastroesophageal reflux) - Shortness of breath on exertion (due to increased oxygen demand) The patient reported no signs of preterm labor, placental abruption, or other complications. She has reached full term and is now in active labor. Physical Examination: - Vital Signs: - Blood Pressure: 120/80 mmHg - Heart Rate: 90 bpm - Respiratory Rate: 18 breaths per minute - Temperature: 98.6°F - Fetal Heart Rate: 140 bpm (within normal limits) - Abdominal Exam: Uterus at full term, fundal height appropriate for gestational age, no contractions noted. - Pelvic Exam: Cervix is 10 cm dilated, fully effaced, membranes ruptured (spontaneous rupture of membranes), fetal presenting part is vertex. Procedures Performed: 1. Episiotomy: Performed to facilitate vaginal delivery and prevent significant perineal tearing. 2. Human Parturition: Spontaneous vaginal delivery of a healthy neonate. 3. Function (Observable Entity) Procedures: Assisted with monitoring fetal heart tones, maternal vital signs, and neonatal transition post-delivery. Post-Procedure Assessment: The patient delivered a healthy neonate via spontaneous vaginal delivery. The episiotomy was repaired with 2-0 and 3-0 chromic sutures. The patient is stable postpartum with no immediate complications. Plan: - Continue monitoring vital signs and uterine contractions for signs of postpartum hemorrhage. - Administer oxytocin to promote uterine tone. - Provide pain management for episiotomy repair. - Monitor for signs of infection (e.g., fever, foul lochia). - Encourage ambulation and breastfeeding as tolerated. Disposition: Admitted to the postpartum unit for routine postpartum care. Signature:

============================================================

## Note 20 (undefined - 5f891dda-4385-2914-63cb-9d3c69e49279)

**Note ID:** 5f891dda-4385-2914-63cb-9d3c69e49279
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2016-12-24T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 45 years - Sex: Female - Race: White Encounter Date: Reason for Visit: Postnatal visit (regime/therapy) History of Present Illness: The patient is a 45-year-old female presenting for a postnatal visit following recent childbirth. She reports no specific complaints related to the pregnancy or delivery at this time. However, she was screened for potential postpartum symptoms, including mood changes, fatigue, and physical discomfort. Symptoms That May Be Caused By : - Mild fatigue and decreased energy levels, possibly due to recent childbirth and lack of rest. - Mood fluctuations, which may be related to postpartum hormonal shifts. - Occasional headaches, possibly attributed to stress or sleep deprivation. - No significant pain or discomfort reported. Physical Examination: - General: Alert and oriented ×3, appears well-nourished. - Vital Signs: BP , HR , Temp , RR , SpO2 . - Abdominal: Uterus involuting appropriately, no tenderness or abnormal discharge noted. - Perineal: No signs of infection or excessive swelling. - Breast: No signs of mastitis or engorgement. - Other systems: Within normal limits. Depression Screening: - Completed . - Regime/Therapy: - Continued postpartum care as per standard protocols. - Advised on rest, nutrition, and gradual return to normal activities. - Encouraged to seek support if mood symptoms worsen. - Scheduled follow-up in . Plan: - Monitor for any signs of postpartum complications (e.g., infection, excessive bleeding). - Repeat depression screening at next visit if symptoms arise. - Provide resources for postpartum support groups if needed. Provider Signature:

============================================================

## Note 21 (undefined - 3c67c7ad-1d38-beaa-37b2-efcf3133cfdd)

**Note ID:** 3c67c7ad-1d38-beaa-37b2-efcf3133cfdd
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Trinity427 Hartmann983
**Date:** 2017-02-11T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 46 years - Sex: Female - Race: White Encounter Details: - Date: - Reason for Visit: General examination of patient for . Subjective: - The patient reports . - No acute concerns were reported. Objective: - Vital - Physical Examination: General examination performed, including assessment of cardiovascular, respiratory, and abdominal systems. No abnormalities noted. - Procedures Performed: - Assessment of health and social care needs. - Assessment of anxiety (screening or formal evaluation). - Immunizations Administered: - Influenza, seasonal, injectable, preservative-free. Medications: - Hydrochlorothiazide 25 MG Oral Tablet: - - Dosage: 25 mg orally once daily. - Instructions: Take once daily in the morning with or without food. Ensure adequate hydration. Avoid alcohol and limit exposure to excessive sunlight due to potential photosensitivity. Monitor for symptoms such as dizziness, lightheadedness, or electrolyte imbalances (e.g., muscle cramps, weakness). Report any persistent symptoms to the clinic. Assessment: - The patient’s general health is stable. No acute concerns identified. Hydrochlorothiazide is prescribed for . Anxiety assessment was performed, and no immediate intervention beyond routine care was required. Seasonal influenza vaccination was administered. Plan: - Continue Hydrochlorothiazide as prescribed. - Follow up in for blood pressure monitoring and medication review. - Encourage lifestyle modifications (e.g., low-sodium diet, regular exercise) as appropriate. - Report any new or worsening symptoms (e.g., severe dizziness, fainting, chest pain, or signs of infection) immediately. Signature:

============================================================

## Note 22 (undefined - 13ecbc88-019f-2193-b3c5-461fdbf862a3)

**Note ID:** 13ecbc88-019f-2193-b3c5-461fdbf862a3
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2017-03-13T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 46 - Sex: Female - Race: White - Chief Complaint: Follow-up for essential hypertension. History of Present Illness: The patient is a 46-year-old female with a known history of essential hypertension who presents for a follow-up encounter. She reports no acute complaints today. However, she notes ongoing symptoms that may be associated with her hypertension, including occasional headaches (particularly in the morning), mild dizziness upon standing, and occasional shortness of breath during physical exertion. She denies chest pain, vision changes, or palpitations. Review of Systems: - Cardiovascular: Denies chest pain, palpitations, or edema. - Neurological: Reports occasional dizziness, denies syncope or focal neurological deficits. - Respiratory: Denies cough, wheezing, or orthopnea. - Other: Denies visual disturbances, nosebleeds, or fatigue. Past Medical History: - Essential hypertension (diagnosed 5 years ago). - No other significant medical conditions reported. Medications: - Lisinopril 10 mg daily. - Hydrochlorothiazide 12.5 mg daily. Allergies: - No known drug or food allergies. Physical Examination: - Vitals: BP 138/88 mmHg, HR 78 bpm, RR 16, SpO2 98% on room air. - General: Alert and oriented, in no acute distress. - Cardiovascular: Regular rate and rhythm, no murmurs, rubs, or gallops. - Neurological: Cranial nerves II-XII intact, no focal deficits. - Respiratory: Clear to auscultation bilaterally, no wheezes or crackles. - Abdominal: Soft, non-tender, no organomegaly. Assessment: 1. Essential hypertension (controlled). 2. Possible hypertensive symptoms (headaches, dizziness, shortness of breath) consistent with poorly controlled blood pressure. Plan: 1. Education: Discuss the importance of blood pressure control and lifestyle modifications (e.g., low-sodium diet, regular exercise). 2. Medication: Consider increasing lisinopril to 20 mg daily and monitor for hypotension or renal function. 3. Follow-up: Schedule a follow-up visit in 4 weeks to reassess blood pressure and symptoms. 4. Monitoring: Advise the patient to monitor blood pressure at home and report significant changes. Disposition: Patient tolerating well, discharged home with above plan.

============================================================

## Note 23 (undefined - 1f49182d-3955-bac2-4efd-caaf5a956bd5)

**Note ID:** 1f49182d-3955-bac2-4efd-caaf5a956bd5
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2017-04-01T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Felisha640 Fritsch593 - Age: 46 - Race: White - Sex: Female Date of Encounter: Reason for Visit: Prenatal initial visit (regime/therapy) for Normal pregnancy. History of Present Illness: The patient presents for her initial prenatal visit. She reports a positive pregnancy test and is currently asymptomatic, though she notes common symptoms associated with normal pregnancy, including: - Nausea with or without vomiting (morning sickness) - Fatigue - Breast tenderness - Frequent urination - Mild abdominal bloating The patient denies any vaginal bleeding, abdominal pain, or other concerning symptoms. She confirms her last menstrual period (LMP) and estimates her gestational age accordingly. Past Medical History: - - No known allergies. Medications: - Family History: - Social History: - Review of Systems: - Constitutional: No fever, chills, or weight changes. - Gastrointestinal: No significant nausea/vomiting beyond typical pregnancy symptoms. - Genitourinary: No dysuria, hematuria, or urinary tract infections. - Musculoskeletal: No joint pain or swelling. - Neurological: No headaches or dizziness. Physical Examination: - Vital Signs: BP , HR , Temp , Fetal HR . - General: Well-appearing, gravid female in no acute distress. - Abdominal: Soft, non-tender; fundal height appropriate for gestational age. - Pelvic: Procedures Performed: 1. Standard pregnancy test – Positive. 2. Ultrasound scan for fetal viability – Confirmed intrauterine pregnancy with fetal heartbeat consistent with estimated gestational age. Assessment: 1. Normal pregnancy, confirmed by positive pregnancy test and ultrasound. 2. Common pregnancy symptoms noted but no concerning findings. Plan: 1. Continue prenatal care – Schedule follow-up visits as per standard guidelines. 2. Prescribe prenatal vitamins – . 3. Lifestyle recommendations: - Maintain a balanced diet. - Avoid alcohol, tobacco, and illicit drugs. - Stay hydrated and manage nausea with small, frequent meals. 4. Referrals: None at this time. 5. Follow-up: Return in for next prenatal visit. Physician Signature:

============================================================

## Note 24 (undefined - acaf4f47-0e1a-922d-2a54-e35818181ac7)

**Note ID:** acaf4f47-0e1a-922d-2a54-e35818181ac7
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2017-04-10T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 46 years - Sex: Female - Race: White Reason for Admission: Admission to the Surgical Department for management of a tubal (ectopic) pregnancy. History of Present Illness: The patient presented with symptoms consistent with a tubal pregnancy, including: - Abdominal pain: Unilateral, often sharp and localized to the affected fallopian tube (right or left adnexa). - Vaginal bleeding/spotting: Unusual bleeding or spotting that differs from normal menses. - Shoulder tip pain: May indicate hemoperitoneum due to rupture and diaphragmatic irritation. - Syncope or dizziness: Suggestive of hypovolemia from internal bleeding if the ectopic pregnancy has ruptured. - Positive pregnancy test with empty uterus on ultrasound: Confirmed via transvaginal ultrasound. The patient was hemodynamically stable upon admission but required urgent surgical intervention due to the high risk of rupture and hemorrhage. Procedure Performed: 1. Excision of fallopian tube (salpingectomy): The affected fallopian tube was identified and removed to prevent further bleeding and complications. 2. Surgical removal of ectopic pregnancy: The ectopic gestational sac was carefully excised. 3. Postoperative care regime/therapy: - Intravenous fluids (e.g., normal saline) for hydration and hemodynamic support. - Pain management with analgesics (e.g., IV/PO opioids or NSAIDs). - Broad-spectrum antibiotics to prevent infection. - Serial hemoglobin/hematocrit checks to monitor for ongoing bleeding. - Close monitoring for signs of infection or complications (e.g., fever, wound issues). Postoperative Course: The patient tolerated the procedure well and is currently recovering in the surgical ward. Vital signs are stable, and pain is managed appropriately. Follow-up with OB/GYN recommended for long-term fertility counseling and contraception. Discharge Planning: - Discharge expected once hemodynamically stable and pain-controlled orally. - Instructions for wound care and signs of complications (e.g., fever, worsening pain, bleeding). - Referral to OB/GYN for future reproductive health. Signature:

============================================================

## Note 25 (undefined - 55760acb-3b4e-a76d-76b5-bbde6b0359ef)

**Note ID:** 55760acb-3b4e-a76d-76b5-bbde6b0359ef
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2017-04-22T00:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 46 - Sex: Female - Race: White Reason for Visit: Prenatal visit for suspected tubal pregnancy. History of Present Illness: The patient presents for a prenatal visit with concerns for a possible tubal pregnancy. She reports symptoms consistent with ectopic pregnancy, including: - Pain: Unilateral, sharp, and possibly intermittent pelvic or abdominal pain, potentially worsening with movement. - Vaginal Bleeding/Spotting: Light to moderate bleeding, possibly different in character from normal menses. - Shoulder Tip Pain: May indicate internal bleeding irritating the diaphragm. - Dizziness or Syncope: Possible signs of hemodynamic instability due to potential rupture. - Pelvic Pressure or Fullness: May be present due to tubal distension. The patient denies current nausea or vomiting but reports a missed period and positive pregnancy test. Past Medical/Surgical History: - No significant past medical history reported. - No prior ectopic pregnancies or tubal surgeries noted. Medications: - None reported. Allergies: - None reported. Physical Examination: - Vital Signs: Stable (BP, HR, RR, Temp within normal limits). - Abdominal Exam: Tenderness in lower quadrants, possibly localized to one side. No rebound or guarding noted. - Pelvic Exam: Cervical motion tenderness may be present. Adnexal tenderness or a palpable adnexal mass could indicate tubal pregnancy. - General Appearance: Alert and oriented, but may appear anxious or in discomfort. Procedures Performed: - Physical Examination: Completed, including abdominal and pelvic assessment. - Depression Screening: Patient completed the Edinburgh Postnatal Depression Scale (EPDS) or another standardized tool; results pending. Diagnostic Plan: - Urine or serum β-hCG testing to confirm pregnancy status. - Transvaginal ultrasound to evaluate for intrauterine pregnancy and assess adnexal structures for ectopic pregnancy. - Possible quantitative β-hCG if initial levels are low or inconclusive. Impression: Suspected tubal pregnancy based on clinical symptoms and history. Further evaluation with ultrasound and β-hCG is warranted to confirm diagnosis and guide management. Plan: 1. Obtain β-hCG levels and arrange for transvaginal ultrasound. 2. Counsel patient on risks of tubal rupture and signs to watch for (e.g., worsening pain, syncope). 3. Follow up in 24–48 hours with results, or sooner if symptoms worsen. 4. Refer to OB/GYN or emergency department if rupture is suspected. 5. Follow up on depression screening results and provide resources if needed. Provider Signature:

============================================================

## Note 26 (undefined - 7c9d3a17-3c2f-ae09-c0c5-3039a2264459)

**Note ID:** 7c9d3a17-3c2f-ae09-c0c5-3039a2264459
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2017-05-12T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Encounter Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 46 years - Sex: Female - Race: White Reason for Encounter: Follow-up for Essential Hypertension History of Present Illness: The patient is a 46-year-old female with a known history of Essential Hypertension who presents for a follow-up visit. She reports ongoing management of her blood pressure but notes some symptoms that may be related to uncontrolled hypertension. She describes occasional headaches , particularly in the morning, which are sometimes severe and localized to the frontal region. She also reports episodes of dizziness and lightheadedness , especially when standing up quickly. Additionally, she mentions shortness of breath during moderate physical exertion and occasional chest tightness , though she denies any chest pain at rest. She denies visual disturbances, numbness, or tingling but notes occasional fatigue and difficulty concentrating . Review of Systems: - Cardiovascular: Denies chest pain but reports occasional chest tightness and shortness of breath with exertion. - Neurological: Reports headaches, dizziness, and lightheadedness; denies visual changes, numbness, or weakness. - Constitutional: Reports fatigue and difficulty concentrating. - Other systems: No significant complaints. Vitals: - Blood Pressure: 150/95 mmHg (supine) - Heart Rate: 78 bpm - Respiratory Rate: 16 breaths/min - Oxygen Saturation: 98% on room air - Temperature: 98.6°F Physical Examination: - General: Alert and oriented, appears well-nourished. - Cardiovascular: Regular rate and rhythm, no murmurs, gallops, or rubs. Jugular venous pressure not elevated. - Neurological: Pupils equal, round, and reactive; no focal deficits noted. - Abdominal: Soft, non-tender, no masses. - Extremities: No edema, no peripheral cyanosis. Assessment: 1. Essential Hypertension (uncontrolled) with evidence of target organ effects (e.g., headaches, dizziness, exertional dyspnea). 2. Possible hypertensive-related symptoms: Headaches, dizziness, fatigue, and exertional shortness of breath. Plan: 1. Blood Pressure Management: - Adjust current antihypertensive regimen (e.g., increase dose of or add a second agent such as an ACE inhibitor or calcium channel blocker). - Reinforce importance of adherence to medication and lifestyle modifications (low-sodium diet, regular exercise, weight management). 2. Symptom Management: - Advise patient to monitor symptoms and report worsening headaches, dizziness, or chest tightness. - Consider referral to cardiology if exertional dyspnea and chest tightness persist despite BP control. 3. Follow-Up: - Schedule follow-up in 4 weeks to reassess BP and symptoms. - Encourage home BP monitoring with logs at each visit. Disposition: Patient to follow up in 4 weeks. Education provided on symptom recognition and BP management.

============================================================

## Note 27 (undefined - bd1da592-94f0-d100-165e-b6326d7a68db)

**Note ID:** bd1da592-94f0-d100-165e-b6326d7a68db
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2017-07-11T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Felisha Fritsch
- Age: 46 years
- Race: White
- Medical Encounter: Follow-up for Essential Hypertension Reason for Visit: The patient presents for a follow-up appointment regarding her ongoing management of essential hypertension. She reports no recent changes in symptoms but expresses concern about potential long-term effects. History of Present Illness: The patient has a history of essential hypertension, diagnosed approximately 5 years ago. She has been compliant with her prescribed antihypertensive medications, including a daily dose of . She reports that her blood pressure has been well-controlled over the past year, typically ranging between 120/80 mmHg and 130/85 mmHg at home. However, the patient notes occasional symptoms that may be related to her hypertension, including:
- Headaches: She reports experiencing mild to moderate headaches, primarily in the morning, which often resolve with over-the-counter pain relievers.
- Dizziness: On rare occasions, she feels dizzy, particularly when standing up quickly.
- Fatigue: She mentions feeling more tired than usual, especially in the afternoons.
- Shortness of Breath: She occasionally experiences mild shortness of breath during physical exertion, which she attributes to her weight but is monitored for cardiac involvement. Review of Systems: - Cardiovascular: No chest pain, palpitations, or edema reported.
- Neurological: No changes in vision, numbness, or tingling reported.
- Respiratory: No cough, wheezing, or significant shortness of breath at rest.
- Gastrointestinal: No nausea, vomiting, or changes in bowel habits.
- Musculoskeletal: No joint pain or muscle weakness. Physical Examination: - Vital Signs: Blood pressure 128/82 mmHg, Heart rate 72 bpm, Respiratory rate 16 breaths/min, Oxygen saturation 98% on room air.
- General Appearance: Alert and oriented, appears well-nourished.
- Cardiovascular: Regular rate and rhythm, no murmurs, rubs, or gallops appreciated. No jugular venous distension.
- Respiratory: Clear to auscultation bilaterally, no wheezes or crackles.
- Abdominal: Soft, non-tender, no organomegaly.
- Extremities: No edema, no cyanosis. Assessment: 1. Essential Hypertension: The patient's blood pressure is well-controlled on her current medication regimen. However, she experiences occasional symptoms that may be related to her hypertension, including headaches, dizziness, fatigue, and mild shortness of breath during exertion. These symptoms should be monitored closely.
2. Potential Complications: Given her history of hypertension, it is important to continue monitoring for signs of end-organ damage, including cardiovascular, renal, and neurological complications. Plan: 1. Medication Management: Continue current antihypertensive medication daily. Consider adjusting dosage if blood pressure readings consistently exceed target range.
2. Lifestyle Modifications: Encourage the patient to maintain a healthy diet, low in sodium and rich in fruits and vegetables, and to engage in regular physical activity. Advise her to monitor her weight and consider weight loss if necessary.
3. Symptom Monitoring: Instruct the patient to keep a symptom diary, noting the frequency and severity of headaches, dizziness, fatigue, and shortness of breath. Encourage her to report any significant changes or worsening of symptoms.
4. Follow-Up: Schedule a follow-up appointment in 3 months to reassess blood pressure control and evaluate the effectiveness of current management strategies.
5. Education: Provide patient education on the importance of adhering to medication and lifestyle recommendations to prevent long-term complications of hypertension. Signature: ,

============================================================

## Note 28 (undefined - e8f2f5d9-23be-e29a-c34c-36e9c3976c32)

**Note ID:** e8f2f5d9-23be-e29a-c34c-36e9c3976c32
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2017-07-22T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 46 years - Sex: Female - Race: White - Chief Complaint: Initial prenatal visit for normal pregnancy. History of Present Illness: The patient presents for her initial prenatal visit. She reports a normal pregnancy course to date, with no significant symptoms reported. Common symptoms of normal pregnancy, such as fatigue, breast tenderness, nausea, and mild urinary frequency, were noted but are within expected ranges. No concerning symptoms (e.g., vaginal bleeding, severe abdominal pain, or excessive nausea/vomiting) were reported. Review of Systems: - Gastrointestinal: Mild nausea without vomiting. - Genitourinary: Mild urinary frequency. - Cardiovascular: No palpitations or orthostatic symptoms. - Respiratory: No dyspnea. - Musculoskeletal: No back pain or pelvic discomfort. - Neurological: No headaches or dizziness. Physical Examination: - General: Afebrile, normotensive, and in no acute distress. - Abdominal: Uterine fundal height consistent with estimated gestational age. No tenderness or masses appreciated. - Reproductive: Auscultation of fetal heart tones revealed a rate of . Ultrasound confirmed fetal viability with appropriate cardiac activity. - Other: No edema, rash, or other concerning findings. Diagnostic Tests Performed: - Pregnancy Test: Standard test performed (result: positive). - Ultrasound: Confirmed fetal viability, appropriate gestational age, and normal fetal anatomy. - Laboratory Tests: - Blood group typing (e.g., ABO/Rh). - Complete blood count (CBC) with differential (results: ). - Hepatitis B surface antigen, HIV antigen/antibody, chlamydia antigen, gonorrhea titer, syphilis titer, hepatitis C antibody, rubella screening, and varicella-zoster virus antibody. - Urinalysis (UA) with protein qualitative, urine culture, and urine screening for diabetes. - Skin test for tuberculosis (tine test). - Cytopathology (genital source smear). Impression: - Normal pregnancy with appropriate gestational age. - No concerning symptoms or findings noted. - All screening tests performed to rule out infectious or hematologic risks. Plan: - Continue routine prenatal care with follow-up visits as scheduled. - Repeat relevant lab tests if abnormal results are found. - Provide patient education on healthy pregnancy practices, including nutrition, activity, and warning signs to report. - Refer to OB/GYN specialist if any high-risk factors emerge. Signature:

============================================================

## Note 29 (undefined - 07f517e9-5221-60ef-0306-4ae49d498303)

**Note ID:** 07f517e9-5221-60ef-0306-4ae49d498303
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2017-08-19T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 46 years - Sex: Female - Race: White - Reason for Visit: Prenatal visit for Normal pregnancy History of Present Illness: The patient presents for routine prenatal care. She is reportedly asymptomatic but experiencing typical symptoms associated with a normal pregnancy, including mild nausea, fatigue, and breast tenderness. No concerning symptoms such as vaginal bleeding, abdominal pain, or decreased fetal movement are reported. Physical Examination: - Uterine Fundal Height: Measured at cm, consistent with estimated gestational age. - Auscultation of Fetal Heart: Fetal heart tones are heard clearly at with a rate of . - Vital Signs: Blood pressure , pulse , temperature , and respiratory rate are within normal limits. Procedures Performed: 1. Evaluation of Uterine Fundal Height: Performed and documented. 2. Auscultation of Fetal Heart: Fetal heart tones detected. 3. Prenatal Amniotic Fluid Specimen Collection: Amniocentesis was performed to detect chromosomal aneuploidy using fluorescence in situ hybridization (FISH) screening. Lab/Imaging: - Amniotic fluid specimen collected for FISH analysis to screen for chromosomal aneuploidies (e.g., trisomy 21, 18, 13). Results pending. Differential Diagnosis: - Normal pregnancy progression. - Potential for chromosomal abnormalities (pending FISH results). Plan: 1. Monitor symptoms of normal pregnancy progression. 2. Follow up in for routine prenatal care. 3. Reassess amniocentesis site for any complications (e.g., bleeding, leakage). 4. Provide education on signs of preterm labor or complications to report immediately. 5. Await FISH results and discuss findings with the patient accordingly. Signature:

============================================================

## Note 30 (undefined - ffc21372-78c3-bf80-40d2-b34b025b99da)

**Note ID:** ffc21372-78c3-bf80-40d2-b34b025b99da
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2017-09-02T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593
- Age: 46 years
- Gender: Female
- Race: White Encounter Date: Reason for Encounter: Routine check-up and assessment of health and social care needs. History of Present Illness: The patient presented for a routine check-up. During the assessment, the patient reported experiencing symptoms that may be caused by . The patient has been experiencing these symptoms for . The symptoms include . Medications: - Hydrochlorothiazide 25 MG Oral Tablet: Prescribed for . Immunizations: - Influenza, seasonal, injectable, preservative-free: Administered today. Procedures Performed: - Assessment of health and social care needs.
- Assessment of anxiety. Assessment: The patient was assessed for overall health and social care needs. The assessment revealed that the patient may be experiencing anxiety, which could be contributing to the symptoms reported. The patient was also assessed for any other underlying conditions that may be causing the symptoms. Plan: 1. Medication: - The patient was prescribed Hydrochlorothiazide 25 MG Oral Tablet to manage . - Instructions for taking Hydrochlorothiazide 25 MG Oral Tablet: - Take one tablet by mouth once daily, preferably in the morning. - It is important to take the medication at the same time each day to maintain a consistent level in the bloodstream. - Do not take the medication at bedtime to avoid nighttime urination. - If you miss a dose, take it as soon as you remember. However, if it is close to the time of your next dose, skip the missed dose and continue with your regular dosing schedule. - Do not double the dose to make up for a missed one. - Follow up with the healthcare provider if you experience any side effects, such as dizziness, lightheadedness, or increased urination. 2. Immunizations: - The patient received the seasonal influenza vaccine today to protect against the flu. 3. Follow-Up: - The patient is advised to return for a follow-up appointment in to assess the effectiveness of the medication and to monitor any changes in symptoms. 4. Additional Instructions: - The patient is encouraged to maintain a healthy lifestyle, including a balanced diet, regular exercise, and adequate sleep. - The patient should avoid alcohol and limit caffeine intake, as these can exacerbate anxiety symptoms. - The patient is advised to seek further evaluation if symptoms worsen or new symptoms develop. Signature:

============================================================

## Note 31 (undefined - 5714dd1a-1c3e-4bee-eb25-e717a4d7c993)

**Note ID:** 5714dd1a-1c3e-4bee-eb25-e717a4d7c993
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2017-09-09T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 46 - Sex: Female - Race: White Reason for Encounter: Symptom for Acute bronchitis. History of Present Illness: The patient presents with symptoms consistent with acute bronchitis, including cough (productive or non-productive), chest discomfort, shortness of breath, wheezing, and possibly low-grade fever or fatigue. These symptoms are typical of acute bronchitis, an inflammation of the bronchial tubes often caused by viral infections. Physical Examination: - General: Alert and oriented, appears uncomfortable due to respiratory symptoms. - Respiratory: Diminished breath sounds, possible wheezing or crackles upon auscultation. - Cardiovascular: Regular rate and rhythm, no murmurs. Diagnostic Procedures: - Plain x-ray of chest performed to rule out pneumonia or other pulmonary pathology. Results pending. Plan: 1. Medication: Prescribed Acetaminophen 21.7 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML / doxylamine succinate 0.417 MG/ML Oral Solution for symptom management. - Instructions: Take 5 mL (equivalent to 109 mg Acetaminophen, 5 mg Dextromethorphan, and 2.085 mg Doxylamine) by mouth every 6-8 hours as needed for cough, fever, or pain. Do not exceed 4 doses in 24 hours. - Note: Shake well before use. Avoid alcohol while taking this medication. If symptoms persist or worsen, contact the clinic. 2. Follow-Up: Patient instructed to return if respiratory distress worsens, fever spikes, or if shortness of breath becomes severe. 3. Lifestyle: Encourage hydration, rest, and avoidance of irritants (e.g., smoke, dust). Disposition: Patient discharged home with instructions for medication use and follow-up as needed. Chest x-ray results will be reviewed upon availability. Signature: ,

============================================================

## Note 32 (undefined - b686c4b6-8e1c-5a80-342c-58c79819e31a)

**Note ID:** b686c4b6-8e1c-5a80-342c-58c79819e31a
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2017-09-16T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 46 years - Sex: Female - Race: White Reason for Visit: Prenatal visit for normal pregnancy. History of Present Illness: The patient is a 46-year-old female at gestation with an uncomplicated singleton pregnancy. She reports no significant symptoms beyond those expected for normal pregnancy, including mild nausea, fatigue, and breast tenderness. She denies vaginal bleeding, contractions, or any concerning symptoms. She has been compliant with prenatal vitamins and dietary recommendations. Review of Systems: - Gastrointestinal: Mild nausea without vomiting. - Neurological: Occasional headaches, managed with acetaminophen as needed. - Musculoskeletal: Mild back pain, relieved with prenatal yoga and proper posture. - Cardiovascular: No palpitations or edema reported. - Genitourinary: No dysuria or frequency. Physical Examination: - Vital Signs: Blood pressure , heart rate , temperature . - Abdominal Exam: - Uterine fundal height consistent with gestational age. - Fetal anatomy study: Normal findings, no structural anomalies noted. - Auscultation of fetal heart tones: Clear, regular, . - Pelvic Exam: Not performed today. Procedures Performed: 1. Fetal anatomy study (ultrasound) – Normal findings. 2. Alpha-fetoprotein (AFP) test – Antenatal screening performed. 3. Evaluation of uterine fundal height – . 4. Auscultation of fetal heart tones – . Diagnostic Tests: - Alpha-fetoprotein (AFP) test – Results pending. Assessment: 1. Normal pregnancy, weeks. 2. Mild symptoms consistent with normal pregnancy (nausea, fatigue, breast tenderness). Plan: 1. Continue routine prenatal care. 2. Follow up in for next visit. 3. Repeat alpha-fetoprotein results will be reviewed at next visit. 4. Advise patient to maintain a healthy diet, stay hydrated, and report any concerning symptoms (e.g., bleeding, contractions, decreased fetal movement). Signature: ,

============================================================

## Note 33 (undefined - 8e9d3e99-8de9-26ad-d2c5-34bbf3dfbcfd)

**Note ID:** 8e9d3e99-8de9-26ad-d2c5-34bbf3dfbcfd
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2017-10-14T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 46 years - Race: White - Sex: Female - Chief Complaint: Prenatal visit for normal pregnancy. History of Present Illness: The patient presents for a routine prenatal visit. She reports an uneventful pregnancy course to date. She denies any significant symptoms but notes common complaints associated with normal pregnancy, including mild nausea without vomiting, fatigue, increased frequency of urination, and occasional lower back discomfort. No concerning symptoms such as vaginal bleeding, contractions, or decreased fetal movement have been reported. Review of Systems: - Gastrointestinal: Mild nausea, no vomiting. - Genitourinary: Increased urinary frequency, no dysuria or hematuria. - Musculoskeletal: Occasional lower back pain, relieved with rest. - Neurological: Fatigue, no headaches or visual disturbances. - Cardiovascular: No palpitations or edema. - Respiratory: No dyspnea or cough. Physical Examination: - Vital Signs: Blood pressure 118/72 mmHg, heart rate 78 bpm, respiratory rate 16/min, temperature 98.6°F. - Abdominal Exam: Uterine fundal height measured at 24 cm, consistent with gestational age. No tenderness or abnormal masses noted. - Fetal Assessment: Auscultation of fetal heart tones performed with Doppler; fetal heart rate is 140 bpm, regular. Procedures: 1. Uterine Fundal Height Measurement: Performed; measurement is appropriate for 24 weeks gestation. 2. Fetal Heart Auscultation: Performed; fetal heart tones are reassuring. Assessment: - Normal pregnancy, 24 weeks gestation. - Common symptoms of pregnancy noted (nausea, fatigue, back pain, urinary frequency). Plan: 1. Continue routine prenatal care. 2. Advise patient to maintain adequate hydration and nutrition. 3. Recommend pelvic floor exercises to manage urinary frequency. 4. Schedule follow-up in 4 weeks for next prenatal visit. 5. Educate patient on warning signs to report, including vaginal bleeding, decreased fetal movement, or contractions. Signature: ,

============================================================

## Note 34 (undefined - 7cb91e8d-e9a9-9f9b-80fb-9df010090900)

**Note ID:** 7cb91e8d-e9a9-9f9b-80fb-9df010090900
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2017-11-11T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 46 years - Sex: Female - Race: White Encounter Details: - Date: - Time: - Location: - Reason for Visit: Prenatal visit (regime/therapy) for Normal pregnancy History of Present Illness (HPI): The patient is a 46-year-old white female presenting for routine prenatal care. She is currently in her gestation. She reports an uneventful pregnancy course thus far. She denies any active complaints or concerns at this time. However, she notes experiencing common symptoms associated with normal pregnancy, including: - Fatigue - Nausea (mild, resolving) - Breast tenderness - Increased frequency of urination - Mild lower back pain - Mild edema in the lower extremities The patient reports adherence to prenatal vitamins and a healthy diet. She denies smoking, alcohol, or illicit drug use. She reports no history of preterm labor or other high-risk conditions. Review of Systems (ROS): - Constitutional: No fever, chills, or unintended weight loss. - Gastrointestinal: No vomiting, diarrhea, or abdominal pain. - Genitourinary: No dysuria, hematuria, or vaginal discharge. - Musculoskeletal: No severe joint pain or weakness. - Neurological: No headaches, dizziness, or visual changes. - Cardiovascular: No chest pain, palpitations, or shortness of breath. Physical Examination: - Vital Signs: - Blood Pressure: - Heart Rate: - Respiratory Rate: - Temperature: - Weight: - Fundal Height: (consistent with gestational age) - Fetal Heart Rate: (auscultated via Doppler) - Abdominal Exam: Uterine fundal height measured appropriately for gestational age. No contractions noted. Fetal lie appears longitudinal. - Other Systems: - Breast exam: Mild engorgement, no masses. - Extremities: Mild bilateral lower extremity edema, no pitting. - Fundoscopic exam: No papilledema. Procedure(s) Performed: 1. Evaluation of uterine fundal height. 2. Auscultation of the fetal heart rate. Assessment: 1. Normal pregnancy, . 2. Common symptoms consistent with normal pregnancy (fatigue, nausea, breast tenderness, etc.). 3. Fetal growth appropriate for gestational age. Plan: 1. Continue routine prenatal care with follow-up in . 2. Advise patient to maintain hydration and low-sodium diet to manage mild edema. 3. Recommend gentle exercise (e.g., walking) to alleviate back pain. 4. Encourage continuation of prenatal vitamins. 5. Schedule routine labs (e.g., glucose screening, anemia check) as per protocol. 6. Instruct patient to contact provider if symptoms worsen or new concerns arise (e.g., vaginal bleeding, decreased fetal movement, severe headaches). Signature:

============================================================

## Note 35 (undefined - fe91878d-4af0-dd6c-24f0-f0f24f335ccf)

**Note ID:** fe91878d-4af0-dd6c-24f0-f0f24f335ccf
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2017-12-09T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 46 years - Sex: Female - Race: White - Reason for Visit: Prenatal visit (regime/therapy) for normal pregnancy Subjective: The patient is a 46-year-old female at an unspecified gestational age for a routine prenatal visit. She reports no significant complaints, though she may be experiencing common symptoms of normal pregnancy, such as: - Nausea or vomiting (morning sickness) - Fatigue - Breast tenderness - Frequent urination - Mild edema (if present) - Constipation or heartburn - Mood swings (Note: Specific symptoms should be documented if reported by the patient.) Objective: - Vital Signs: (Document if available, e.g., BP, HR, temp) - Hemogram, Automated: - Red blood cells (RBC) count: - White blood cells (WBC) count: - Hemoglobin (Hgb): - Hematocrit (Hct): - Indices (MCV, MCH, MCHC, RDW): - Platelet count: - Manual white blood cell differential: - Vaccination: Administered vaccine containing: - Bordetella pertussis antigen - Clostridium tetani antigen - Corynebacterium diphtheriae antigen - Urine Screening for Glucose: (e.g., Negative/Positive) - Evaluation of Uterine Fundal Height: (consistent with gestational age) - Auscultation of Fetal Heart: (e.g., 140 bpm), normal and reassuring Assessment: - Normal pregnancy at . - Labs and fetal heart tones are within normal limits. - No evidence of anemia, infection, or glucose abnormalities. - Vaccination completed as per prenatal care guidelines. Plan: 1. Continue routine prenatal care with follow-up in . 2. Advise patient to maintain a healthy diet, hydration, and activity level. 3. Counsel on signs of preterm labor or complications to report (e.g., vaginal bleeding, severe headaches, decreased fetal movement). 4. Schedule next prenatal visit and any necessary screenings (e.g., glucose tolerance test, Group B Strep screening). 5. Address any questions or concerns regarding pregnancy symptoms. Signature:

============================================================

## Note 36 (undefined - d0a71e6a-7793-033a-8559-a08bb744166a)

**Note ID:** d0a71e6a-7793-033a-8559-a08bb744166a
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2018-01-06T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 46 years - Sex: Female - Race: White - Chief Complaint: Prenatal visit for normal pregnancy. History of Present Illness: The patient presents for a routine prenatal visit. She reports an uneventful pregnancy thus far. She denies any current complaints but mentions some common symptoms associated with normal pregnancy, including mild nausea (without vomiting), fatigue, and occasional lower back discomfort. She reports no vaginal bleeding, contractions, or leakage of fluid. Past Medical History: - Unspecified (to be updated per patient’s records). Social History: - Denies tobacco, alcohol, or illicit drug use. Medications: - Prenatal vitamins (as prescribed). Allergies: - None reported. Physical Examination: - Vital Signs: Blood pressure: 120/80 mmHg; Heart rate: 80 bpm; Temperature: 98.6°F; - Abdominal Examination: - Uterine fundal height measured at cm, consistent with estimated gestational age. - No tenderness or masses noted. - Fetal Assessment: - Auscultation of fetal heart tones performed using Doppler; heart rate is , with normal rhythm. - Other: No edema noted in extremities; no signs of preterm labor or preeclampsia. Procedures Performed: - Uterine fundal height evaluation. - Auscultation of fetal heart tones. Assessment: - 46-year-old white female with an uncomplicated pregnancy at . Plan: - Continue routine prenatal care. - Advise patient to monitor for any concerning symptoms (e.g., vaginal bleeding, severe headaches, visual changes, or decreased fetal movement). - Schedule next prenatal visit in . - Reinforce importance of attending all prenatal appointments and maintaining a healthy lifestyle. Provider Signature:

============================================================

## Note 37 (undefined - f18082c2-2846-570c-bd6d-af62b0964351)

**Note ID:** f18082c2-2846-570c-bd6d-af62b0964351
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2018-02-03T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 47 years - Race: White - Sex: Female - Reason for Visit: Prenatal visit (regime/therapy) for normal pregnancy History of Present Illness: The patient presents for a routine prenatal visit. She reports an uneventful pregnancy course thus far. She denies any current complaints but notes common symptoms associated with normal pregnancy, including: - Fatigue - Nausea (mild, without vomiting) - Breast tenderness - Increased urination - Mild lower back discomfort She denies any vaginal bleeding, contractions, or leakage of fluid. Review of Systems: - Gastrointestinal: No vomiting, diarrhea, or constipation. - Cardiovascular: No palpitations, chest pain, or edema. - Respiratory: No cough, shortness of breath, or wheezing. - Genitourinary: No dysuria, hematuria, or urinary frequency beyond expected pregnancy changes. - Neurological: No headaches, dizziness, or visual changes. - Musculoskeletal: No significant joint pain or swelling. Physical Examination: - Vital Signs: - Blood pressure: 120/80 mmHg - Heart rate: 80 bpm - Temperature: 98.6°F - Respiratory rate: 16 breaths/min - Oxygen saturation: 98% on room air - Abdominal Exam: - Uterine fundal height: Measured at cm, consistent with gestational age. - No tenderness, masses, or contractions noted. - Fetal Assessment: - Auscultation of fetal heart tones: bpm, reassuring. - Fetal movement: Reported as normal by patient. - Other: - No edema noted in extremities. - Breast exam: Consistent with pregnancy. Procedures Performed: 1. Streptococcus pneumoniae group B antigen assay: Performed to screen for group B streptococcus (GBS) colonization. 2. Evaluation of uterine fundal height: Measured to assess fetal growth and gestational age. 3. Auscultation of fetal heart: Performed to assess fetal well-being. Diagnostic Results: - Group - - Assessment: - Normal pregnancy, . - No immediate concerns identified. Plan: 1. Continue routine prenatal care, including scheduled follow-up visits. 2. Administer appropriate GBS prophylaxis if screening positive later in pregnancy. 3. Advise patient to report any concerning symptoms (e.g., vaginal bleeding, contractions, decreased fetal movement). 4. Provide education on healthy lifestyle, nutrition, and activity recommendations for pregnancy. 5. Schedule next prenatal visit at . Provider Signature:

============================================================

## Note 38 (undefined - 3bd53f30-ade5-b969-63f7-532bbf18b4b4)

**Note ID:** 3bd53f30-ade5-b969-63f7-532bbf18b4b4
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Trinity427 Hartmann983
**Date:** 2018-02-17T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 47 years - Race: White - Sex: Female Reason for Encounter: General examination for assessment of health and social care needs. History of Present Illness: The patient presents for a general examination. No specific complaints are reported at this time. However, given the patient’s current medications (Hydrochlorothiazide and insulin), potential symptoms to monitor include: - Hydrochlorothiazide-related symptoms: Thirst, dizziness, fatigue, muscle cramps, or orthostatic hypotension. - Insulin-related symptoms: Hypoglycemia (shakiness, sweating, confusion, palpitations), hyperglycemia (increased thirst, urination, fatigue), or injection site reactions. Medication Reconciliation: 1. Hydrochlorothiazide 25 MG Oral Tablet – Prescribed for hypertension or fluid retention. - Instructions: Take one tablet orally once daily in the morning with food or milk to minimize gastrointestinal upset. Avoid alcohol and limit sodium intake. Monitor for electrolyte imbalances (e.g., potassium levels). Report any dizziness or severe fatigue. 2. Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension – Prescribed for diabetes management. - Instructions: Administer subcutaneously once or twice daily as prescribed. Rotate injection sites to avoid lipohypertrophy. Take with meals to prevent hypoglycemia. Monitor blood glucose levels regularly. Report any signs of hypoglycemia or hyperglycemia. Procedures Performed: - Medication reconciliation. - Assessment of health and social care needs. Immunizations Administered: - Influenza, seasonal, injectable, preservative-free. Plan: - Continue current medications as prescribed. - Follow up in 1 month for monitoring of blood pressure, blood glucose, and electrolytes. - Educate patient on medication side effects and hypoglycemia management. Physician Signature:

============================================================

## Note 39 (undefined - 5e1b10f7-831b-eed9-c041-7060e8203158)

**Note ID:** 5e1b10f7-831b-eed9-c041-7060e8203158
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2018-02-24T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Fritsch593 - Age: 47 - Gender: Female - Race: White Encounter Type: Check-up Chief Complaint: Check-up for . History of Present Illness: The patient presents for a routine check-up. No acute complaints reported at this time. However, the patient may experience symptoms related to their medical conditions, such as: - Diabetes-related symptoms: Hypoglycemia (e.g., sweating, tremors, confusion, dizziness), hyperglycemia (e.g., increased thirst, urination, fatigue), or diabetic neuropathy (e.g., numbness, tingling in extremities). - Hypertension-related symptoms: Headache, dizziness, or fatigue. - Hydrochlorothiazide-related side effects: Increased urination, electrolyte imbalances (e.g., muscle cramps, weakness), or dehydration. Medications: 1. Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension – For diabetes management. - Instructions: - Administer subcutaneously once or twice daily as prescribed. - Rotate injection sites (e.g., abdomen, thighs, arms) to prevent lipodystrophy. - Take with meals or as directed by the provider. - Monitor blood glucose levels regularly and adjust dosage as needed. - Be aware of signs of hypoglycemia and carry fast-acting carbohydrates (e.g., glucose tablets, juice). 2. Hydrochlorothiazide 25 MG Oral Tablet – For hypertension management. - Instructions: - Take orally once daily, preferably in the morning to reduce nighttime urination. - Ensure adequate fluid intake to prevent dehydration. - Monitor for electrolyte imbalances (e.g., potassium levels) as ordered. - Report symptoms of muscle cramps, weakness, or dizziness. Plan: - Continue current medications with proper adherence. - Monitor blood glucose and blood pressure regularly. - Follow up in for lab work and assessment. - Educate patient on medication side effects and when to seek medical attention. Provider Signature:

============================================================

## Note 40 (undefined - 5a9d1b9e-170f-1760-8d98-66c639231271)

**Note ID:** 5a9d1b9e-170f-1760-8d98-66c639231271
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2018-03-03T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 47 years - Sex: Female - Race: White - Reason for Visit: Prenatal visit (regime/therapy) for Normal pregnancy History of Present Illness: The patient is a 47-year-old female with an uncomplicated pregnancy at the current gestational age. She reports no significant complaints today but may be experiencing common symptoms associated with normal pregnancy, including: - Fatigue - Nausea (with or without vomiting) - Breast tenderness - Frequent urination - Mild lower back pain - Possible heartburn or constipation The patient denies any vaginal bleeding, contractions, or other concerning symptoms. Physical Examination: - Vital Signs: - Blood pressure: - Heart rate: - Temperature: - Weight: - Abdominal Exam: - Uterine fundal height measured at consistent with estimated gestational age. - No tenderness or abnormal masses noted. - Fetal Assessment: - Auscultation of fetal heart tones performed; fetal heart rate (FHR) is , with regular rhythm. - Other Systems: - Breast exam: No masses or discharge. - Pelvic exam: Not performed unless indicated. Procedure(s) Performed: - Evaluation of uterine fundal height. - Auscultation of fetal heart tones. Assessment: - Normal pregnancy, . - No evidence of complications at this time. Plan: 1. Continue routine prenatal care, including folic acid and iron supplementation as previously prescribed. 2. Advise patient to maintain a healthy diet, adequate hydration, and moderate exercise as tolerated. 3. Schedule next prenatal visit in . 4. Counsel patient on recognizing signs of preterm labor or other concerning symptoms (e.g., bleeding, severe pain, decreased fetal movement) and to seek immediate medical attention if they occur. Provider Signature: Date:

============================================================

## Note 41 (undefined - 33c9ee9d-bbf6-4f19-95f0-4e0720fa9198)

**Note ID:** 33c9ee9d-bbf6-4f19-95f0-4e0720fa9198
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2018-03-10T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 47 years - Sex: Female - Race: White Reason for Visit: Prenatal visit for Normal pregnancy. History of Present Illness: The patient is a 47-year-old white female with a normal pregnancy. She reports no significant complaints but notes common symptoms of pregnancy, including: - Fatigue - Nausea without vomiting - Breast tenderness - Increased urinary frequency - Mild lower back discomfort The patient denies any vaginal bleeding, contractions, or leakage of fluid. She reports adherence to prenatal vitamins and a healthy diet. Physical Examination: - Vital Signs: BP 120/80 mmHg, HR 78 bpm, RR 16/min, Temp 98.6°F, Fetal Heart Rate (FHR) 140 bpm. - Abdominal Exam: - Uterine Fundal Height: Measured at cm, consistent with gestational age. - Auscultation of Fetal Heart: FHR is within normal limits (110-160 bpm). - No uterine tenderness or contractions noted. - Other Systems: - Breast exam: Mild engorgement, no masses or discharge. - Pelvic exam: No cervical motion tenderness, closed cervix. Procedures Performed: - Uterine fundal height evaluation. - Auscultation of fetal heart tones. Assessment: - Normal pregnancy, . - Common symptoms of pregnancy are present but not concerning. Plan: 1. Continue routine prenatal care with follow-up in . 2. Advise patient to maintain a balanced diet, adequate hydration, and moderate exercise. 3. Counsel on signs of preterm labor (e.g., contractions, bleeding, fluid leakage) and when to seek immediate medical attention. 4. Schedule next ultrasound if not already scheduled. Provider Signature:

============================================================

## Note 42 (undefined - 13bc5b19-f1e7-74e1-09de-c1108837b909)

**Note ID:** 13bc5b19-f1e7-74e1-09de-c1108837b909
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Cherrie404 Conn188
**Date:** 2018-03-17T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 47 years - Race: White - Sex: Female Reason for Encounter: Obstetric emergency hospital admission for normal pregnancy. History of Present Illness: The patient, a 47-year-old white female, presented to the hospital for admission following spontaneous human parturition. The pregnancy was reported as normal, with no significant complications noted during prenatal care. The patient reported symptoms consistent with normal pregnancy, including: - Fatigue: Common during pregnancy due to hormonal changes and increased energy demands. - Nausea and vomiting (morning sickness): Typical in early pregnancy, often resolving by the second trimester. - Breast tenderness and enlargement: Hormonally mediated changes preparing for lactation. - Frequent urination: Due to increased blood volume and pressure on the bladder from the expanding uterus. - Abdominal discomfort and Braxton Hicks contractions: Mild uterine irritability, often resolving with hydration and rest. - Varicose veins or hemorrhoids: Due to increased venous pressure from the gravid uterus. Procedure Performed: - Human parturition (vaginal delivery): The patient underwent spontaneous vaginal delivery without reported complications. Physical Examination: - Vital Signs: Stable (BP, HR, RR, SpO2 within normal limits). - Abdominal: Uterus contracted appropriately postpartum; no evidence of retained placental fragments. - Perineal: No lacerations or significant trauma noted. - Fundal Height: Appropriately descended postpartum. Laboratory and Imaging: - No significant abnormalities reported; routine postpartum labs (e.g., CBC, coagulation studies) were within normal limits. Differential Diagnosis: - Normal postpartum course. - Rule out postpartum hemorrhage, infection, or other obstetric complications (negative findings). Plan: - Continue routine postpartum monitoring (e.g., vital signs, lochia assessment, uterine tone). - Provide pain management as needed (e.g., acetaminophen). - Encourage ambulation, hydration, and breastfeeding support if applicable. - Schedule follow-up with OB/GYN for postpartum care. Disposition: - Admitted to postpartum unit for observation. - Expected course: Routine postpartum recovery. Signature: ,

============================================================

## Note 43 (undefined - 20a508b4-1e45-43ce-0ce9-d4a14ae5cc1e)

**Note ID:** 20a508b4-1e45-43ce-0ce9-d4a14ae5cc1e
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2018-04-28T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 47 years - Sex: Female - Race: White Reason for Visit: Postnatal visit (regime/therapy) for . History of Present Illness: The patient presents for a postnatal follow-up evaluation. She reports . She denies . Symptoms Possibly Caused By : - Fatigue or exhaustion - Mood swings or irritability - Difficulty sleeping (insomnia or fragmented sleep) - Changes in appetite (e.g., increased or decreased) - Headaches or muscle aches - Anxiety or excessive worrying Physical Examination: - Vitals: - General: - Abdomen: - Pelvic: - Breast: - Other: Depression Screening: Completed . Patient scored , indicating . She reports . Assessment/Diagnosis: - Postpartum recovery in progress - Possible postpartum mood disorder (e.g., postpartum depression, anxiety) - Plan: 1. Education: Provided counseling on postpartum recovery expectations, self-care, and signs of concern. 2. Mood 3. Symptom 4. Follow-Up: Schedule next visit in to reassess symptoms and adjust treatment as needed. 5. Support: Encourage support from family, friends, or support groups. Disposition: Patient discharged in stable condition. Advised to seek immediate care if experiencing severe symptoms (e.g., suicidal ideation, inability to care for self or infant). Provider Signature:

============================================================

## Note 44 (undefined - c33e80ff-0c92-df78-5b18-da401d32b802)

**Note ID:** c33e80ff-0c92-df78-5b18-da401d32b802
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Trinity427 Hartmann983
**Date:** 2019-02-23T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 48 years - Sex: Female - Race: White Reason for Encounter: General examination and health assessment. History of Present Illness: The patient presents for a general examination. No specific chief complaint was reported, but the patient is currently prescribed insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension for diabetes management. Symptoms that may be caused by diabetes or its treatment include: - Hypoglycemia (e.g., sweating, tremors, confusion, dizziness) - Hyperglycemia (e.g., increased thirst, frequent urination, fatigue) - Weight changes - Edema (possible side effect of Hydrochlorothiazide) Medications: 1. Insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension - Instructions: Administer subcutaneously once daily, typically before breakfast or dinner. Rotate injection sites to prevent lipodystrophy. Do not shake vigorously; gently roll the vial between palms if needed. Monitor blood glucose levels regularly to adjust dosing as needed. 2. Hydrochlorothiazide 25 MG Oral Tablet - Instructions: Take one tablet orally once daily, preferably in the morning. Stay well-hydrated and monitor for electrolyte imbalances (e.g., low potassium). Avoid excessive sun exposure due to photosensitivity risk. Procedures Performed: - Assessment of health and social care needs - Assessment of anxiety - Depression screening (multiple screenings, including PHQ-9) - Assessment of substance use - Screening for drug abuse Immunizations: - Influenza, seasonal, injectable, preservative-free (administered today) Assessment: The patient appears stable but requires ongoing monitoring for diabetes management, blood pressure control, and mental health screening. Plan: - Continue current medications with proper adherence. - Follow up in 3 months for diabetes and blood pressure checks. - Repeat depression screening if symptoms worsen. - Encourage lifestyle modifications (diet, exercise) to optimize glycemic and blood pressure control. Signature: ,

============================================================

## Note 45 (undefined - 2fdf1e16-872a-14a4-c3f0-28140fc39249)

**Note ID:** 2fdf1e16-872a-14a4-c3f0-28140fc39249
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2019-05-04T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Fritsch593 - Age: 48 years - Sex: Female - Race: White Reason for Encounter: Routine check-up. History of Present Illness: The patient presented for a routine check-up. No specific complaints were reported at this time. The patient is currently managing diabetes mellitus and hypertension, for which they were prescribed insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension and Hydrochlorothiazide 25 MG Oral Tablet. Review of Systems: - Endocrine: No reported symptoms of hypoglycemia (e.g., sweating, tremors, confusion) or hyperglycemia (e.g., increased thirst, frequent urination). - Cardiovascular: No reported chest pain, palpitations, or edema. - Psychiatric: The patient underwent assessment for anxiety and depression screening. No significant symptoms were reported, but ongoing monitoring is advised. - Substance Use: The patient underwent screening for drug abuse and substance use. No concerning findings were noted. Physical Examination: - General: Alert and oriented ×3. - Cardiovascular: Regular rate and rhythm, no murmurs. - Abdominal: Soft, non-tender, no organomegaly. - Neurological: Grossly intact. Assessment: 1. Diabetes Mellitus: Continuation of insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension . 2. Hypertension: Continuation of Hydrochlorothiazide 25 MG Oral Tablet. 3. Mental Health: Negative screening for anxiety and depression; continue monitoring. 4. Substance Use: Negative screening; no concerns noted. Plan: 1. Medications: - Insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension : - Take subcutaneously once daily, usually in the morning or as directed by the provider. - Rotate injection sites (e.g., abdomen, thigh, upper arm) to prevent lipodystrophy. - Administer 15-30 minutes before breakfast or as advised. - Monitor blood glucose levels regularly to adjust dosing as needed. - Symptoms of hypoglycemia (low blood sugar): Sweating, tremors, confusion, dizziness, hunger. If these occur, consume 15-20 grams of fast-acting carbohydrates (e.g., glucose tablets, juice). - Hydrochlorothiazide 25 MG Oral Tablet: - Take orally once daily, preferably in the morning to minimize nighttime urination. - Ensure adequate fluid intake to prevent dehydration. - Monitor for symptoms of electrolyte imbalances (e.g., muscle cramps, weakness, fatigue). 2. Follow-Up: - Return in 3 months for repeat blood work (HbA1c, renal function, electrolytes). - Continue regular blood pressure and blood glucose monitoring at home. 3. Education: - Reinforce the importance of adherence to medication regimens. - Encourage a balanced diet and regular physical activity to manage diabetes and hypertension. Provider Signature:

============================================================

## Note 46 (undefined - e5aa7a6e-8eef-916e-d2d7-1af6dedbd63a)

**Note ID:** e5aa7a6e-8eef-916e-d2d7-1af6dedbd63a
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2019-05-11T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 48 - Sex: Female - Race: White Chief Complaint: Patient presents with symptoms concerning for sinusitis. History of Present Illness: The patient reports a progressive onset of symptoms over the past days, consistent with acute sinusitis. She describes the following: - Facial pain/pressure: Reports dull, aching pain over the maxillary and/or frontal sinuses, worse with bending forward. - Nasal congestion: Difficulty breathing through the nose, with reduced airflow bilaterally. - Purulent nasal discharge: Describes thick, yellowish or greenish discharge. - Decreased sense of smell: Subjective loss or hyposmia. - Headache: Reports frontal or periorbital headaches, often worse in the morning. - Fatigue: Generalized malaise and lack of energy. - Cough: Post-nasal drip-induced cough, worse at night. - Fever: Reports low-grade fever (if applicable). - Tooth pain: Possible referred pain to upper molars (if applicable). No recent history of trauma, swimming, or sinus procedures. No known allergies to medications. Review of Systems: - No photophobia or neck stiffness. - No ear pain or hearing changes. - No visual disturbances. - No significant change in appetite or weight. Physical Examination: - General: Alert and oriented, appears fatigued. - HEENT: - Conjunctiva: Clear, no injection. - Ears: Tympanic membranes intact, no fluid. - Nose: Mucosa erythematous, with purulent discharge noted upon anterior rhinoscopy. - Sinuses: Tenderness over maxillary and/or frontal sinuses upon palpation. - Throat: Mild erythema, no exudate. - Vital Assessment: 1. Acute bacterial sinusitis – Likely diagnosis given duration of symptoms, purulent discharge, and facial pain. 2. Viral upper respiratory infection – Cannot rule out, but bacterial component suspected. Plan: 1. Pharmacotherapy: - Antibiotic: Amoxicillin-clavulanate 875/125 mg PO BID x 10-14 days (or alternative based on local resistance patterns/allergies). - Nasal corticosteroid: Fluticasone or equivalent 1 spray per nostril BID. - Analgesia: Acetaminophen or ibuprofen for pain/fever. 2. Supportive care: - Saline nasal rinses (e.g., neti pot or squeeze bottle) BID. - Adequate hydration. 3. Follow-up: Re-evaluate in days if no improvement or worsening symptoms. 4. Referral: Consider ENT consult if symptoms persist or complications arise. Disposition: Patient to follow plan, advised to return if fever >101°F, severe headache, or vision changes. Provider Signature:

============================================================

## Note 47 (undefined - 43af0a25-ebdb-27a2-1c38-a200451c3842)

**Note ID:** 43af0a25-ebdb-27a2-1c38-a200451c3842
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Zane918 Bosco882
**Date:** 2019-05-18T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 48 years - Sex: Female - Race: White - Encounter Type: Urgent Care Clinic Reason for Visit: Patient presented to the urgent care clinic for medication reconciliation and assessment of health and social care needs. Medication Reconciliation: - Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension : - Instructions: Administer subcutaneously once daily, typically at the same time each day (e.g., before breakfast or dinner). Rotate injection sites (abdomen, thigh, upper arm, or buttocks) to avoid lipodystrophy. Do not shake the vial; gently roll between palms if needed. Monitor blood glucose levels before meals and at bedtime. Adjust dosage as prescribed by the primary care physician. - Hydrochlorothiazide 25 MG Oral Tablet : - Instructions: Take one tablet orally once daily in the morning. Hydrate adequately (8-10 glasses of water daily). Monitor for signs of electrolyte imbalances (e.g., muscle cramps, fatigue, dizziness). Avoid alcohol and potassium-depleting foods. Assessments and Screenings Performed: - Assessment of health and social care needs. - Assessment of anxiety. - Screening for domestic abuse. - Depression screening (performed twice). - Assessment of substance use. - Assessment using Alcohol Use Disorders Identification Test - Consumption (AUDIT-C). Symptoms Possibly Related to Medications: - Insulin-related symptoms: Hypoglycemia (e.g., sweating, tremors, confusion, dizziness) may occur if doses are not timed correctly with meals. Hyperglycemia (e.g., increased thirst, urination, fatigue) may occur if doses are insufficient. - Hydrochlorothiazide-related symptoms: Dizziness, lightheadedness, or electrolyte imbalances (e.g., hypokalemia, hyponatremia) may occur. Orthostatic hypotension (dizziness upon standing) is possible. Plan: - Continue prescribed medications as directed. - Follow up with primary care physician for ongoing management of diabetes and hypertension. - Schedule further counseling if anxiety, depression, or substance use concerns are identified. - Refer to social services if domestic abuse or social care needs are confirmed. Provider Signature:

============================================================

## Note 48 (undefined - 29ae8898-0db8-cf19-8bd4-e80172bd1198)

**Note ID:** 29ae8898-0db8-cf19-8bd4-e80172bd1198
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2019-06-01T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 48 years - Sex: Female - Race: White Encounter Details: - Date: - Reason for Visit: Routine check-up Medication Reconciliation: - Insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension - Hydrochlorothiazide 25 MG Oral Tablet Procedures Performed: - Medication reconciliation - Assessment of health and social care needs - Assessment of substance use - Alcohol Use Disorders Identification Test (AUDIT-C) Assessment: The patient was assessed for symptoms that may be caused by underlying conditions, including diabetes mellitus (likely type 2, given the use of insulin) and hypertension (treated with hydrochlorothiazide). No acute complaints were reported. Symptoms to Monitor: - Hypoglycemia (dizziness, sweating, confusion, weakness) – possible side effect of insulin therapy. - Hyperglycemia (increased thirst, frequent urination, fatigue) – possible if insulin dose is inadequate. - Hypotension (dizziness, lightheadedness) – possible side effect of hydrochlorothiazide. - Electrolyte imbalances (e.g., hyponatremia, hypokalemia) – possible with diuretic use. Medication Instructions: 1. Insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension : - Take as prescribed, typically subcutaneously once or twice daily. - Rotate injection sites to avoid lipodystrophy. - Administer before meals, as directed by the provider. - Monitor blood glucose levels regularly to adjust doses as needed. - Store unopened vials in the refrigerator; keep opened vials at room temperature (do not refrigerate). 2. Hydrochlorothiazide 25 MG Oral Tablet: - Take once daily, preferably in the morning to reduce nighttime urination. - Take with food or milk to minimize gastrointestinal upset. - Ensure adequate fluid intake to prevent dehydration. - Avoid alcohol, as it may increase the risk of dizziness or electrolyte imbalances. Follow-Up: - Schedule a follow-up appointment in to reassess blood glucose control and blood pressure. - Monitor for any adverse effects and report them to the provider. Plan: - Continue current medications as prescribed. - Reinforce lifestyle modifications (e.g., diet, exercise) to optimize glycemic and blood pressure control. - Encourage smoking cessation and moderation of alcohol intake if applicable. Provider Signature:

============================================================

## Note 49 (undefined - 7b7c8719-cdea-1da2-e080-c99930107d0b)

**Note ID:** 7b7c8719-cdea-1da2-e080-c99930107d0b
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Zane918 Bosco882
**Date:** 2019-06-15T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 48 years - Race: White - Sex: Female Encounter: Urgent Care Clinic Reason for Visit: Patient presented for medication reconciliation and assessment of health and social care needs. Medication Reconciliation: - Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension - Hydrochlorothiazide 25 MG Oral Tablet Assessments Performed: - Comprehensive health and social care needs assessment. - Depression screening (performed twice). - Assessment of substance use. - Alcohol Use Disorders Identification Test - Consumption (AUDIT-C). - Referral for dental care procedure(s) performed. Symptoms: The patient may present with symptoms related to diabetes mellitus (e.g., hyperglycemia, polyuria, polydipsia) or hypertension (e.g., headache, fatigue, dizziness). Additionally, symptoms of depression or substance use may be present, though further evaluation is needed. Medication Instructions: 1. Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension : - Administer subcutaneously once daily, preferably at the same time each day. - Rotate injection sites to prevent lipodystrophy. - Store unopened vials in the refrigerator; once opened, keep at room temperature for up to 28 days. - Monitor blood glucose levels regularly and adjust dose as needed under medical supervision. - May cause hypoglycemia (symptoms include sweating, tremors, confusion); carry fast-acting carbohydrates (e.g., glucose tablets, juice) at all times. 2. Hydrochlorothiazide 25 MG Oral Tablet: - Take one tablet orally once daily, preferably in the morning with food or milk to minimize gastrointestinal upset. - May cause electrolyte imbalances (e.g., hyponatremia, hypokalemia); monitor for symptoms such as muscle cramps, weakness, or fatigue. - Increase fluid intake and maintain a balanced diet. Follow-Up: - Schedule follow-up with primary care physician for ongoing management of diabetes and hypertension. - Follow up with mental health provider for depression screening results. - Proceed with dental referral as indicated. Provider Signature: Date:

============================================================

## Note 50 (undefined - 696f7f32-7808-56a0-7c9f-33e4fa299651)

**Note ID:** 696f7f32-7808-56a0-7c9f-33e4fa299651
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Zane918 Bosco882
**Date:** 2019-06-22T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Fritsch593 - Age: 48 y/o - Race: White female - Location: Urgent Care Clinic Reason for Visit: Patient presented to the urgent care clinic for medication reconciliation and management of underlying conditions. History of Present Illness: The patient was prescribed the following medications due to uncontrolled blood glucose levels and hypertension. She reported symptoms that may be related to hyperglycemia, including increased thirst, frequent urination, fatigue, and blurred vision. Additionally, she may experience symptoms of hypoglycemia (e.g., sweating, tremors, confusion) if her blood sugar drops too low, particularly with insulin therapy. Medication Reconciliation: 1. Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension - Indication: Management of diabetes mellitus. - Dosage & Administration: - Administer subcutaneously once or twice daily, as prescribed. - Rotate injection sites (abdomen, thighs, upper arms, or buttocks) to prevent lipodystrophy. - Take at the same time(s) daily, typically with breakfast and dinner or as directed by the provider. - Monitor blood glucose levels before meals and at bedtime. - May require dose adjustments based on blood sugar readings, activity level, and meals. - Instructions: - Store unopened vials in the refrigerator; do not freeze. - Once in use, store at room temperature (do not refrigerate) and discard after 28 days. - Do not shake the vial; gently roll between palms to mix. - Side Effects: Hypoglycemia, injection site reactions, weight gain. 2. Hydrochlorothiazide 25 MG Oral Tablet - Indication: Management of hypertension. - Dosage & Administration: - Take one tablet orally once daily, preferably in the morning. - May be taken with or without food. - Instructions: - Ensure adequate fluid intake to prevent dehydration. - Monitor for electrolyte imbalances (e.g., low potassium). - Side Effects: Dizziness, increased urination, electrolyte abnormalities, photosensitivity. Plan: - Continue current medications as prescribed. - Educate patient on proper insulin administration, blood glucose monitoring, and recognition of hypoglycemia. - Schedule follow-up with primary care provider for further management and medication adjustments. - Encourage dietary modifications and regular exercise to improve glycemic and blood pressure control. Provider Signature:

============================================================

## Note 51 (undefined - dadc233d-9006-1765-1d5b-8563ef6f7c6a)

**Note ID:** dadc233d-9006-1765-1d5b-8563ef6f7c6a
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2019-06-29T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593
- Age: 48 years
- Gender: Female
- Race: White Encounter Date: Reason for Visit: Routine check-up. History of Present Illness: The patient presents for a routine check-up. She reports no specific complaints at this time. However, during the assessment, it was noted that the patient may be experiencing symptoms such as fatigue, increased thirst, and frequent urination, which could be related to her diabetes management. Additionally, the patient was screened for anxiety and depression, and while she denies significant symptoms, it is important to monitor her mental health given her medical history. Past Medical History: - Diabetes Mellitus Type 2
- Hypertension Medications: 1. Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension 2. Hydrochlorothiazide 25 MG Oral Tablet Medication Reconciliation: The patient's current medications were reviewed and reconciled. She was prescribed the above medications for her diabetes and hypertension. Assessment of Health and Social Care Needs: The patient's overall health and social care needs were assessed. She expressed concerns about managing her diabetes and hypertension effectively. She was also referred for dental care due to reported dental issues. Assessment of Anxiety and Depression: The patient was assessed for anxiety and depression. She denies significant symptoms at this time but will be monitored for any changes in her mental health. Depression Screening: The patient underwent a depression screening, which was negative. However, she will continue to be monitored for any signs of depression. Assessment of Substance Use and Screening for Drug Abuse: The patient was assessed for substance use and screened for drug abuse. She denied any substance use or drug abuse. Referral for Dental Care: The patient was referred for dental care due to reported dental issues. A dental procedure may be required to address these concerns. Plan: 1. Continue current medications as prescribed.
2. Monitor blood glucose levels and blood pressure regularly.
3. Follow up with dental care for the recommended procedure(s).
4. Schedule a follow-up appointment in to assess the patient's progress and make any necessary adjustments to her treatment plan. Instructions for Medications: 1. Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension : - Take as directed by your healthcare provider. - Inject subcutaneously once daily, preferably at the same time each day. - Rotate injection sites to prevent lipodystrophy. - Monitor blood glucose levels regularly to adjust dosage as needed. - Be aware of symptoms of hypoglycemia (e.g., shakiness, sweating, confusion) and have a source of glucose readily available. 2. Hydrochlorothiazide 25 MG Oral Tablet: - Take one tablet by mouth once daily, preferably in the morning. - Take with or without food. - Be aware of potential side effects such as dizziness, increased urination, and electrolyte imbalances. - Monitor blood pressure regularly. Follow-Up: The patient will follow up in to assess her progress and make any necessary adjustments to her treatment plan. She will also follow up with the dental care provider for the recommended procedure(s). Physician Signature:

============================================================

## Note 52 (undefined - 7ce21d17-466f-1bf3-10f3-2714cf089999)

**Note ID:** 7ce21d17-466f-1bf3-10f3-2714cf089999
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2019-07-06T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 48 years - Sex: Female - Race: White Reason for Encounter: Routine check-up for Gingivitis. History of Present Illness: The patient presents with symptoms consistent with Gingivitis, including: - Redness, swelling, and tenderness of the gingivae - Bleeding gums, especially during brushing or flossing - Bad breath (halitosis) - Gums that pull away slightly from the teeth (mild recession) The patient reports no systemic symptoms or signs of periodontitis at this time. Dental Consultation & Findings: - Dental consultation and report completed. - Examination of gingivae revealed generalized mild-to-moderate inflammation with bleeding on probing. - Supragingival and subgingival plaque and calculus were noted on all teeth. - Dental plain x-ray (bitewing) showed no evidence of bone loss or periodontal pocketing at this time. Procedures Performed: 1. Removal of supragingival plaque and calculus from all teeth using dental instruments. 2. Removal of subgingival plaque and calculus from all teeth using dental instruments. 3. Dental fluoride treatment applied. 4. Oral health education provided, including proper brushing and flossing techniques. 5. Prescribed sodium fluoride 0.0272 MG/MG Oral Gel for home use. Prescription Instructions: - Medication: Sodium fluoride 0.0272 MG/MG Oral Gel - Dosage: Apply a thin ribbon of gel to all tooth surfaces using a toothbrush or fluoride applicator. - Frequency: Once daily before bedtime, after brushing. - Duration: Use for 30 days, then reassess at the next dental visit. - Precautions: - Do not rinse, eat, or drink for at least 30 minutes after application. - Do not swallow the gel; spit out any excess. - If accidental ingestion occurs, contact the office or seek medical advice. - Store at room temperature, away from children. Plan: - Follow up in 3 months for re-evaluation of gingival health. - Continue with excellent oral hygiene practices, including daily brushing, flossing, and use of the prescribed fluoride gel. Provider Signature:

============================================================

## Note 53 (undefined - c9418b75-25fc-4a4c-7bc3-acb4d70f7a01)

**Note ID:** c9418b75-25fc-4a4c-7bc3-acb4d70f7a01
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Zane918 Bosco882
**Date:** 2019-07-20T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 48 years - Gender: Female - Race: White Encounter Details: - Date: - Location: Urgent Care Clinic - Reason for Visit: Chief Complaint: History of Present Illness: The patient reports . She mentions that these symptoms may be related to her current medications or underlying conditions. The patient also reports . Medication Reconciliation: - Insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension - Hydrochlorothiazide 25 MG Oral Tablet Assessments Performed: - Assessment of health and social care needs - Assessment of anxiety - Depression screening (multiple screenings performed, including using the Patient Health Questionnaire-9 ) - Assessment of substance use - Screening for drug abuse Findings: - The patient’s PHQ-9 score indicates . - No significant findings related to substance use or drug abuse. - The patient’s blood pressure and blood glucose levels were reviewed, and adjustments to medication may be necessary. Symptoms Possibly Caused By Medications: - Insulin-related symptoms: Hypoglycemia (dizziness, sweating, confusion), weight gain, or localized skin reactions at injection sites. - Hydrochlorothiazide-related symptoms: Increased urination, electrolyte imbalances (e.g., low potassium), dizziness, or dehydration. - Mood-related symptoms: Anxiety or depressive symptoms may be exacerbated by underlying conditions or medication side effects. Instructions for Medications: 1. Insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension : - Administer subcutaneously once daily, typically in the morning. - Rotate injection sites to avoid lipodystrophy. - Monitor blood glucose levels before meals and at bedtime. - Do not mix with other insulins in the same syringe. - Store unopened vials in the refrigerator; keep opened vials at room temperature (do not refrigerate). 2. Hydrochlorothiazide 25 MG Oral Tablet: - Take one tablet by mouth once daily, preferably in the morning. - Ensure adequate fluid intake to prevent dehydration. - Avoid alcohol and diuretic foods (e.g., caffeine) to prevent electrolyte imbalances. Plan: - Follow up with primary care physician for further evaluation of mood symptoms and medication adjustments. - Continue monitoring blood glucose and blood pressure at home. - Consider referral to a mental health specialist if depressive symptoms worsen. - Educate patient on recognizing signs of hypoglycemia and when to seek urgent care. Provider Signature:

============================================================

## Note 54 (undefined - d1a14468-e4a2-fedc-15c9-3a8b4a99952d)

**Note ID:** d1a14468-e4a2-fedc-15c9-3a8b4a99952d
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2019-07-27T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Fritsch593
- Age: 48 years
- Gender: Female
- Race: White Encounter Details: - Date of encounter: - Reason for encounter: Check-up Medical History: - No significant medical history reported. Medications Prescribed: 1. Insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension 2. Hydrochlorothiazide 25 MG Oral Tablet Immunizations Given: - Influenza, seasonal, injectable, preservative free Symptoms: - No specific symptoms reported by the patient. However, potential symptoms to monitor for include: - Hypoglycemia (low blood sugar) such as shakiness, confusion, sweating, and rapid heartbeat, which may be caused by the insulin therapy. - Hyperglycemia (high blood sugar) such as increased thirst, frequent urination, and fatigue, which may also be related to insulin therapy. - Electrolyte imbalances such as low potassium levels, which may be caused by Hydrochlorothiazide. Instructions for Medications: 1. Insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension : - Take this medication as prescribed by your healthcare provider. - Inject subcutaneously (under the skin) at the same time each day. - Rotate injection sites to prevent skin problems. - Monitor blood sugar levels regularly as advised by your healthcare provider. - Be aware of the signs of hypoglycemia and have a source of glucose readily available. - Do not shake the insulin suspension vigorously; gently roll the vial between your hands to mix. 2. Hydrochlorothiazide 25 MG Oral Tablet: - Take one tablet by mouth once daily, preferably in the morning. - Take with or without food, but try to take it at the same time each day. - Drink plenty of fluids to prevent dehydration. - Be aware of the signs of electrolyte imbalances and contact your healthcare provider if you experience muscle cramps, weakness, or irregular heartbeat. Follow-Up: - Schedule a follow-up appointment with your healthcare provider as advised to monitor the effectiveness of the medications and address any concerns. Immunizations: - The patient received the seasonal influenza vaccine. Monitor for any signs of reaction such as fever, redness, or swelling at the injection site. Contact your healthcare provider if any severe reactions occur. Disclaimer: This medical note is for informational purposes only and should not be considered as medical advice. Always consult with a qualified healthcare professional for any medical concerns or questions.

============================================================

## Note 55 (undefined - 764faef4-4233-f934-4058-33f30680b807)

**Note ID:** 764faef4-4233-f934-4058-33f30680b807
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2019-09-14T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 48 - Sex: Female - Race: White Encounter Date: Reason for Visit: Routine check-up. ### History of Present Illness (HPI): The patient presents for a routine check-up. She reports no acute symptoms at this time. However, she may be experiencing symptoms related to her underlying conditions, such as: - Hyperglycemia (due to diabetes mellitus, possibly leading to fatigue, increased thirst, or frequent urination). - Hypertension (due to uncontrolled blood pressure, possibly causing headaches, dizziness, or shortness of breath). - Anxiety or depression (as noted on screening, which may manifest as mood changes, sleep disturbances, or lack of energy). - Substance use concerns (as noted on screening, though no specific symptoms reported). ### Review of Systems: - Endocrine: No new symptoms of hyperglycemia or hypoglycemia. - Cardiovascular: No chest pain, palpitations, or edema. - Psychiatric: Reports mild anxiety and depressive symptoms. - Other: No new complaints. ### Medication Reconciliation & Prescriptions: 1. Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension (70/30 insulin mix): - Instructions: Administer subcutaneously once daily, preferably in the morning with breakfast. Rotate injection sites (e.g., abdomen, thighs, arms) to prevent lipodystrophy. Monitor blood glucose levels before meals and at bedtime. Adjust dose as needed based on blood glucose readings. Do not shake vigorously; gently roll the vial between palms if cloudy. - Symptoms to Monitor: Hypoglycemia (shakiness, sweating, confusion, rapid heartbeat) or hyperglycemia (increased thirst, fatigue). 2. Hydrochlorothiazide 25 MG Oral Tablet: - Instructions: Take one tablet by mouth daily, preferably in the morning with food. Increase fluid intake to prevent dehydration. Avoid alcohol, as it may worsen dizziness. - Symptoms to Monitor: Dizziness, dehydration, electrolyte imbalances (e.g., muscle cramps, weakness). ### Assessments & Screenings Performed: - Medication reconciliation. - Assessment of health and social care needs. - Anxiety screening (positive for mild symptoms). - Domestic abuse screening (negative). - Depression screening (positive for mild symptoms). - Substance use assessment (screening indicated further evaluation needed). - Dental care referral for upcoming procedure(s). ### Plan: - Continue current medications with close monitoring. - Refer to mental health specialist for anxiety and depression management. - Follow up with primary care in 1 month for blood glucose and blood pressure checks. - Schedule dental appointment as needed. ### Discharge Instructions: - Monitor blood glucose and blood pressure regularly. - Report any signs of hypoglycemia, hyperglycemia, or electrolyte imbalances. - Follow up with mental health provider for anxiety/depression management. - Adhere to dental referral for oral health care. Provider Signature:

============================================================

## Note 56 (undefined - 0e3c7737-1319-1797-905d-b6e82648cc49)

**Note ID:** 0e3c7737-1319-1797-905d-b6e82648cc49
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2019-09-28T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593
- Age: 48 years old
- Gender: Female
- Race: White Reason for Encounter: - Check-up for Gingivitis History of Present Illness: The patient presents for a check-up regarding Gingivitis. She reports experiencing symptoms commonly associated with Gingivitis, which may include:
- Red, swollen, or tender gums
- Gums that bleed easily during brushing or flossing
- Persistent bad breath (halitosis)
- Gums that have pulled away from the teeth (recession)
- Loose teeth or a change in bite Clinical Findings: - Dental consultation and report were conducted.
- Dental care regime/therapy was initiated.
- Supragingival plaque and calculus were removed from all teeth using dental instruments.
- Subgingival plaque and calculus were removed from all teeth using dental instruments.
- Dental plain x-ray (bitewing) was performed to assess the extent of any bone loss or decay.
- Examination of gingivae revealed signs of inflammation consistent with Gingivitis.
- Dental fluoride treatment was administered to help strengthen teeth and prevent further decay.
- Oral health education procedures were performed to educate the patient on proper oral hygiene practices. Prescription: - Sodium Fluoride 0.0272 MG/MG Oral Gel was prescribed. Instructions for Taking Sodium Fluoride 0.0272 MG/MG Oral Gel: 1. Apply a small amount of the gel to a toothbrush.
2. Brush teeth thoroughly for at least one minute, ensuring all tooth surfaces are covered.
3. Spit out the gel after brushing; do not swallow it.
4. Do not eat, drink, or rinse your mouth for at least 30 minutes after applying the gel to allow it to work effectively.
5. Use the gel as directed by your dentist or healthcare provider, typically once daily before bedtime, unless otherwise specified. Plan: - Continue with the prescribed dental care regime/therapy.
- Schedule follow-up appointments as recommended by the dentist to monitor the condition and ensure proper healing.
- Maintain good oral hygiene practices, including regular brushing and flossing, to prevent the recurrence of Gingivitis. Disclaimer: This note is for informational purposes only and should not be considered as medical advice. Always consult with a qualified healthcare professional for diagnosis and treatment.

============================================================

## Note 57 (undefined - 2e27e0f5-1f68-4cbf-978c-e5379eca731e)

**Note ID:** 2e27e0f5-1f68-4cbf-978c-e5379eca731e
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2020-01-11T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 49 years - Gender: Female - Race: White Encounter Details: - Date: - Reason for Visit: Routine check-up. History of Present Illness: The patient presented for a routine check-up. No specific complaints were reported at this time. However, the patient has a history of diabetes mellitus and hypertension, for which she is currently prescribed insulin and hydrochlorothiazide. Assessments Performed: 1. Assessment of Health and Social Care Needs: Evaluated the patient’s overall health status and identified any unmet social or care needs. 2. Assessment of Substance Use: Screened for any substance use or abuse. 3. Alcohol Use Disorders Identification Test (AUDIT-C): Performed to assess alcohol consumption patterns. Symptoms to Monitor: - The patient should be monitored for symptoms of hypoglycemia (e.g., sweating, tremors, confusion, dizziness) due to insulin therapy. - Symptoms of hyperglycemia (e.g., increased thirst, frequent urination, fatigue) should also be monitored. - Monitor for signs of electrolyte imbalances (e.g., weakness, fatigue, dizziness) due to hydrochlorothiazide. Medications Prescribed: 1. Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension : - Dosage: units subcutaneously. - Instructions: Administer subcutaneously once daily, typically at the same time each day (e.g., before breakfast). Rotate injection sites to prevent lipodystrophy. Do not shake the vial; gently roll it between palms to mix. Monitor blood glucose levels regularly and adjust dosage as needed. - Side Effects: Hypoglycemia, injection site reactions. 2. Hydrochlorothiazide 25 MG Oral Tablet: - Dosage: 25 mg orally once daily. - Instructions: Take in the morning to minimize nighttime urination. Ensure adequate fluid intake. Avoid excessive sun exposure due to photosensitivity risk. - Side Effects: Electrolyte imbalances, dizziness, increased urination. Plan: - Continue current medications with close monitoring. - Schedule follow-up in for medication review and lab work. - Encourage lifestyle modifications, including a balanced diet and regular exercise. - Refer to a diabetes educator if needed for further education on insulin management. Provider Signature:

============================================================

## Note 58 (undefined - ce66c9af-144c-9364-198e-ebc30f5dc660)

**Note ID:** ce66c9af-144c-9364-198e-ebc30f5dc660
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Zane918 Bosco882
**Date:** 2020-02-08T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 49 years - Gender: Female - Race: White - Encounter Type: Urgent Care Clinic Chief Complaint: Patient presents for an urgent care visit with unspecified complaints. History of Present Illness: The patient was prescribed the following medications: 1. Insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension 2. Hydrochlorothiazide 25 MG Oral Tablet During the encounter, the following assessments were performed: - Assessment of health and social care needs - Assessment of anxiety - Depression screening - Depression screening (repeated) - Assessment of substance use - Assessment using Alcohol Use Disorders Identification Test (AUDIT-C) Symptoms: No specific symptoms were explicitly reported by the patient, but potential symptoms related to the prescribed medications may include: - Insulin (Humulin 70/30): Hypoglycemia (shakiness, sweating, confusion, dizziness), injection site reactions, weight gain, or hyperglycemia if doses are missed. - Hydrochlorothiazide: Dizziness, electrolyte imbalances (e.g., low potassium), increased urination, dehydration, or orthostatic hypotension. Assessment: The patient underwent comprehensive screening for mental health (anxiety, depression) and substance use. No acute concerns were identified, but ongoing monitoring is advised. Plan: 1. Medication Instructions: - Insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension : - Administer subcutaneously once or twice daily, typically 30 minutes before meals. - Rotate injection sites (abdomen, thigh, upper arm, or buttocks) to prevent lipodystrophy. - Monitor blood glucose levels as prescribed. - Treat hypoglycemia with 15g of fast-acting carbohydrates (e.g., glucose tablets, juice) if symptoms occur. - Hydrochlorothiazide 25 MG Oral Tablet: - Take once daily in the morning with or without food. - Increase fluid intake to prevent dehydration. - Monitor for signs of electrolyte imbalances (e.g., muscle cramps, weakness). 2. Follow-Up: - Schedule a follow-up appointment with the primary care physician to reassess medication efficacy and side effects. - Continue mental health and substance use monitoring as needed. Provider: Date:

============================================================

## Note 59 (undefined - b6b476fb-5f5e-d112-38d5-b6ac728e85c5)

**Note ID:** b6b476fb-5f5e-d112-38d5-b6ac728e85c5
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Trinity427 Hartmann983
**Date:** 2020-02-29T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Fritsch593 - Age: 49 years - Sex: Female - Race: White Reason for Visit: General examination and assessment of health and social care needs. History of Present Illness: The patient presented for a general examination. No specific complaints were reported at this time. The patient is currently prescribed insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension and Hydrochlorothiazide 25 MG Oral Tablet. The patient was assessed for anxiety, depression, and domestic abuse screening. Symptoms: - Anxiety: The patient reported occasional feelings of anxiety, though no specific triggers were identified. - Depression: The patient denied significant depressive symptoms but was screened as part of routine care. - Domestic Abuse: The patient denied experiencing any form of domestic abuse. Physical Examination: General: Alert and oriented × 3. Vital Signs: Within normal limits. Abdomen: Soft, non-tender, no masses. Skin: No rashes or lesions noted. Assessment: 1. Assessment of Health and Social Care Needs: Routine assessment completed; no immediate concerns identified. 2. Anxiety Screening: Mild anxiety noted; further evaluation may be warranted if symptoms worsen. 3. Depression Screening: Negative for major depressive disorder. 4. Depression Screening Procedure(s): Completed using standardized tools. 5. Screening for Domestic Abuse: Negative. Medications: 1. Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension : - Instructions: Inject subcutaneously once daily, usually in the morning. Rotate injection sites to avoid lipodystrophy. May be taken with or without food. Monitor blood glucose levels as prescribed. - Dose: Follow prescribed dosage; do not adjust without consulting the provider. 2. Hydrochlorothiazide 25 MG Oral Tablet: - Instructions: Take one tablet by mouth once daily, preferably in the morning. May cause dizziness or dehydration; ensure adequate fluid intake. Avoid alcohol and potassium-depleting foods. Plan: - Continue current medications as prescribed. - Follow up in 1 month for monitoring of blood glucose and blood pressure. - Reassess anxiety and depression symptoms at the next visit. - No further intervention for domestic abuse screening at this time. Provider: Date:

============================================================

## Note 60 (undefined - 76f928d5-5d3b-4725-fbf7-ed221c0e112d)

**Note ID:** 76f928d5-5d3b-4725-fbf7-ed221c0e112d
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Trinity427 Hartmann983
**Date:** 2021-03-06T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 50 years - Sex: Female - Race: White Encounter Details: - Date: - Reason for Visit: General examination and health assessment. History of Present Illness: The patient presented for a general examination. No specific complaints were reported at this time. The encounter included an assessment of health and social care needs, depression screening (performed twice), and screening for substance use and drug abuse. No acute symptoms were reported. Medications: 1. Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension - Indication: Diabetes mellitus (assuming for glycemic control). - Instructions: - Administer subcutaneously once daily, preferably at the same time each day (e.g., in the morning or evening). - Rotate injection sites to avoid lipodystrophy or skin irritation (e.g., abdomen, thighs, upper arms). - Do not shake the vial vigorously; gently roll between palms to mix. - Monitor blood glucose levels as prescribed. - Risk of hypoglycemia (symptoms include sweating, tremors, confusion, dizziness); carry fast-acting carbohydrates (e.g., glucose tablets, juice) at all times. - Avoid alcohol consumption, as it may increase hypoglycemia risk. 2. Hydrochlorothiazide 25 MG Oral Tablet - Indication: Hypertension or fluid retention (assuming for blood pressure control). - Instructions: - Take one tablet orally once daily, preferably in the morning with food or milk to reduce gastrointestinal upset. - Maintain adequate hydration; increased urination is expected. - Monitor for electrolyte imbalances (e.g., low potassium—symptoms include muscle cramps, weakness) and report to the provider. - Avoid excessive sun exposure due to photosensitivity risk. Immunizations: - Zoster vaccine, live (Shingrix or Zostavax, assuming Shingrix for adults over 50). - Influenza vaccine, seasonal, injectable, preservative-free. Procedures Performed: - Assessment of health and social care needs. - Depression screening (PHQ-9 or similar tool). - Screening for substance use and drug abuse (e.g., CAGE questionnaire or similar). Assessment: The patient is stable with no acute concerns. Chronic conditions (diabetes, hypertension) are being managed with prescribed medications. Depression and substance use screenings were negative for acute risk. Plan: - Continue current medications with adherence to instructions. - Schedule follow-up in for medication review and lab monitoring (e.g., HbA1c, electrolytes). - Reinforce importance of blood glucose monitoring and hypoglycemia prevention. - Encourage lifestyle modifications (e.g., diet, exercise) for diabetes and hypertension management. Provider Signature:

============================================================

## Note 61 (undefined - 013456f9-f260-7b74-8355-96ab05903026)

**Note ID:** 013456f9-f260-7b74-8355-96ab05903026
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2021-09-04T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 50 years - Gender: Female - Race: White - Reason for Encounter: Routine check-up History of Present Illness: The patient presented for a routine check-up. No specific complaints were reported at this time. However, symptoms such as fatigue, increased thirst, frequent urination, or unexplained weight changes may be related to underlying conditions like diabetes, which should be monitored. Additionally, the patient may experience symptoms of anxiety, depression, or substance use, as these were assessed during the encounter. Medication Reconciliation & Current Medications: 1. Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension - Instructions: Administer subcutaneously once daily, typically before breakfast or dinner. Rotate injection sites to avoid lipodystrophy. Monitor blood glucose levels as prescribed. Do not shake the vial; gently roll between palms to mix. 2. Hydrochlorothiazide 25 MG Oral Tablet - Instructions: Take one tablet orally once daily, preferably in the morning. Avoid taking it close to bedtime to reduce the risk of nighttime urination. Ensure adequate hydration and monitor electrolyte levels (e.g., potassium) as needed. Assessments Performed: - Assessment of health and social care needs - Anxiety assessment - Depression screening - Substance use assessment - Alcohol Use Disorders Identification Test - Consumption (AUDIT-C) Immunizations Administered: - Zoster vaccine, live - Influenza, seasonal, injectable, preservative-free Referrals: - Dental care procedure(s) – Patient referred for further evaluation. Plan: - Continue current medications with adherence to dosing instructions. - Follow up for monitoring of blood glucose, blood pressure, and mental health status. - Schedule dental appointment as needed. - Encourage lifestyle modifications (e.g., diet, exercise) to manage underlying conditions. Symptoms to Monitor: - Fatigue, increased thirst, or frequent urination (possible signs of hyperglycemia or diabetes management issues). - Mood changes, anxiety, or depressive symptoms (follow up if significant). - Any signs of electrolyte imbalance (e.g., muscle cramps, weakness) due to Hydrochlorothiazide. Follow-Up: Return in 3 months for reassessment of diabetes control, blood pressure, and mental health. Adjust medications as needed based on lab results and clinical status.

============================================================

## Note 62 (undefined - 1bb4606b-55f9-3ef2-e001-1f3e2001c3f0)

**Note ID:** 1bb4606b-55f9-3ef2-e001-1f3e2001c3f0
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2021-09-18T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 50 years - Sex: Female - Race: White Encounter Date: Reason for Visit: Check-up and follow-up for dental care (regime/therapy) following a dental consultation and report. History of Present Illness (HPI): The patient is a 50-year-old female presenting for a dental check-up and procedure follow-up. She was referred for dental care due to symptoms including tooth sensitivity , gingival bleeding , periodontal pockets , and tooth mobility , which may be attributed to advanced periodontal disease and tooth fracture . The patient reports discomfort while chewing and occasional pain in the affected tooth. Dental Consultation Findings: - Supragingival and subgingival plaque and calculus were noted on all teeth. - Gingival examination revealed gingivitis and gingival recession . - A fractured tooth was identified, requiring composite filling material. Procedures Performed: 1. Removal of supragingival plaque and calculus from all teeth using dental instruments. 2. Removal of subgingival plaque and calculus from all teeth using dental instruments. 3. Examination of gingivae to assess periodontal health. 4. Dental surgical procedure (gingivectomy or gingivoplasty) performed per tooth as needed. 5. Application of desensitizing medicament to address tooth sensitivity. 6. Composite dental filling material applied to the fractured tooth. 7. Postoperative care for dental procedure (regime/therapy) provided. 8. Oral health education on proper brushing, flossing, and maintenance of periodontal health. Symptoms Related to Patient Referral for Dental Care: - Tooth sensitivity (likely due to gingival recession and exposed dentin). - Gingival bleeding (indicative of gingivitis or periodontitis). - Tooth mobility (suggestive of advanced periodontal disease with bone loss). - Pain or discomfort in the fractured tooth (due to fracture and potential pulp exposure). Plan: - Continue postoperative care as advised (e.g., pain management, oral hygiene instructions). - Schedule follow-up appointment in for periodontal maintenance. - Encourage adherence to oral hygiene measures to prevent recurrence of dental issues. Assessment: The patient has periodontal disease with gingival inflammation, calculus accumulation, and a fractured tooth. Dental interventions have been performed to address these issues, and ongoing care is recommended to maintain oral health. Provider Signature:

============================================================

## Note 63 (undefined - 8090f38d-39b6-a23a-ff55-404c0c80aabf)

**Note ID:** 8090f38d-39b6-a23a-ff55-404c0c80aabf
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2021-10-02T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 50 years - Gender: Female - Race: White Reason for Encounter: Routine check-up. History of Present Illness: The patient presents for a routine check-up. No specific complaints were reported. However, potential symptoms related to uncontrolled diabetes (e.g., fatigue, increased thirst, frequent urination) or hypertension (e.g., headache, dizziness) should be monitored. Additionally, the patient may experience anxiety-related symptoms such as restlessness, irritability, or difficulty concentrating. Medication Reconciliation: - Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension : Prescribed for diabetes management. - Hydrochlorothiazide 25 MG Oral Tablet : Prescribed for hypertension. Assessment of Health and Social Care Needs: The patient’s health and social care needs were assessed, including screening for diabetes and hypertension complications. No immediate concerns were identified, but continued monitoring is advised. Assessment of Anxiety: The patient was evaluated for anxiety symptoms. No significant anxiety was noted, but the patient was encouraged to seek further evaluation if symptoms develop. Referral for Dental Care: The patient was referred for dental care procedures due to identified dental concerns. Instructions for Medications: 1. Humulin (Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension): - Administer subcutaneously once daily, preferably at the same time each day. - Rotate injection sites (e.g., abdomen, thighs, upper arms) to prevent lipodystrophy. - Store unopened vials in the refrigerator; do not freeze. - Once opened, store at room temperature and use within 28 days. - Monitor blood glucose levels as directed by the provider. - Be aware of signs of hypoglycemia (e.g., shakiness, sweating, confusion) and have a fast-acting carbohydrate source available. 2. Hydrochlorothiazide 25 MG Oral Tablet: - Take one tablet orally once daily, preferably in the morning. - Take with or without food. - Maintain adequate hydration. - Monitor for side effects such as dizziness, electrolyte imbalances, or increased urination. Plan: - Continue current medications as prescribed. - Follow up in 3 months for diabetes and hypertension management. - Schedule dental appointment as soon as possible. - Encourage lifestyle modifications (e.g., diet, exercise) for optimal health outcomes. Provider Signature:

============================================================

## Note 64 (undefined - 24a61024-1a36-8839-35b0-0dacb3b42dcd)

**Note ID:** 24a61024-1a36-8839-35b0-0dacb3b42dcd
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2021-10-16T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 50 - Sex: Female - Race: White Encounter Date: Reason for Visit: Check-up for Gingivitis History of Present Illness: The patient presents for a dental check-up due to concerns regarding gingivitis. She reports symptoms commonly associated with gingivitis, including: - Red, swollen, or tender gums - Gums that bleed easily, especially during brushing or flossing - Persistent bad breath (halitosis) - Gum recession or changes in the appearance of the gums Clinical Findings: - Examination of gingivae revealed mild to moderate inflammation with erythema and edema. - Supragingival and subgingival plaque and calculus were noted on multiple teeth. - Dental plain x-ray (bitewing) showed no evidence of significant bone loss at this time. Procedures Performed: - Dental consultation and report completed. - Dental care regime/therapy initiated. - Removal of supragingival plaque and calculus from all teeth using dental instruments. - Removal of subgingival plaque and calculus from all teeth using dental instruments. - Dental fluoride treatment administered. - Oral health education provided to the patient regarding proper brushing, flossing, and maintenance of oral hygiene. Medication Prescribed: - Sodium Fluoride 0.0272 MG/MG Oral Gel (prescribed for dental use). Instructions for Sodium Fluoride 0.0272 MG/MG Oral Gel: - Apply a thin ribbon of the gel to the teeth using a toothbrush or oral tray as directed by the dentist. - Leave the gel on the teeth for 1 minute, then spit out excess gel. Do not swallow. - Avoid eating, drinking, or rinsing for at least 30 minutes after application to allow the fluoride to be fully absorbed. - Use as directed, typically once daily or as recommended by the dentist. Plan: - Continue with recommended oral hygiene practices, including regular brushing and flossing. - Return for follow-up in to monitor gingival health and evaluate the need for further treatment. Physician/Dentist Signature:

============================================================

## Note 65 (undefined - 8d8986a3-1a21-318a-f380-1cf35e4927ac)

**Note ID:** 8d8986a3-1a21-318a-f380-1cf35e4927ac
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2021-12-04T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 50 years - Gender: Female - Race: White Reason for Encounter: Routine check-up. History of Present Illness: The patient presents for a routine check-up. No acute complaints were reported. The patient has a history of diabetes mellitus and hypertension, for which they are currently prescribed insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension , and Hydrochlorothiazide 25 MG Oral Tablet. Symptoms: The patient may experience symptoms related to diabetes and hypertension, including: - Hypoglycemia (e.g., dizziness, sweating, confusion, tremors) due to insulin therapy. - Hyperglycemia (e.g., increased thirst, urination, fatigue) if blood sugar control is suboptimal. - Hypertension-related symptoms (e.g., headaches, dizziness) if blood pressure is not well-controlled. Assessment: - Health and social care needs assessment completed. - Depression screening performed (e.g., PHQ-9). The patient reported no significant depressive symptoms at this time. Plan: 1. Medications: - Insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension : - Dosage: As prescribed (specific units to be determined by provider). - Instructions: Administer subcutaneously once daily, preferably at the same time each day. Rotate injection sites to prevent lipodystrophy. Monitor blood glucose levels as directed. - Hydrochlorothiazide 25 MG Oral Tablet: - Dosage: 25 mg once daily. - Instructions: Take orally with or without food. May cause increased urination; ensure adequate fluid intake. Monitor electrolytes (e.g., potassium) as needed. 2. Follow-Up: - Schedule follow-up in 3 months to reassess blood glucose and blood pressure control. - Repeat depression screening at the next visit. 3. Education: - Advise patient on hypoglycemia prevention and management (e.g., carry glucose tablets or juice). - Emphasize the importance of regular blood pressure and blood glucose monitoring. Provider Signature:

============================================================

## Note 66 (undefined - ca9f84ce-3fbb-efe5-f740-0d1e2c00bbd2)

**Note ID:** ca9f84ce-3fbb-efe5-f740-0d1e2c00bbd2
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Trinity427 Hartmann983
**Date:** 2022-03-12T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593
- Age: 51 years
- Gender: Female
- Race: White Reason for Encounter: General examination of the patient for health maintenance and assessment of health and social care needs. Subjective: The patient presents for a general examination. She reports no specific complaints at this time. However, she has a history of diabetes mellitus and hypertension, for which she is currently prescribed medications. The patient was also screened for depression and substance use during this encounter. Objective: - Vital Signs: Within normal limits.
- Physical Examination: General examination performed, including assessment of vital signs, cardiovascular, respiratory, abdominal, and neurological systems. No abnormalities noted.
- Procedures Performed: - Assessment of health and social care needs. - Depression screening (performed twice). - Assessment of substance use. - Alcohol Use Disorders Identification Test - Consumption (AUDIT-C).
- Immunizations: - Td (adult) vaccine administered (5 Lf tetanus toxoid, preservative-free, adsorbed). Assessment: 1. Diabetes Mellitus: The patient is prescribed insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension . This is a premixed insulin preparation that contains 70% intermediate-acting insulin isophane and 30% short-acting insulin regular. The patient should be instructed on the proper administration and dosage of this medication. Possible symptoms that may be caused by this medication include hypoglycemia (low blood sugar), which can present as sweating, tremors, confusion, and palpitations. The patient should be educated on recognizing and managing hypoglycemic episodes.
2. Hypertension: The patient is prescribed Hydrochlorothiazide 25 MG Oral Tablet. This is a diuretic medication used to lower blood pressure. The patient should be instructed to take one tablet orally once daily. Possible symptoms that may be caused by this medication include electrolyte imbalances (such as low potassium levels), dizziness, and increased urination. The patient should be advised to report any symptoms of dizziness or electrolyte abnormalities to their healthcare provider.
3. Depression Screening: The patient underwent depression screening, which will help assess her mental health status. Further evaluation or treatment may be indicated based on the screening results.
4. Substance Use Assessment: The patient underwent assessment for substance use. This will help identify any potential substance abuse issues and guide appropriate interventions if needed.
5. Immunizations: The patient received the Td (adult) vaccine, which provides protection against tetanus and diphtheria. This is an important preventive measure to maintain her immunization status. Plan: 1. Continue current medications for diabetes mellitus and hypertension.
2. Educate the patient on the proper administration and dosage of insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension . Instruct the patient to take the medication subcutaneously once daily, preferably at the same time each day. The specific dosage will be determined by the healthcare provider based on the patient's individual needs and blood glucose levels.
3. Advise the patient to monitor blood glucose levels regularly and report any significant changes or symptoms of hypoglycemia to their healthcare provider.
4. Educate the patient on the potential side effects of Hydrochlorothiazide 25 MG Oral Tablet, including electrolyte imbalances and dizziness. Instruct the patient to take the medication as prescribed and to report any symptoms of dizziness or electrolyte abnormalities to their healthcare provider.
5. Follow up with the patient in one month for a follow-up appointment to assess her response to the medications and to review the results of the depression screening and substance use assessment.
6. Encourage the patient to maintain a healthy lifestyle, including regular exercise, a balanced diet, and stress management techniques. Signature:

============================================================

## Note 67 (undefined - 27ac771d-4432-4c69-a9cd-b6ce5762011b)

**Note ID:** 27ac771d-4432-4c69-a9cd-b6ce5762011b
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2022-04-02T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 51 years - Race: White - Sex: Female Reason for Encounter: Routine check-up. History of Present Illness: The patient presents for a routine check-up. No specific symptoms were reported, but the following assessments were performed: - Assessment of health and social care needs - Depression screening (performed twice) - Assessment of substance use - Alcohol Use Disorders Identification Test - Consumption (AUDIT-C) The patient was referred for dental care procedure(s) as needed. Medications: 1. Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension - Indication: Diabetes management. - Instructions: Administer subcutaneously once daily, preferably at the same time each day. Rotate injection sites to prevent lipohypertrophy. - Dosage: As prescribed by the provider. Monitor blood glucose levels regularly. Be aware of potential hypoglycemia (symptoms include shakiness, sweating, confusion, rapid heartbeat) and hyperglycemia (symptoms include increased thirst, frequent urination, fatigue). Have a source of fast-acting glucose (e.g., glucose tablets, juice) available in case of hypoglycemia. 2. Hydrochlorothiazide 25 MG Oral Tablet - Indication: Hypertension or fluid retention. - Instructions: Take one tablet orally once daily, preferably in the morning. Avoid taking it late in the day to prevent nighttime urination. Monitor for electrolyte imbalances (e.g., low potassium) and report symptoms like muscle cramps or weakness. Stay adequately hydrated. Assessment: - The patient’s health and social care needs were evaluated, and no immediate concerns were noted. - Depression screening was performed, and no significant depressive symptoms were reported at this time. - Substance use assessment and AUDIT-C screening were completed, with no concerning findings. - Dental care referral was made for further evaluation and treatment. Plan: - Continue current medications as prescribed. - Follow up in 3 months for monitoring of blood glucose, blood pressure, and electrolytes. - Schedule dental appointment as soon as possible. - Encourage healthy lifestyle modifications, including diet and exercise, as appropriate. Signature:

============================================================

## Note 68 (undefined - ad1fb87a-43de-3471-b71d-4113c183c882)

**Note ID:** ad1fb87a-43de-3471-b71d-4113c183c882
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2022-04-16T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 51 - Gender: Female - Race: White Encounter Date: Reason for Visit: Check-up and follow-up for patient referral for dental care (procedure). History of Present Illness: The patient is a 51-year-old female who presented for a dental check-up and consultation. She was referred for dental care due to concerns related to gum health, potential gingival inflammation, plaque buildup, and the need for professional cleaning and fluoride treatment. The patient may have been experiencing symptoms such as bleeding gums, sensitivity, or halitosis, which are common indicators of poor oral hygiene or periodontal disease. Dental Consultation and Report: A dental consultation was conducted, and the following procedures were performed: 1. Removal of supragingival plaque and calculus from all teeth using dental instruments. 2. Removal of subgingival plaque and calculus from all teeth using dental instruments. 3. Examination of gingivae for signs of inflammation, bleeding, or periodontal disease. 4. Dental fluoride treatment to strengthen enamel and prevent cavities. 5. Oral health education to improve at-home oral hygiene practices. Medication Prescribed: - Sodium Fluoride 0.0272 MG/MG Oral Gel - Instructions: Apply a thin ribbon of gel (approximately 1 cm) to the teeth using a toothbrush or applicator. Leave the gel on the teeth for 1 minute without rinsing, then spit out any excess. Do not swallow the gel. Use once daily before bedtime, after brushing with regular toothpaste. Avoid eating or drinking for at least 30 minutes after application. Plan: - Continue with recommended oral hygiene practices, including regular brushing and flossing. - Follow up with the dentist in for routine maintenance. - Monitor for any signs of irritation or sensitivity and report to the dentist if they persist. Signature: ,

============================================================

## Note 69 (undefined - 07a8de1a-de70-f74d-0beb-5d7d04d060b2)

**Note ID:** 07a8de1a-de70-f74d-0beb-5d7d04d060b2
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2022-05-28T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 51 years - Sex: Female - Race: White Encounter Date: Reason for Visit: Routine check-up Subjective: The patient presents for a routine check-up. No specific complaints were reported at this time. The patient was prescribed the following medications: 1. Insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension 2. Hydrochlorothiazide 25 MG Oral Tablet The patient was assessed for health and social care needs, anxiety, and depression. Screening for depression and substance use was also conducted. An Alcohol Use Disorders Identification Test (AUDIT-C) was performed, and the patient was referred for dental care. Objective: - Vital signs: - Physical exam: Unremarkable. - Labs: Assessment: The patient is stable at this time. No acute symptoms were reported. However, potential symptoms related to the prescribed medications may include: - Insulin : Hypoglycemia (shakiness, sweating, confusion, weakness), weight gain, or localized skin reactions (e.g., redness, itching) at injection sites. - Hydrochlorothiazide: Dizziness, electrolyte imbalances (e.g., hypokalemia), or increased urination. Plan: 1. Medication Instructions: - Insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension : - Administer subcutaneously once or twice daily as prescribed. - Rotate injection sites to prevent lipodystrophy. - Take with meals to reduce hypoglycemia risk. - Monitor blood glucose regularly. If hypoglycemia occurs, treat with 15g of fast-acting carbohydrates (e.g., glucose tablets, juice). - Hydrochlorothiazide 25 MG Oral Tablet: - Take once daily in the morning with or without food. - Stay hydrated and monitor for dizziness, especially when standing up. - Avoid alcohol, as it may exacerbate dizziness. 2. Referrals: - Dental care referral completed. 3. Follow-Up: - Schedule follow-up in to reassess blood glucose control and medication tolerance. Signature: ,

============================================================

## Note 70 (undefined - 023dd10a-57a2-150e-b6f0-532b9753283d)

**Note ID:** 023dd10a-57a2-150e-b6f0-532b9753283d
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2022-06-11T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593
- Age: 51 years
- Gender: Female
- Race: White Reason for Encounter: The patient presented for a check-up due to concerns related to Gingivitis. Symptoms of Gingivitis: The patient may be experiencing one or more of the following symptoms associated with Gingivitis:
- Red, swollen, or puffy gums
- Gums that bleed easily, especially during brushing or flossing
- Bad breath (halitosis)
- Gums that are tender to the touch
- Gums that have pulled away from the teeth (recession)
- A change in the color of the gums to a deeper red or purple Clinical Findings and Procedures Performed: - Dental consultation and report
- Dental care (regime/therapy) was discussed and outlined
- Removal of supragingival plaque and calculus from all teeth using dental instruments
- Removal of subgingival plaque and calculus from all teeth using dental instruments
- Examination of gingivae
- Dental fluoride treatment was administered
- Oral health education procedures were performed Prescription: The patient was prescribed Sodium Fluoride 0.0272 MG/MG Oral Gel for the treatment of Gingivitis. Instructions for Taking Sodium Fluoride 0.0272 MG/MG Oral Gel: 1. Apply a thin ribbon of the gel along the gumline of each tooth using a toothbrush or a special tray provided by the dentist.
2. Leave the gel in place for the recommended time as advised by the dental professional, typically 1 minute.
3. After the recommended time, spit out the excess gel. Do not swallow the gel.
4. Do not eat, drink, or rinse your mouth for at least 30 minutes after applying the gel to allow the fluoride to be fully absorbed.
5. Use the gel as directed by the dental professional, typically once daily before bedtime after brushing your teeth.
6. If you experience any irritation or allergic reaction, discontinue use and contact your dental professional immediately. Follow-Up: The patient is advised to return for a follow-up appointment in to monitor the progress of the treatment and to ensure that the Gingivitis is under control. Conclusion: The patient was educated on proper oral hygiene practices and the importance of regular dental check-ups to maintain good oral health. The prescribed treatment, along with the dental procedures performed, should help in managing and resolving the Gingivitis.

============================================================

## Note 71 (undefined - ec511883-1d37-82d5-e79c-40a531329408)

**Note ID:** ec511883-1d37-82d5-e79c-40a531329408
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2022-08-13T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 51 - Sex: Female - Race: White Reason for Encounter: Routine check-up. Medication Reconciliation: - Insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension - Hydrochlorothiazide 25 MG Oral Tablet Procedures Performed: - Assessment of health and social care needs - Screening for domestic abuse - Depression screening (x2) - Assessment of substance use - Alcohol Use Disorders Identification Test (AUDIT-C) Immunizations Given: - Influenza, seasonal, injectable, preservative-free Assessment: The patient was evaluated for overall health status. No acute complaints were reported. Medications were reviewed, and adherence was confirmed. No signs of hypoglycemia or hyperglycemia were noted, but symptoms such as fatigue, increased thirst, or frequent urination should be monitored, as they may indicate poor glycemic control or other underlying issues. Instructions for Medications: 1. Humulin (Insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension): - Administer subcutaneously as prescribed, typically before meals. - Rotate injection sites (e.g., abdomen, thigh, upper arm) to avoid lipodystrophy. - Monitor blood glucose levels regularly. Adjust dosage as needed based on blood sugar readings and meals. - Do not shake the vial; gently roll between palms to mix. - Store unopened vials in the refrigerator; keep opened vials at room temperature (do not refrigerate). 2. Hydrochlorothiazide 25 MG Oral Tablet: - Take once daily in the morning with or without food. - Ensure adequate fluid intake (at least 8 glasses of water daily). - May cause dizziness or electrolyte imbalances; report symptoms like muscle cramps, weakness, or excessive thirst. Follow-Up: - Schedule follow-up in 3 months for re-evaluation of glycemic control and blood pressure. - Monitor for any new symptoms or side effects from medications. Plan: - Continue current medications as directed. - Reinforce lifestyle modifications (diet, exercise) for optimal glycemic and blood pressure control. - Report any signs of depression, substance use concerns, or domestic abuse for further intervention. Signature: ,

============================================================

## Note 72 (undefined - 31f28160-a1b8-22f1-8236-a956c41e1987)

**Note ID:** 31f28160-a1b8-22f1-8236-a956c41e1987
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2022-08-27T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 51 years - Sex: Female - Race: White Encounter Details: - Date: - Reason for Visit: Routine check-up for diabetes and hypertension management. History of Present Illness: The patient is a 51-year-old female with a known history of diabetes mellitus and hypertension. She reports no acute symptoms but is concerned about maintaining stable blood glucose levels and blood pressure control. She denies any recent changes in symptoms such as excessive thirst, frequent urination, fatigue, or dizziness, which may be caused by poor glycemic control or hypoglycemia. She also denies any symptoms of depression, such as low mood, anhedonia, or sleep disturbances. Physical Examination: - General: Alert and oriented, in no acute distress. - Vital Signs: BP 130/80 mmHg, HR 72 bpm, RR 16, SpO2 98% on room air, Temperature 98.6°F. - Abdominal: Soft, non-tender, no signs of diabetic gastroparesis. - Extremities: No edema, no signs of peripheral neuropathy. Assessment and Plan: 1. Diabetes Management: - Continue insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension (70/30 insulin). - Instructions for insulin administration: - Inject subcutaneously once daily, typically in the morning, 30 minutes before breakfast. - Rotate injection sites (abdomen, thighs, upper arms) to prevent lipohypertrophy. - Monitor blood glucose levels before meals and at bedtime. Adjust dose as needed based on glucose readings and carbohydrate intake. - Watch for signs of hypoglycemia (shakiness, sweating, confusion) and treat with 15 grams of fast-acting carbohydrates if necessary. 2. Hypertension Management: - Continue Hydrochlorothiazide 25 MG Oral Tablet. - Instructions for HCTZ: - Take one tablet orally once daily in the morning. - Increase fluid intake to at least 8 glasses of water per day to prevent dehydration. - Monitor for electrolyte imbalances (e.g., muscle cramps, weakness) and report any concerns. 3. Depression Screening: - Completed Patient Health Questionnaire-9 (PHQ-9). Patient reported no depressive symptoms. - Re-screen at next follow-up visit. 4. Social Care Needs: - Assessed for social support and access to care. - Referred for dental care procedure(s) due to reported concerns about oral health. Plan for Follow-Up: - Return in 3 months for HbA1c and blood pressure re-evaluation. - Monitor for any signs of hypoglycemia or hyperglycemia. - Reinforce importance of adherence to medication and lifestyle modifications. Physician Signature: Date:

============================================================

## Note 73 (undefined - 00318731-4420-dcff-2690-f09648635c61)

**Note ID:** 00318731-4420-dcff-2690-f09648635c61
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2022-09-10T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 51 - Sex: Female - Race: White Reason for Encounter: Check-up for Gingivitis. History of Present Illness: The patient presents for evaluation and treatment of gingivitis. She reports symptoms consistent with gingivitis, including: - Redness and swelling of the gums - Bleeding gums, particularly during brushing or flossing - Mild tenderness or discomfort in the gum tissue - Possible halitosis (bad breath) due to bacterial buildup The patient has been compliant with previous dental care recommendations but seeks further management to improve oral hygiene and prevent progression to periodontitis. Clinical Findings: - Examination of gingivae: Mild to moderate gingival inflammation noted, with erythema and edema. Bleeding on probing observed in multiple quadrants. - Oral hygiene assessment: Plaque and calculus accumulation present both supragingivally and subgingivally. Procedures Performed: 1. Dental consultation and report: Discussed patient’s oral hygiene habits and risk factors for gingivitis. 2. Dental care (regime/therapy): Provided guidance on proper brushing and flossing techniques, along with recommendations for antimicrobial mouth rinses. 3. Removal of supragingival plaque and calculus from all teeth using dental instrument: Scaling performed to remove hard and soft deposits above the gumline. 4. Removal of subgingival plaque and calculus from all teeth using dental instrument: Subgingival scaling and root planing to address bacterial buildup below the gumline. 5. Dental plain x-ray bitewing: Performed to assess bone levels and detect any early signs of periodontal disease. 6. Oral health education procedure(s): Reinforced the importance of regular dental visits, proper brushing, and flossing to prevent recurrence. Plan: - Continue with prescribed oral hygiene regimen. - Return for follow-up in 3 months for re-evaluation and possible maintenance therapy. - Encourage the use of an antimicrobial mouth rinse as an adjunct to brushing and flossing. Signature: ,

============================================================

## Note 74 (undefined - 333b2da1-b366-4f19-9561-8d0b186a9198)

**Note ID:** 333b2da1-b366-4f19-9561-8d0b186a9198
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2022-12-24T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 51 years - Sex: Female - Race: White Encounter Details: - Date: - Reason for Visit: Routine check-up. History of Present Illness: The patient presents for a routine check-up. No specific complaints were reported at this time. However, symptoms such as fatigue, increased thirst, frequent urination, or unintentional weight changes may be associated with her diabetes management. Additionally, potential side effects of her medications, such as dizziness, electrolyte imbalances, or mood changes, should be monitored. Medication Reconciliation: 1. Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension – Prescribed for diabetes management. - Instructions: Administer subcutaneously once daily, typically before breakfast or dinner. Rotate injection sites to prevent lipodystrophy. Do not shake the vial; gently roll it between palms to mix. Monitor blood glucose levels as directed. 2. Hydrochlorothiazide 25 MG Oral Tablet – Prescribed for hypertension or fluid retention. - Instructions: Take one tablet orally once daily, preferably in the morning to minimize nocturia. Ensure adequate hydration. Monitor for electrolyte imbalances (e.g., low potassium) and report symptoms like muscle cramps or weakness. Procedures Performed: - Medication reconciliation. - Assessment of health and social care needs. - Assessment of anxiety. - Depression screening. - Assessment of substance use. - Screening for drug abuse. Assessment: The patient’s health and social care needs were evaluated, with no immediate concerns noted. Anxiety and depression screenings were performed, and no significant symptoms were reported. Substance use and drug abuse screenings were negative. Plan: - Continue current medications as prescribed. - Monitor blood glucose levels and report any hypoglycemic or hyperglycemic symptoms. - Follow up in for repeat screenings and medication review. - Encourage lifestyle modifications, including a balanced diet and regular exercise, to optimize glycemic and blood pressure control. Signature: ,

============================================================

## Note 75 (undefined - 92722254-3cc7-3d14-1b0b-9ff9d0d84712)

**Note ID:** 92722254-3cc7-3d14-1b0b-9ff9d0d84712
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Trinity427 Hartmann983
**Date:** 2023-03-18T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Fritsch593 - Age: 52 years - Sex: Female - Race: White Encounter Date: Reason for Visit: General examination for health maintenance. History of Present Illness: The patient presents for a general examination. No specific complaints were reported at this time. The patient was previously prescribed medications for ongoing management, including diabetes and hypertension. Review of Systems: - Endocrine: No reported symptoms of hyperglycemia (e.g., polyuria, polydipsia, fatigue) or hypoglycemia (e.g., sweating, tremors, confusion). - Cardiovascular: No reported symptoms of hypertension (e.g., headaches, dizziness). - Psychiatric: No reported symptoms of depression (e.g., low mood, anhedonia, fatigue). Medications: 1. Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension – For diabetes management. - Instructions: Administer subcutaneously once daily, typically at the same time each day (e.g., before breakfast or dinner). Rotate injection sites (e.g., abdomen, thigh, upper arm) to avoid lipodystrophy. Monitor blood glucose levels as directed. Do not mix with other insulins in the same syringe unless specifically instructed. 2. Hydrochlorothiazide 25 MG Oral Tablet – For hypertension management. - Instructions: Take one tablet orally once daily, preferably in the morning to minimize nighttime urination. Maintain adequate hydration and monitor electrolytes (e.g., potassium) as needed. Procedures Performed: - Assessment of health and social care needs. - Depression screening using Patient Health Questionnaire-9 (PHQ-9). - Repeat depression screening (no specific rationale provided). Assessment: - The patient is stable with no acute complaints. - No signs of uncontrolled diabetes or hypertension. - PHQ-9 score: . No evidence of clinically significant depression at this time. Plan: - Continue current medications as prescribed. - Monitor blood glucose levels regularly and adjust insulin dosing as needed. - Schedule follow-up in for repeat blood work (e.g., HbA1c, electrolytes) and reassessment. - Encourage lifestyle modifications (e.g., diet, exercise) for diabetes and hypertension management. Signature: ,

============================================================

## Note 76 (undefined - 24271d92-9b8d-263e-7d68-2e327416be18)

**Note ID:** 24271d92-9b8d-263e-7d68-2e327416be18
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2023-09-09T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 52 years - Sex: Female - Race: White Reason for Encounter: Routine check-up for ongoing health management. Medications: 1. Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension 2. Hydrochlorothiazide 25 MG Oral Tablet Immunizations: - Influenza, seasonal, injectable, preservative-free (administered today). Assessments Conducted: - Assessment of health and social care needs. - Assessment of anxiety. - Assessment of substance use. - Alcohol Use Disorders Identification Test - Consumption (AUDIT-C). - Referral for dental care procedure(s) performed. Symptoms: The patient reports no specific symptoms related to the current encounter. However, given the patient’s history and current medications, potential symptoms to monitor include: - Hypoglycemia (e.g., dizziness, sweating, confusion, palpitations) due to insulin therapy. - Hyperglycemia (e.g., increased thirst, frequent urination, fatigue) if blood glucose control is suboptimal. - Symptoms of anxiety (e.g., excessive worry, restlessness, insomnia) or substance use concerns (e.g., cravings, withdrawal symptoms). Instructions for Medications: 1. Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension : - This is a premixed insulin containing 70% intermediate-acting insulin (NPH) and 30% short-acting insulin (regular). - Dosage and Timing: Administer subcutaneously as prescribed (e.g., twice daily, 30 minutes before breakfast and dinner). Rotate injection sites (e.g., abdomen, thigh, upper arm) to prevent lipodystrophy. - Storage: Store unopened vials in the refrigerator; keep opened vials at room temperature (do not refrigerate). - Monitoring: Check blood glucose levels as directed (e.g., before meals and at bedtime). - Hypoglycemia Prevention: Carry fast-acting carbohydrates (e.g., glucose tablets, juice) at all times. Adjust dose if hypoglycemia or hyperglycemia occurs. - Preparation: Gently roll the vial between palms to mix; do not shake vigorously. 2. Hydrochlorothiazide 25 MG Oral Tablet: - Dosage and Timing: Take one tablet orally once daily, preferably in the morning with food or milk to reduce gastrointestinal upset. - Hydration: Maintain adequate fluid intake to prevent dehydration or electrolyte imbalances. - Monitoring: Report symptoms of electrolyte disturbances (e.g., muscle cramps, weakness, fatigue) or dizziness. - Side Effects: Common side effects include increased urination, dizziness, or mild nausea. Follow-Up and Referrals: - Continue monitoring blood glucose levels and medication adherence. - Follow up in 3 months for reevaluation. - Dental referral completed for further assessment/procedures. Provider: Date:

============================================================

## Note 77 (undefined - 998f06cd-d264-7156-3a17-56ba17305e83)

**Note ID:** 998f06cd-d264-7156-3a17-56ba17305e83
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2023-09-23T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 52 years - Sex: Female - Race: White Date of Encounter: Reason for Visit: Check-up for patient referral for dental care (procedure). History of Present Illness: The patient presents for a dental check-up following a prior consultation and referral for dental care. She reports symptoms that may be associated with oral health issues, including potential pain or discomfort while chewing, sensitivity to hot or cold foods, bleeding gums, or halitosis (bad breath). These symptoms may be indicative of underlying dental problems such as plaque buildup, gingivitis, or periodontal disease, which necessitated the referral for dental intervention. Dental Procedures Performed: 1. Dental Consultation and Report: Initial assessment and documentation of dental findings. 2. Dental Care (Regime/Therapy): Comprehensive dental treatment plan discussed and initiated. 3. Removal of Supragingival Plaque and Calculus: Scaling performed to remove plaque and calculus from the visible surfaces of all teeth using dental instruments. 4. Removal of Subgingival Plaque and Calculus: Root planing or deep cleaning performed to remove plaque and calculus from below the gumline using dental instruments. 5. Dental Plain X-Ray (Bitewing): Radiographs taken to assess for cavities, bone loss, or other underlying dental issues. 6. Examination of Gingivae: Evaluation of gum health, including signs of inflammation, bleeding, or recession. 7. Oral Health Education: Patient counseled on proper oral hygiene techniques, including brushing, flossing, and the use of mouthwash to maintain optimal oral health. Findings: - Moderate supragingival plaque and calculus noted on all teeth. - Subgingival plaque and calculus present, particularly in the posterior regions. - Bitewing X-rays revealed no significant cavities but showed mild bone loss in some areas. - Gingival examination revealed mild gingivitis with occasional bleeding upon probing. Plan: - Continue with prescribed dental care regime/therapy. - Schedule follow-up appointment in for re-evaluation. - Reinforce oral health education and recommend daily flossing and use of antiseptic mouthwash. - Monitor for any worsening symptoms such as increased pain, swelling, or mobility of teeth. Provider Signature:

============================================================

## Note 78 (undefined - ea9b34ce-4332-6e12-173b-bd1e2f773a00)

**Note ID:** ea9b34ce-4332-6e12-173b-bd1e2f773a00
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2023-10-21T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 52 years - Gender: Female - Race: White Encounter Date: Reason for Visit: Routine check-up. History of Present Illness: The patient presents for a routine check-up. She reports no acute complaints but mentions ongoing management of diabetes mellitus and hypertension. She has been using insulin therapy and antihypertensive medication as prescribed. No new symptoms were reported, though she may experience occasional symptoms such as: - Hypoglycemia (e.g., dizziness, sweating, confusion) due to insulin therapy. - Hyperglycemia (e.g., increased thirst, frequent urination, fatigue) if blood sugar control is suboptimal. - Orthostatic hypotension (e.g., lightheadedness upon standing) due to hydrochlorothiazide. Social and Dental History: The patient was assessed for health and social care needs. A referral for dental care was made due to reported dental issues requiring procedure(s). Physical Examination: - General: Alert and oriented, appears well-nourished. - Vitals: BP , HR , RR , Temp . - Cardiovascular: Regular rate and rhythm, no murmurs. - Abdominal: Soft, non-tender, no palpable masses. - Extremities: No edema. Assessment: 1. Diabetes mellitus (ongoing management). 2. Hypertension (ongoing management). 3. Dental care needs (referral made). Plan: 1. Medications: - Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension : - - Instructions: Administer subcutaneously once daily, typically in the morning. Rotate injection sites (abdomen, thigh, upper arm) to prevent lipodystrophy. Monitor blood glucose before meals and at bedtime. Adjust dose as needed based on blood glucose readings. Avoid skipping meals after insulin administration to prevent hypoglycemia. - Hydrochlorothiazide 25 MG Oral Tablet: - Dosage: 25 mg orally once daily. - Instructions: Take in the morning to minimize nighttime diuresis. Maintain adequate hydration. Monitor for electrolyte imbalances (e.g., potassium levels) and report symptoms like muscle cramps or weakness. Avoid excessive sun exposure due to photosensitivity risk. 2. Referrals: - Dental referral for procedure(s) as needed. 3. Follow-Up: - Return in for diabetes and hypertension follow-up. Adjust medications as necessary. Provider Signature: Date:

============================================================

## Note 79 (undefined - e5fd4461-1af8-bdf2-7c4d-8889111b23e9)

**Note ID:** e5fd4461-1af8-bdf2-7c4d-8889111b23e9
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2023-11-04T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 52 - Sex: Female - Race: White Reason for Encounter: - Check-up and patient referral for dental care (procedure). Chief Complaint: - Patient presents for dental evaluation and treatment, including a referral for dental care due to symptoms such as gingival inflammation, bleeding gums, and potential dental caries , which may require intervention. History of Present Illness: - The patient reports concerns regarding oral hygiene, gingival health, and potential cavities. She was referred for dental care to address these issues, including plaque and calculus buildup, gingival inflammation, and possible caries. Physical Examination: - General: Alert and oriented. - Oral Cavity: Examination of gingivae revealed mild to moderate inflammation and bleeding on probing. Supragingival and subgingival plaque and calculus were noted on all teeth. Dental Procedures Performed: 1. Dental Consultation and Report: Comprehensive dental evaluation conducted. 2. Dental Care (Regime/Therapy): Implemented a dental care plan to address gingival inflammation and plaque buildup. 3. Removal of Supragingival Plaque and Calculus: Performed using dental instruments. 4. Removal of Subgingival Plaque and Calculus: Performed using dental instruments. 5. Dental Plain X-ray (Bitewing): Taken to assess for dental caries and bone levels. 6. Examination of Gingivae: Evaluated for inflammation, bleeding, and pocket depth. 7. Dental Fluoride Treatment: Applied to strengthen enamel and prevent caries. 8. Oral Health Education: Provided instructions on proper brushing, flossing, and plaque control. Medication Prescribed: - Sodium Fluoride 0.0272 MG/MG Oral Gel – To be used for at-home fluoride treatment. Instructions for Sodium Fluoride 0.0272 MG/MG Oral Gel: - Apply a thin ribbon of gel to a toothbrush and brush teeth thoroughly for 1 minute. - Do not rinse, eat, or drink for at least 30 minutes after application to allow fluoride absorption. - Use once daily before bedtime, preferably after brushing with regular toothpaste. - Avoid swallowing the gel; spit out any excess. - If accidental ingestion occurs, contact a healthcare provider immediately. Plan: - Follow up with the dentist in 6 months for re-evaluation. - Continue daily use of sodium fluoride gel as prescribed. - Maintain good oral hygiene practices, including brushing twice daily and flossing. Disposition: - Patient discharged in stable condition with instructions for follow-up and medication use. Signature:

============================================================

## Note 80 (undefined - b7b57d63-dba6-987c-07f9-a559fe0c8f13)

**Note ID:** b7b57d63-dba6-987c-07f9-a559fe0c8f13
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2024-02-17T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 53 - Sex: Female - Race: White Encounter Date: Reason for Visit: Routine check-up History of Present Illness: The patient presents for a routine check-up. No specific complaints were reported at this time. However, given the patient’s medical history, potential symptoms related to diabetes (e.g., polyuria, polydipsia, fatigue) or hypertension (e.g., headaches, dizziness) should be monitored. Medication Reconciliation: 1. Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension – Used for glycemic control in diabetes. 2. Hydrochlorothiazide 25 MG Oral Tablet – Used for blood pressure management. Assessments Completed: - Assessment of health and social care needs - Depression screening (performed twice) - Assessment of substance use - Alcohol Use Disorders Identification Test – Consumption (AUDIT-C) - Referral for dental care procedure(s) Physical Examination: Plan: 1. Medication Instructions: - Humulin (70/30 insulin mixture): - Inject subcutaneously once or twice daily, as prescribed. - Administer 30 minutes before meals. - Rotate injection sites to avoid lipodystrophy. - Monitor blood glucose levels regularly. - Do not shake the vial; gently roll between palms to mix. - Hydrochlorothiazide 25 mg: - Take orally once daily, preferably in the morning. - Ensure adequate hydration. - May cause dizziness; avoid abrupt postural changes. - Monitor electrolytes (e.g., potassium) as needed. 2. Follow-Up: - Repeat depression screening and AUDIT-C in 3 months. - Follow up with dental provider for recommended procedures. 3. Referrals: - Dental care (procedures to be determined by dentist). Discharge Instructions: - Continue all prescribed medications as directed. - Monitor for signs of hypoglycemia (e.g., sweating, tremors, confusion) or hyperglycemia (e.g., increased thirst, fatigue). - Report any significant changes in mood, substance use, or alcohol consumption. Signature: ,

============================================================

## Note 81 (undefined - 21bc773e-01ac-943a-a3dd-b6ef14dc48ec)

**Note ID:** 21bc773e-01ac-943a-a3dd-b6ef14dc48ec
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2024-03-02T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 53 - Sex: Female - Race: White Reason for Encounter: Check-up for patient referral for dental care (procedure). History of Present Illness: The patient is a 53-year-old female who was referred for dental care due to symptoms potentially related to oral health issues. These may include: - Persistent bad breath (halitosis) - Gum bleeding, swelling, or tenderness (gingivitis/periodontitis) - Tooth sensitivity or pain - Loose teeth or changes in bite alignment - Difficulty chewing or speaking due to oral discomfort - Visible plaque or tartar buildup on teeth Clinical Findings & Procedures Performed: 1. Dental Consultation and Report: Reviewed patient’s dental history and concerns. 2. Dental Care (Regime/Therapy): Established a treatment plan for addressing identified oral health issues. 3. Removal of Supragingival Plaque and Calculus: Performed using dental instruments to clean visible plaque and tartar from all tooth surfaces. 4. Removal of Subgingival Plaque and Calculus: Performed using dental instruments to address plaque and calculus below the gumline. 5. Examination of Gingivae: Evaluated gum health for signs of inflammation, infection, or recession. 6. Oral Health Education: Provided patient with instructions on proper brushing, flossing, and maintenance of oral hygiene to prevent recurrence of issues. Plan: - Continue with prescribed oral hygiene regimen. - Schedule follow-up dental visits as recommended. - Monitor for any recurrence of symptoms (e.g., bleeding gums, pain, or halitosis). Provider Signature:

============================================================

## Note 82 (undefined - 2f468f2c-ea71-6ec3-b796-7b71b65e9b63)

**Note ID:** 2f468f2c-ea71-6ec3-b796-7b71b65e9b63
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Trinity427 Hartmann983
**Date:** 2024-03-23T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Fritsch593 - Age: 53 years - Sex: Female - Race: White Encounter Date: Reason for Visit: General examination History of Present Illness: The patient presented for a general examination. No specific complaints were reported at this time. However, the patient is currently on insulin therapy for diabetes management and hydrochlorothiazide for blood pressure control. Medication Reconciliation: 1. Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension : - Dosage: As prescribed by the provider. - Instructions: Administer subcutaneously once or twice daily, typically 15-30 minutes before meals. Rotate injection sites to prevent lipodystrophy. Monitor blood glucose levels regularly to adjust dosing as needed. 2. Hydrochlorothiazide 25 MG Oral Tablet : - Dosage: 25 mg orally once daily. - Instructions: Take in the morning to minimize nighttime urination. Adequate hydration is recommended. Monitor for electrolyte imbalances (e.g., potassium levels) and report symptoms such as muscle cramps, weakness, or dizziness. Assessments Performed: - Assessment of health and social care needs. - Assessment of anxiety. - Assessment of substance use. - Alcohol Use Disorders Identification Test - Consumption (AUDIT-C). Referrals: - Dental care procedure(s) performed. Potential Symptoms: Given the patient’s current medications, potential symptoms to monitor include: - Hypoglycemia (from insulin therapy): Symptoms may include sweating, tremors, confusion, palpitations, or dizziness. - Hyperglycemia (if insulin dose is insufficient): Symptoms may include increased thirst, frequent urination, fatigue, or blurred vision. - Electrolyte imbalances (from hydrochlorothiazide): Symptoms may include muscle cramps, weakness, or irregular heartbeat. - Anxiety or substance use-related concerns as identified during assessment. Plan: - Continue current medications with proper adherence. - Schedule follow-up appointments for diabetes and blood pressure monitoring. - Follow up with dental provider for recommended procedures. - Monitor for any adverse effects or symptoms related to medications and report them promptly. Signature: ,

============================================================

## Note 83 (undefined - 39685b46-9f39-49d4-34b3-8368b3345b07)

**Note ID:** 39685b46-9f39-49d4-34b3-8368b3345b07
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2024-03-30T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Okay, here is a medical note for the encounter, incorporating the provided details and adding relevant standard information. Medical Record Note Patient: Fritsch593, Felisha640, Adelaide981 Age: 53 Sex: Female Race: White Date of Encounter: Attending/Provider: Reason for Visit: Routine check-up. Subjective: Patient presents for a routine check-up. She is currently managed with insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension and Hydrochlorothiazide 25 MG Oral Tablet. She reports no specific complaints today but acknowledges managing underlying conditions (presumably diabetes mellitus and hypertension, given the medications). No acute symptoms reported. Objective: Vitals: Physical Examination: Laboratory Data: Assessment: 1. Diabetes Mellitus: Currently managed with Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension . Patient is on a basal-bolus or premixed insulin regimen. Potential Symptoms: Monitor for signs of hypo- or hyperglycemia. Symptoms of hypoglycemia (low blood sugar) can include sweating, tremor, palpitations, hunger, confusion, dizziness, and potentially loss of consciousness. Symptoms of hyperglycemia (high blood sugar) can include increased thirst, increased urination, fatigue, and blurred vision. Patient should monitor blood glucose levels as directed.
2. Hypertension: Currently managed with Hydrochlorothiazide 25 MG Oral Tablet. Potential Symptoms: Thiazide diuretics like Hydrochlorothiazide can cause electrolyte imbalances. Monitor for symptoms of low potassium (muscle cramps, weakness, irregular heartbeat) or dehydration (thirst, decreased urination, dizziness). Monitor blood pressure regularly.
3. Routine Check-up: Annual preventative health assessment. Plan: 1. Continue Medications: Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension : Instructions: Take subcutaneously . Inject under the skin (subcutaneously) using a syringe and needle or an insulin pen device. Rotate injection sites daily (e.g., abdomen, thigh, upper arm, buttocks) to prevent lipodystrophy. Do not shake vigorously; gently roll the vial/pen between palms if needed before drawing up/using. Follow specific instructions regarding meal timing relative to injection. Monitor blood glucose levels regularly as instructed. Know the signs and symptoms of hypoglycemia and hyperglycemia and how to treat hypoglycemia (e.g., with fast-acting carbohydrates). Store unopened insulin in the refrigerator; opened vials/pens can often be stored at room temperature (check specific product information) but discard after the recommended time (e.g., 28 days). Hydrochlorothiazide 25 MG Oral Tablet: Instructions: Take one tablet by mouth once daily, preferably in the morning with food or milk to minimize stomach upset. Take as prescribed, even if feeling well. This medication helps control blood pressure. It may increase urination. Increase fluid intake and maintain an adequate potassium-rich diet or take potassium supplements as advised by your provider, as this medication can lower potassium levels. Avoid excessive sun exposure and use sunscreen, as thiazides can increase sensitivity to sunlight. Report muscle cramps or weakness to the provider.
2. Monitoring: Continue regular blood glucose monitoring. Monitor blood pressure at home if advised. Schedule follow-up appointment in or sooner if symptoms occur or blood glucose/blood pressure control deteriorates.
3. Lifestyle: Encourage continued adherence to a healthy diet, regular physical activity as tolerated, smoking cessation if applicable, and weight management.
4. Follow-up: Return in for medication review and monitoring of blood glucose and blood pressure control. Patient should contact the office if experiencing symptoms of hypoglycemia (shakiness, sweating, confusion) or hyperglycemia (increased thirst/urination, fatigue), or if blood glucose readings are consistently out of the target range, or if blood pressure readings are consistently elevated.

============================================================

## Note 84 (undefined - 04a426de-346f-2335-022c-c05bda03343f)

**Note ID:** 04a426de-346f-2335-022c-c05bda03343f
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2024-04-06T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 53 - Sex: Female - Race: White Date of Encounter: Reason for Visit: Check-up for Gingivitis History of Present Illness: The patient presents for a dental check-up due to concerns regarding gingivitis. She reports symptoms commonly associated with gingivitis, including: - Mild to moderate gum redness and swelling (gingival inflammation) - Bleeding gums, particularly during brushing or flossing - Possible mild tenderness or discomfort in the gums - No reported tooth mobility or loose teeth at this time Past Medical History: Dental Consultation & Findings: - Dental Consultation: Performed with review of patient’s dental history and concerns. - Dental Report: Reviewed prior dental records, noting presence of gingivitis. - Dental Care (Regime/Therapy): Discussed and reinforced proper oral hygiene practices, including brushing techniques and flossing. - Removal of Supragingival Plaque and Calculus: Performed using dental instruments to remove visible plaque and calculus from all tooth surfaces. - Removal of Subgingival Plaque and Calculus: Performed using dental instruments to address plaque and calculus below the gumline. - Dental Plain X-ray (Bitewing): Obtained to assess bone levels and detect any underlying pathology. No significant findings noted. - Examination of Gingivae: Revealed generalized mild-to-moderate gingival inflammation with some bleeding on probing. No evidence of periodontal pockets >4mm at this time. - Oral Health Education: Provided education on proper brushing, flossing, and the importance of regular dental visits to prevent progression to periodontitis. Plan: 1. Continue diligent oral hygiene practices, including brushing twice daily with fluoride toothpaste and daily flossing. 2. Return for a follow-up dental cleaning in 3 months to monitor gingival health. 3. Consider use of an antiseptic mouth rinse (e.g., chlorhexidine) if gingival inflammation persists. 4. Maintain regular dental check-ups every 6 months. Provider Signature:

============================================================

## Note 85 (undefined - b11f3267-898b-be15-39b8-b00d1d9cc813)

**Note ID:** b11f3267-898b-be15-39b8-b00d1d9cc813
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2024-04-20T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 53 years - Gender: Female - Race: White Reason for Encounter: Routine check-up for ongoing medical management. History of Present Illness: The patient presents for a follow-up visit to assess her current health status and medication management. She has a history of diabetes mellitus and hypertension, which are being managed with the following medications: insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension , and Hydrochlorothiazide 25 MG Oral Tablet. Review of Systems: - Endocrine: The patient may experience symptoms such as fatigue, increased thirst, frequent urination, or dizziness, which could be related to her diabetes management. - Cardiovascular: No reported chest pain, shortness of breath, or palpitations. However, she may experience mild edema due to her hypertension and diuretic use. - Neurological: No reported headaches, dizziness, or confusion. - Gastrointestinal: No reported nausea, vomiting, or abdominal pain. - Renal: No reported changes in urination patterns beyond those associated with her diabetes. - Substance Use: The patient was assessed for substance use, and no current drug or alcohol abuse was reported. Physical Examination: - General: Alert and oriented ×3, appears well-nourished. - Vital Signs: BP 130/80 mmHg, HR 78 bpm, RR 16 breaths/min, Temp 98.6°F. - Cardiovascular: Regular rate and rhythm, no murmurs or gallops. - Abdominal: Soft, non-tender, no hepatosplenomegaly. - Extremities: Mild bilateral lower extremity edema, consistent with diuretic use. Medication Reconciliation: 1. Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension : - Dosage: As prescribed by the provider. - Instructions: Administer subcutaneously once daily, typically before breakfast or dinner. Rotate injection sites to prevent lipodystrophy. Monitor blood glucose levels as directed. - Side Effects: Hypoglycemia (symptoms include sweating, tremors, confusion, or weakness), weight gain, or local injection site reactions. 2. Hydrochlorothiazide 25 MG Oral Tablet: - Dosage: 25 mg once daily. - Instructions: Take orally with or without food. Ensure adequate fluid intake to prevent dehydration. - Side Effects: Dizziness, electrolyte imbalances (e.g., hypokalemia), or increased urination. Assessments Performed: - Assessment of health and social care needs. - Assessment of substance use (negative for drug or alcohol abuse). - Screening for drug abuse (negative). - Referral for dental care procedure(s) due to reported dental concerns. Plan: - Continue current medications with close monitoring of blood glucose and blood pressure. - Follow up in 3 months for reevaluation. - Schedule dental referral as needed. - Educate patient on hypoglycemia prevention and management. Signature: ,

============================================================

## Note 86 (undefined - 07e62e74-9996-1400-d1ee-b3735de2d2d2)

**Note ID:** 07e62e74-9996-1400-d1ee-b3735de2d2d2
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2024-05-04T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 53 years - Sex: Female - Race: White Reason for Encounter: - Routine dental check-up and follow-up for patient referral for dental care (procedure). Symptoms: - Patient may have experienced symptoms such as toothache, sensitivity, or discomfort due to the need for dental care (procedure). These symptoms could be caused by conditions such as dental caries, fractured tooth, or periodontal disease, which necessitated the referral for dental care. Dental Consultation and Procedures Performed: - Dental consultation and report completed. - Dental care (regime/therapy) initiated. - Removal of supragingival plaque and calculus from all teeth using dental instruments. - Removal of subgingival plaque and calculus from all teeth using dental instruments. - Examination of gingivae. - Application of composite dental filling material to dentin of tooth following fracture of tooth. - Dental fluoride treatment administered. - Oral health education procedure(s) performed. Prescription: - Sodium fluoride 0.0272 MG/MG Oral Gel prescribed. Instructions for Taking Sodium Fluoride 0.0272 MG/MG Oral Gel: - Apply a small amount (pea-sized) of the gel to your teeth using a toothbrush or a clean finger. - Gently brush the gel onto all surfaces of your teeth for 1 minute. - Spit out the excess gel after brushing, but do not rinse your mouth with water for at least 30 minutes to allow the fluoride to work effectively. - Use the gel once daily, preferably at bedtime, after brushing your teeth with regular toothpaste. - Do not swallow the gel. If swallowed, contact your healthcare provider or seek medical attention immediately. Follow-Up: - Schedule a follow-up appointment in 6 months for another dental check-up and evaluation. Signature:

============================================================

## Note 87 (undefined - dc61d4f9-d492-ced2-743c-2e3ae532a75c)

**Note ID:** dc61d4f9-d492-ced2-743c-2e3ae532a75c
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2024-06-22T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient: Fritsch593, 53-year-old white female Date of Encounter: Reason for Visit: Routine check-up ### Subjective: Patient presents for a routine check-up. She reports no acute complaints but mentions ongoing management of diabetes and hypertension. No new symptoms reported. Patient reports adherence to current medications. ### Objective: - Vitals: - Assessments Performed: - Health and social care needs assessment - Depression screening (negative) - Substance use assessment (negative) - Alcohol Use Disorders Identification Test—Consumption (AUDIT-C) (negative) - Referrals: - Dental care procedure(s) (reason not specified in note) ### Assessment: Patient is stable with controlled diabetes and hypertension. No signs of depression or substance use. Dental referral indicates potential need for oral health intervention. ### Plan: 1. Medications: - Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension : - Instructions: Administer subcutaneously once daily, preferably in the morning. Rotate injection sites (abdomen, thigh, upper arm) to prevent lipodystrophy. Do not shake vigorously; gently roll between palms if needed. Take with breakfast or before the first meal of the day. Monitor blood glucose levels as per prior instructions. - Hydrochlorothiazide 25 MG Oral Tablet: - Instructions: Take one tablet orally once daily in the morning. Ensure adequate hydration (8-10 glasses of water daily). Avoid alcohol, as it may potentiate dizziness. Monitor for signs of electrolyte imbalances (e.g., muscle cramps, weakness). 2. Follow-Up: - Repeat HbA1c and renal function tests in 3 months. - Schedule dental appointment within 1 month. 3. Education: - Review signs of hypoglycemia (e.g., sweating, tremors, confusion) and hyperglycemia (e.g., thirst, polyuria). - Encourage continued adherence to medication and lifestyle modifications. ### Symptoms to Monitor: - Hypoglycemia: Shakiness, sweating, confusion, rapid heartbeat (due to insulin). - Hyperglycemia: Increased thirst, frequent urination, fatigue (if blood glucose remains uncontrolled). - Hydrochlorothiazide Side Effects: Dizziness, electrolyte imbalances, increased urination. Provider: Signature:

============================================================

## Note 88 (undefined - 99cb33a1-9ca2-dcbd-31a5-8ce2ad42b547)

**Note ID:** 99cb33a1-9ca2-dcbd-31a5-8ce2ad42b547
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2024-07-06T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 53 years - Sex: Female - Race: White Reason for Encounter: Check-up and patient referral for dental care (procedure). History of Present Illness: The patient presents for a dental check-up following a prior dental consultation and report. She reports symptoms that may be associated with poor oral hygiene or periodontal disease, including: - Mild to moderate gingival bleeding upon brushing or flossing. - Occasional discomfort or sensitivity in the gums. - Possible halitosis (bad breath) or a persistent metallic taste in the mouth. - No reported severe toothache or loose teeth at this time. Dental Procedures Performed: 1. Dental Consultation and Report: Initial assessment of oral health status. 2. Dental Care (Regime/Therapy): Established a personalized oral hygiene plan. 3. Removal of Supragingival Plaque and Calculus: Scaling performed using dental instruments to remove plaque and tartar from above the gumline. 4. Removal of Subgingival Plaque and Calculus: Root planing performed to remove plaque and calculus from below the gumline. 5. Dental Plain X-ray (Bitewing): Taken to evaluate interdental areas and assess for cavities or bone loss. 6. Examination of Gingivae: Gingival health assessed for inflammation, recession, or pockets. 7. Oral Health Education: Patient educated on proper brushing, flossing techniques, and the importance of regular dental visits. Findings: - Moderate supragingival calculus noted on multiple teeth. - Mild subgingival calculus present in posterior regions. - Gingival inflammation observed, with slight bleeding on probing in several areas. - Bitewing X-rays show no significant caries or bone loss at this time. Plan: - Continue with recommended oral hygiene regimen. - Schedule follow-up dental cleaning in 6 months. - Encourage daily flossing and use of an antiseptic mouthwash. - Refer back to dentist if symptoms worsen or new concerns arise. Disposition: Patient discharged in stable condition with improved oral hygiene instructions. Signature: ,

============================================================

## Note 89 (undefined - 5756138d-9027-e3a4-9866-b36619bfbdfd)

**Note ID:** 5756138d-9027-e3a4-9866-b36619bfbdfd
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2024-11-16T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 53 - Sex: Female - Race: White Encounter Date: Reason for Visit: Routine check-up. History of Present Illness: The patient presents for a routine check-up. No specific complaints were reported at this time. The patient is currently managing diabetes mellitus and hypertension, for which she is prescribed insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension and Hydrochlorothiazide 25 MG Oral Tablet. Assessment of Health and Social Care Needs: - Screening for domestic abuse: Negative. - Depression screening: Negative. - Assessment of substance use: Negative for drug or alcohol abuse. Immunizations Administered: - Influenza, seasonal, injectable, preservative free. Medications: 1. Insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension : - Instructions: Inject subcutaneously once daily, typically before breakfast or as prescribed. Rotate injection sites to prevent lipodystrophy. Monitor blood glucose levels as directed. May cause hypoglycemia (symptoms include sweating, tremors, confusion, dizziness) or hyperglycemia (symptoms include increased thirst, urination, fatigue). Adjust dose as needed based on blood glucose readings and dietary intake. 2. Hydrochlorothiazide 25 MG Oral Tablet : - Instructions: Take orally once daily in the morning with food or as directed. May cause dizziness, electrolyte imbalances (e.g., low potassium), or increased urination. Avoid alcohol and limit salt intake. Report any unusual fatigue, muscle cramps, or changes in urination. Referrals: - Dental care: Referral made for dental procedure(s). Plan: - Continue current medications with proper adherence. - Schedule follow-up in for diabetes and hypertension management. - Monitor for any adverse effects of medications. - Encourage regular exercise and a balanced diet. Signature: ,

============================================================

## Note 90 (undefined - 4037aba5-3d73-5b95-36cd-fbe965697dfb)

**Note ID:** 4037aba5-3d73-5b95-36cd-fbe965697dfb
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Zane918 Bosco882
**Date:** 2024-11-30T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593
- Age: 53 years
- Gender: Female
- Race: White
- Date of Visit: Chief Complaint: The patient presents to the urgent care clinic for assessment of health and social care needs. History of Present Illness: The patient is a 53-year-old white female who has been prescribed insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension , Hydrochlorothiazide 25 MG Oral Tablet. She has been experiencing symptoms that may be caused by the medication or an underlying condition. The patient has also undergone assessment of anxiety, depression screening, depression screening, assessment of substance use, and screening for drug abuse. Past Medical History: - Diabetes Mellitus
- Hypertension Medications: 1. Insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension 2. Hydrochlorothiazide 25 MG Oral Tablet Allergies: No known drug allergies. Physical Examination: - General: The patient appears well-nourished and in no acute distress.
- Vital Signs: Blood pressure, heart rate, respiratory rate, and temperature are within normal limits.
- Abdomen: Soft, non-tender, and non-distended.
- Skin: No signs of injection site reactions. Assessment: The patient has been assessed for health and social care needs, anxiety, depression, and substance use. She has also been screened for drug abuse. The patient has been referred for dental care procedure(s). Plan: 1. Medication Instructions: - Insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension : - Administer subcutaneously once daily, preferably at the same time each day. - Rotate injection sites to prevent lipodystrophy. - Monitor blood glucose levels regularly and adjust dosage as needed. - Store unopened insulin in the refrigerator and opened insulin at room temperature. - Hydrochlorothiazide 25 MG Oral Tablet: - Take one tablet orally once daily, preferably in the morning. - Ensure adequate fluid intake to prevent dehydration. - Monitor blood pressure regularly. 2. Referrals: - Referral for dental care procedure(s) has been made. 3. Follow-Up: - Schedule a follow-up appointment in to monitor medication effectiveness and address any concerns. 4. Education: - Educate the patient on the importance of adherence to medication and lifestyle modifications. - Provide resources for managing diabetes and hypertension. Signature:

============================================================

## Note 91 (undefined - 9ea31cb1-fd26-509b-af42-f53b9500a9dc)

**Note ID:** 9ea31cb1-fd26-509b-af42-f53b9500a9dc
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Zane918 Bosco882
**Date:** 2024-12-07T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Urgent Care Clinic Medical Note Patient Information: - Name: Fritsch593, Adelaide981 Felisha640 - Age: 53 years - Sex: Female - Race: White Date of Encounter: Clinic: Urgent Care Clinic Reason for Visit: The patient presented to the urgent care clinic for medication reconciliation and management of underlying conditions. History of Present Illness: The patient was prescribed the following medications for ongoing management of diabetes mellitus and hypertension: 1. Insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension – for glycemic control. 2. Hydrochlorothiazide 25 MG Oral Tablet – for blood pressure management. The patient reported no acute symptoms but was seen for medication reconciliation to ensure proper dosing and administration. Symptoms to Monitor (Potential Side Effects): - Hyperglycemia (High Blood Sugar): Possible symptoms include increased thirst, frequent urination, fatigue, and blurred vision. - Hypoglycemia (Low Blood Sugar): Possible symptoms include sweating, tremors, confusion, dizziness, and weakness. - Electrolyte Imbalances (from Hydrochlorothiazide): Possible symptoms include muscle cramps, weakness, or increased thirst. Medication Instructions: 1. Insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension : - This is a 70/30 insulin mixture (70% intermediate-acting insulin isophane and 30% short-acting insulin regular). - Administer subcutaneously (under the skin) once daily, typically in the morning. - Rotate injection sites (e.g., abdomen, thighs, arms) to prevent lipodystrophy. - Monitor blood glucose levels as prescribed by the physician. - Store unopened vials in the refrigerator; once opened, keep at room temperature for up to 28 days. 2. Hydrochlorothiazide 25 MG Oral Tablet: - Take one tablet by mouth once daily , preferably in the morning. - Ensure adequate fluid intake to prevent dehydration. - May cause dizziness; avoid sudden changes in posture. Procedures Performed: - Medication reconciliation completed. Plan: - Continue current medications as prescribed. - Follow up with primary care physician for ongoing management. - Educate patient on monitoring for hypoglycemia and hyperglycemia symptoms. - Schedule lab work for electrolyte levels and renal function as needed. Provider Signature:

============================================================

## Note 92 (undefined - 04690eb7-847e-5368-a4f1-5ea3c94a4094)

**Note ID:** 04690eb7-847e-5368-a4f1-5ea3c94a4094
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Cherrie404 Conn188
**Date:** 2024-12-14T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Emergency Department Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 53 years - Race: White - Sex: Female Chief Complaint: Brought to the emergency room for severe symptoms of diabetic ketoacidosis (DKA) . History of Present Illness: The patient is a 53-year-old female who presented with symptoms consistent with diabetic ketoacidosis, including nausea, vomiting, abdominal pain, and significant polyuria. She was found to be in a state of altered mental status with Kussmaul respirations and severe dehydration. The patient has a known history of diabetes mellitus, and her home medications include insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension and Hydrochlorothiazide 25 MG Oral Tablet. It is unclear whether her insulin regimen was followed appropriately prior to presentation. Past Medical History: - Diabetes mellitus (type 1 or 2 not specified) - Hypertension - Anxiety (screening performed) - Depression (screening performed) - Substance use (screening performed) Medications: 1. Insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension : - Instructions: Administer subcutaneously once daily, typically before breakfast. Rotate injection sites to prevent lipodystrophy. Ensure proper mixing of the suspension by gently rolling the vial between palms before drawing up the dose. Monitor blood glucose levels as prescribed. 2. Hydrochlorothiazide 25 MG Oral Tablet : - Instructions: Take one tablet orally once daily, preferably in the morning to minimize diuresis during sleep. Ensure adequate hydration. Monitor electrolytes (especially potassium) and renal function as ordered. Procedures Performed: - Assessment of health and social care needs - Assessment of anxiety - Depression screening - Depression screening (repeated) - Assessment of substance use - Screening for drug abuse Physical Examination: - Vitals: T 38.2°C, HR 110 bpm, BP 90/60 mmHg, RR 24 breaths/min, SpO2 95% on room air. - General: Altered mental status, lethargic, dehydrated appearance. - Abdomen: Tender, non-tender, no guarding. - Respiratory: Kussmaul respirations noted. Diagnostic Studies: - Fingerstick blood glucose: 450 mg/dL - Venous blood gas: pH 7.15, HCO3 10 mEq/L - Urinalysis: Glucosuria +4, Ketones +4 - Basic metabolic panel: BUN 40 mg/dL, Creatinine 2.1 mg/dL, Hyperkalemia Assessment & Plan: 1. Diagnosis: Diabetic ketoacidosis (DKA). 2. Immediate Management: - IV normal saline infusion at 1 L over the first hour, then adjusted based on fluid status. - IV regular insulin infusion at 0.1 U/kg/hr after initial fluid resuscitation. - Electrolyte replacement (potassium, magnesium as needed). - Continuous cardiac and glucose monitoring. 3. Further Workup: - Electrocardiogram (ECG) to assess for hyperkalemia effects. - Repeat blood gas and glucose levels every 2 hours. 4. Disposition: Admit to the intensive care unit (ICU) for close monitoring. 5. Follow-Up: - Educate patient/family on proper insulin administration and hypoglycemia prevention. - Refer to endocrinology for long-term diabetes management. - Address psychosocial factors (anxiety, depression, substance use) with psychiatric consult if needed. Signature: ,

============================================================

## Note 93 (undefined - 1fbb8e04-32fd-d74d-9f1d-b4639c62db8f)

**Note ID:** 1fbb8e04-32fd-d74d-9f1d-b4639c62db8f
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Zane918 Bosco882
**Date:** 2024-12-21T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Okay, here is a medical note based on the information provided. Please Note: This note is generated based on the limited information provided (patient identifiers, age, medications, clinic type). It is incomplete and lacks crucial details like chief complaint, history, physical exam, and specific findings that would be present in a real medical encounter. The symptoms and instructions are general examples. In a real scenario, the scribe would document the actual patient's presentation and the provider's specific instructions. Medical Note Patient Identification: Name: DOB: MRN: Age: 53 y/o Sex: Female Race: White Location: Urgent Care Clinic Date of Service: Time of Service: Provider: Chief Complaint: History of Present Illness: The patient is a 53-year-old female presenting to the urgent care clinic today. Based on the medications observed/prescribed, she appears to be managed for Diabetes Mellitus (likely Type 2, given the use of a premixed insulin) and Hypertension. The specific reason for this visit is not documented in the provided information. However, common symptoms potentially related to her underlying conditions or medication management that might prompt an urgent care visit could include: Hyperglycemia symptoms (e.g., increased thirst, increased urination, fatigue, blurred vision, unintended weight loss). Hypoglycemia symptoms (e.g., sweating, tremor, palpitations, confusion, dizziness, weakness, potentially related to insulin dosing or timing). Symptoms potentially related to Hypertension (e.g., headache, dizziness, shortness of breath, though often asymptomatic). Concerns about medication side effects (e.g., electrolyte imbalances like low potassium from Hydrochlorothiazide, injection site reactions from insulin). Acute illness potentially affecting blood sugar control. Note: This history is inferred from the medication list and is not based on a documented patient interview or examination. Past Medical History (Inferred from Medications): Diabetes Mellitus (Type likely 2) Hypertension Medications: 1. Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension Indication: Diabetes Mellitus Instructions (General): Administer subcutaneously (under the skin) as prescribed. This is typically a twice-daily injection, often given before meals (e.g., breakfast and dinner). Rotate injection sites (e.g., abdomen, thigh, upper arm, buttocks) to prevent lipodystrophy. Draw up the correct dose using a U-100 insulin syringe. Inject at room temperature. Monitor blood glucose levels regularly as directed. Be aware of signs and symptoms of hypoglycemia (low blood sugar) and hyperglycemia (high blood sugar). The specific dose, timing, and any instructions regarding blood sugar adjustments should be clarified with the prescribing provider.
2. Hydrochlorothiazide 25 MG Oral Tablet Indication: Hypertension Instructions (General): Take one tablet by mouth once daily, preferably in the morning. Taking it later in the day may increase the risk of nighttime urination (nocturia). Take exactly as prescribed, even if feeling well. Do not stop taking it without consulting the doctor. This medication can affect electrolytes (especially potassium); periodic monitoring may be required as directed by the provider. May increase sensitivity to sunlight; use sun protection. Report any muscle cramps, weakness, or signs of dehydration to the provider. Allergies: Review of Systems: Physical Examination: Assessment: 1. Patient presenting to urgent care. .
2. Currently prescribed Humulin 70/30 insulin and Hydrochlorothiazide 25mg. Plan: Educate patient on potential symptoms related to their conditions (hyper/hypoglycemia, HTN effects) and medication side effects (especially HCTZ-related). Reinforce medication instructions as documented above. Advise patient to follow up with their primary care provider or endocrinologist as scheduled or sooner if symptoms arise or worsen. . Signature: Scribed by: Provider:

============================================================

## Note 94 (undefined - 02b8e8b0-f02c-2364-8c50-c30a313cc33c)

**Note ID:** 02b8e8b0-f02c-2364-8c50-c30a313cc33c
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Zane918 Bosco882
**Date:** 2024-12-28T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Urgent Care Clinic Visit Note Patient Information: - Name: Fritsch593, Adelaide981 Felisha640 - Age: 53 years - Sex: Female - Race: White Reason for Visit: Urgent care clinic visit for medication reconciliation and assessment of health and social care needs. History of Present Illness: The patient presents today for medication reconciliation and assessment of health and social care needs. She reports taking insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension and Hydrochlorothiazide 25 MG Oral Tablet. No specific acute complaints were reported, but the patient was also assessed for anxiety, depression, and screened for domestic abuse as part of a comprehensive health evaluation. Medication Reconciliation & Instructions: 1. Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension : - Indication: Diabetes management. - Dosage: As prescribed (specific dose and frequency not documented in this encounter). - Instructions: - Inject subcutaneously as directed by the prescribing physician. - Rotate injection sites to avoid lipohypertrophy or skin irritation. - Monitor blood glucose levels regularly. - Symptoms of hypoglycemia (low blood sugar) may include sweating, tremors, confusion, or dizziness. If hypoglycemia occurs, treat with 15 grams of fast-acting carbohydrates (e.g., glucose tablets, juice) and recheck blood sugar in 15 minutes. - Symptoms of hyperglycemia (high blood sugar) may include increased thirst, frequent urination, fatigue, or blurred vision. Contact a healthcare provider if these symptoms persist. 2. Hydrochlorothiazide 25 MG Oral Tablet: - Indication: Hypertension or fluid management. - Dosage: 25 mg orally once daily. - Instructions: - Take once daily, preferably in the morning to avoid nocturia (nighttime urination). - May cause dizziness or electrolyte imbalances (e.g., low potassium). Monitor for symptoms such as muscle cramps or weakness. - Maintain adequate hydration and a balanced diet. Assessments Performed: - Medication reconciliation. - Assessment of health and social care needs. - Assessment of anxiety. - Screening for domestic abuse. - Depression screening (procedure(s) performed). Plan: - Continue current medications as prescribed. - Follow up with primary care physician for ongoing management of diabetes and hypertension. - Referral to mental health services if depression or anxiety symptoms are significant. - Recommend routine monitoring of blood glucose, blood pressure, and electrolytes. Signature: ,

============================================================

## Note 95 (undefined - 2df5580d-9e3d-4fa2-067e-efe7f77e6042)

**Note ID:** 2df5580d-9e3d-4fa2-067e-efe7f77e6042
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2025-01-04T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593
- Age: 53 years
- Gender: Female
- Race: White Reason for Encounter: Routine check-up. History of Present Illness: The patient presents for a routine check-up. During the encounter, a medication reconciliation was performed to ensure all current medications are accounted for and appropriate for the patient's condition. The patient is currently prescribed the following medications:
1. Insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension 2. Hydrochlorothiazide 25 MG Oral Tablet Symptoms: The patient may experience symptoms related to the prescribed medications. Potential symptoms include:
- Hypoglycemia (low blood sugar) with insulin use, which may present as sweating, tremors, confusion, dizziness, or rapid heartbeat.
- Hyperglycemia (high blood sugar) if insulin dosage is insufficient, which may present as increased thirst, frequent urination, fatigue, or blurred vision.
- Electrolyte imbalances (e.g., hyponatremia, hypokalemia) with Hydrochlorothiazide use, which may present as muscle cramps, weakness, dizziness, or irregular heartbeat.
- Photosensitivity or allergic reactions to Hydrochlorothiazide, which may present as rash or itching. Medication Instructions: 1. Insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension : - This is a premixed insulin containing 70% intermediate-acting insulin isophane and 30% short-acting insulin regular. - Administer subcutaneously as directed by the healthcare provider. The injection should be given at the same time each day to maintain consistent blood sugar control. - Rotate injection sites to prevent lipodystrophy (changes in fat tissue under the skin). - Do not shake the insulin vial vigorously; gently roll it between the palms to mix the contents. - Monitor blood glucose levels regularly as advised by the healthcare provider. - Be aware of the signs and symptoms of hypoglycemia and have a fast-acting carbohydrate (e.g., glucose tablets, juice) available to treat low blood sugar if it occurs. 2. Hydrochlorothiazide 25 MG Oral Tablet: - Take one tablet by mouth once daily, preferably in the morning to minimize the risk of nighttime urination (nocturia). - Take with food or milk to reduce the risk of stomach upset. - Ensure adequate fluid intake throughout the day to prevent dehydration. - Be mindful of potential side effects such as dizziness or electrolyte imbalances. If experiencing severe dizziness or signs of electrolyte imbalance, contact the healthcare provider. - Avoid prolonged exposure to sunlight or use sunscreen, as Hydrochlorothiazide may increase sensitivity to sunlight. Follow-Up: The patient will be advised to follow up in for monitoring of blood glucose levels, blood pressure, and electrolyte levels. Any concerning symptoms should be reported to the healthcare provider promptly. Provider Signature:

============================================================

## Note 96 (undefined - 5e72fd15-55a1-2ec7-66f7-fbd9a2600191)

**Note ID:** 5e72fd15-55a1-2ec7-66f7-fbd9a2600191
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2025-01-11T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 54 years - Sex: Female - Race: White Reason for Encounter: Check-up for Gingivitis. History of Present Illness: The patient presents for a dental check-up due to concerns regarding Gingivitis. She reports symptoms commonly associated with Gingivitis, including: - Bleeding gums , particularly during brushing or flossing. - Swollen or inflamed gums , which may appear red or dark pink instead of a healthy pink color. - Tenderness or discomfort in the gum tissue. - Bad breath (halitosis) , possibly due to bacterial buildup. - Receding gums , though this may also indicate progression to periodontitis if untreated. The patient denies systemic symptoms such as fever or malaise, but acknowledges that poor oral hygiene has been a contributing factor. Dental Consultation and Findings: - Dental Consultation: Reviewed prior dental consultation report, noting ongoing concerns about Gingivitis. - Dental Care Regime/Therapy: Discussed and reinforced proper oral hygiene practices, including brushing techniques and the use of antiseptic mouthwash. - Removal of Supragingival Plaque and Calculus: Performed using dental instruments to remove hardened plaque (tartar) from the tooth surfaces above the gumline. - Removal of Subgingival Plaque and Calculus: Conducted using specialized instruments to clean plaque and calculus beneath the gumline, addressing areas contributing to inflammation. - Dental Plain X-ray (Bitewing): Taken to assess bone levels and detect any underlying issues, such as early bone loss. Results were within normal limits for the time being. - Examination of Gingivae: Revealed generalized mild-to-moderate gingival inflammation with localized areas of bleeding upon probing. No deep pockets suggestive of periodontitis were noted. - Oral Health Education: Provided detailed instructions on maintaining optimal oral hygiene, emphasizing daily flossing, proper brushing, and regular dental visits. Plan: 1. Continue with diligent oral hygiene practices, including brushing twice daily with fluoride toothpaste and daily flossing. 2. Use an antiseptic mouthwash as recommended to reduce bacterial load. 3. Schedule follow-up appointment in 3 months to reassess gingival health and ensure Gingivitis is under control. 4. Encourage routine dental visits every 6 months for preventive care. Signature:

============================================================

## Note 97 (undefined - 74d9017d-7e5c-6f54-25ec-313230de9094)

**Note ID:** 74d9017d-7e5c-6f54-25ec-313230de9094
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2025-01-18T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 54 - Sex: Female - Race: White Chief Complaint: Patient presents with symptoms concerning for viral sinusitis. History of Present Illness: The patient reports a 5-day history of progressive facial pressure, nasal congestion, and purulent nasal discharge. She also describes worsening frontal and maxillary sinus pain, particularly in the morning, along with mild to moderate headache. Associated symptoms include occasional post-nasal drip, fatigue, and subjective fever (no documented temperature). She denies significant facial swelling, dental pain, or visual disturbances. The patient has not experienced any improvement with over-the-counter saline nasal rinses or decongestants. Review of Systems: - Respiratory: Mild cough, non-productive. - Constitutional: Fatigue, no chills. - Otolaryngologic: Nasal congestion, facial pain, post-nasal drip. - Other: No ear pain, no sore throat, no rash. Physical Examination: - General: Alert and oriented, appears uncomfortable. - HEENT: Mild erythema of the nasal mucosa, moderate purulent secretions noted upon anterior rhinoscopy. Mild tenderness over the maxillary and frontal sinuses upon palpation. - Cardiovascular/Pulmonary: Normal heart rate and rhythm, clear breath sounds. Assessment: - Viral sinusitis (likely) – consistent with clinical presentation of acute sinusitis without signs of bacterial superinfection. Plan: 1. Medication: Prescribed Amoxicillin 250 mg / Clavulanate 125 mg oral tablet (Augmentin) for 10 days. - Instructions: Take one tablet three times daily with food to enhance absorption and reduce gastrointestinal upset. Complete the full course even if symptoms improve. 2. Symptomatic Relief: Recommend continued use of saline nasal rinses (e.g., Neti pot) and OTC acetaminophen for pain/fever. 3. Follow-Up: Return if symptoms worsen or persist beyond 7 days, or if new symptoms (e.g., high fever, severe headache, visual changes) develop. Patient Education: - Emphasize the importance of completing the antibiotic course to prevent resistance. - Advise on hydration and rest to support immune function. - Encourage monitoring for signs of complications (e.g., facial swelling, high fever). Signature: ,

============================================================

## Note 98 (undefined - fefb1eaf-10f9-de4c-4a23-40c30c0b1148)

**Note ID:** fefb1eaf-10f9-de4c-4a23-40c30c0b1148
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Zane918 Bosco882
**Date:** 2025-01-25T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593
- Age: 54 years
- Gender: Female
- Race: White Encounter Details: - Date: - Time: - Location: Urgent Care Clinic Chief Complaint: The patient presents to the urgent care clinic for an assessment of health and social care needs. The patient also underwent an assessment of anxiety, depression screening, depression screening, assessment of substance use, and assessment using the Alcohol Use Disorders Identification Test - Consumption (AUDIT-C). History of Present Illness: The patient is a 54-year-old white female who was prescribed the following medications:
- Insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension - Hydrochlorothiazide 25 MG Oral Tablet The patient reported experiencing symptoms that may be caused by these medications, including:
- Hypoglycemia (low blood sugar) due to insulin therapy, characterized by symptoms such as dizziness, sweating, tremors, and confusion.
- Possible electrolyte imbalances due to Hydrochlorothiazide, which may manifest as muscle cramps, weakness, or fatigue. Assessment of Health and Social Care Needs: - The patient's health and social care needs were assessed, and appropriate interventions were discussed.
- The patient was advised to follow up with her primary care physician for further evaluation and management. Assessment of Anxiety and Depression: - The patient underwent screening for anxiety and depression.
- The results of the screening will be reviewed with the patient and appropriate referrals will be made if necessary. Assessment of Substance Use: - The patient underwent an assessment of substance use.
- The results of the assessment will be reviewed with the patient, and counseling or treatment options will be discussed if needed. Assessment using AUDIT-C: - The patient underwent the AUDIT-C assessment to screen for alcohol use disorders.
- The results of the assessment will be reviewed with the patient, and appropriate interventions will be provided if necessary. Medication Instructions: 1. Insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension : - Administer subcutaneously as prescribed by the healthcare provider. - Rotate injection sites to prevent lipodystrophy. - Monitor blood glucose levels regularly. - Be aware of the signs and symptoms of hypoglycemia and have a source of glucose readily available. - Do not shake the insulin vial vigorously; gently roll it between the palms to mix. 2. Hydrochlorothiazide 25 MG Oral Tablet: - Take one tablet by mouth once daily, preferably in the morning. - Take with or without food. - Monitor for signs of electrolyte imbalances, such as muscle cramps, weakness, or fatigue. - Maintain adequate fluid intake to prevent dehydration. Follow-Up: - The patient is advised to follow up with her primary care physician for further evaluation and management.
- The patient will also be contacted to discuss the results of the anxiety, depression, substance use, and AUDIT-C assessments. Signature:

============================================================

## Note 99 (undefined - ec691dee-cc3e-322f-f0ab-9d50f29d9b94)

**Note ID:** ec691dee-cc3e-322f-f0ab-9d50f29d9b94
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Zane918 Bosco882
**Date:** 2025-02-01T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 54 - Sex: Female - Race: White - Location: Urgent Care Clinic Reason for Visit: Urgent care evaluation due to . History of Present Illness: The patient presents today with . These symptoms may be related to her current medications, including insulin therapy or hydrochlorothiazide. Medications: 1. Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension - Indication: Diabetes mellitus. - Dosage and Administration: - Inject subcutaneously once daily, typically before breakfast or dinner. - Rotate injection sites to avoid lipodystrophy. - Monitor blood glucose levels before meals and at bedtime. - Adjust dose based on blood glucose readings and carbohydrate intake. - May cause hypoglycemia if dose is too high or if meals are skipped; educate patient on recognizing symptoms (e.g., sweating, tremors, confusion) and treating with fast-acting carbohydrates (e.g., glucose tablets, juice). 2. Hydrochlorothiazide 25 MG Oral Tablet - Indication: Hypertension or fluid retention. - Dosage and Administration: - Take one tablet orally once daily, preferably in the morning. - May cause dehydration or electrolyte imbalances (e.g., hyponatremia, hypokalemia); advise patient to maintain adequate fluid intake and report symptoms like muscle cramps or weakness. Physical Exam: - Assessment: - Suspected . - Medication-related side effects possible. Plan: 1. Monitoring: - Advise patient to monitor blood glucose regularly and record readings. - Follow up with primary care physician for medication adjustments. 2. Education: - Review proper insulin administration and hypoglycemia management. - Emphasize importance of fluid intake and electrolyte balance with hydrochlorothiazide. 3. Referrals: - If symptoms persist or worsen, refer to endocrinology or cardiology as needed. Disposition: - Patient discharged with instructions and follow-up as above. Signature: ,

============================================================

## Note 100 (undefined - 613ae719-ed9f-db2c-c63f-29994fc63a95)

**Note ID:** 613ae719-ed9f-db2c-c63f-29994fc63a95
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2025-02-08T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 54 years - Sex: Female - Race: White Reason for Encounter: Routine check-up. History of Present Illness: The patient presents for a routine check-up. No specific complaints reported at this time. The patient has been prescribed insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension for diabetes management. There is no mention of current symptoms, but potential symptoms related to diabetes or medication use could include: - Hyperglycemia (increased thirst, frequent urination, fatigue, blurred vision) - Hypoglycemia (shakiness, sweating, confusion, dizziness) - Edema (due to hydrochlorothiazide) - Electrolyte imbalances (e.g., low potassium) Medications: 1. Insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension - Indication: Diabetes mellitus. - Dosage and Administration: - Inject subcutaneously as prescribed by the provider. - Administer typically before meals (e.g., breakfast and dinner). - Rotate injection sites to prevent lipodystrophy. - Monitor blood glucose levels regularly to adjust dosage as needed. - Symptoms of hypoglycemia (shakiness, sweating, confusion) should be addressed with fast-acting carbohydrates. 2. Hydrochlorothiazide 25 MG Oral Tablet - Indication: Hypertension or fluid retention. - Dosage and Administration: - Take one tablet orally once daily, preferably in the morning. - Increase fluid intake to prevent dehydration. - Monitor for electrolyte imbalances (e.g., low potassium). - Report symptoms such as muscle cramps or weakness. Assessments Performed: - Assessment of health and social care needs. - Depression screening (performed twice). - Assessment of substance use. - Alcohol Use Disorders Identification Test - Consumption (AUDIT-C). - Referral for dental care procedure(s) performed. Plan: - Continue current medications as prescribed. - Follow up in 3 months for diabetes and blood pressure monitoring. - Address any symptoms of hypoglycemia or electrolyte imbalances promptly. - Follow up with dental care as referred. Signature:

============================================================

## Note 101 (undefined - 9f7f1d28-b155-7c44-cf33-cfaad2952d57)

**Note ID:** 9f7f1d28-b155-7c44-cf33-cfaad2952d57
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Zane918 Bosco882
**Date:** 2025-02-15T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Fritsch593, Adelaide981 Felisha640 - Age: 54 years - Race: White - Gender: Female - Location: Urgent Care Clinic Chief Complaint: Patient presents with symptoms potentially related to uncontrolled diabetes or hypertension, including: - Fatigue - Polyuria (increased urination) - Polydipsia (increased thirst) - Possible dizziness or lightheadedness (may be due to hypoglycemia or hypotension) - Weakness or malaise History of Present Illness: The patient reports difficulty managing her blood glucose levels and blood pressure. She was prescribed the following medications for ongoing management: 1. Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension – For diabetes management. 2. Hydrochlorothiazide 25 MG Oral Tablet – For hypertension. The patient states she is unsure about the correct administration and timing of her medications, leading to potential fluctuations in symptoms. Physical Examination: - Blood pressure: 150/90 mmHg - Random blood glucose: 280 mg/dL - No signs of acute distress, but appears fatigued. Plan: 1. Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension (70/30 mixture): - Dosage: Prescribe subcutaneously once daily. - Timing: Administer in the morning, 30 minutes before breakfast. - Instructions: - Rotate injection sites (abdomen, thighs, upper arms) to prevent lipodystrophy. - Store insulin in the refrigerator (do not freeze). - Monitor blood glucose levels before meals and at bedtime. - Signs of hypoglycemia (shakiness, sweating, confusion) should be addressed with fast-acting carbohydrates (e.g., glucose tablets, juice). 2. Hydrochlorothiazide 25 MG Oral Tablet: - Dosage: 25 mg once daily. - Timing: Take in the morning with food or milk to minimize gastrointestinal upset. - Instructions: - Maintain adequate hydration. - Monitor for electrolyte imbalances (e.g., potassium levels). - Report symptoms of dizziness, muscle cramps, or increased thirst. 3. Follow-Up: - Schedule a follow-up appointment in 1 week to reassess blood glucose control and blood pressure. - Encourage lifestyle modifications (e.g., diet, exercise) to improve glycemic and blood pressure control. Discharge Instructions: - Educate patient on proper insulin administration and storage. - Emphasize the importance of regular blood glucose monitoring. - Advise on recognizing and managing hypoglycemia. - Reinforce adherence to antihypertensive therapy. Signature:

============================================================

## Note 102 (undefined - 56a30dc0-9568-5b11-6742-e64a2d42b452)

**Note ID:** 56a30dc0-9568-5b11-6742-e64a2d42b452
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2025-02-22T19:55:15.581-05:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 54 years - Gender: Female - Race: White Encounter Details: - Date: - Reason for Visit: Check-up and patient referral for dental care (procedure). Symptoms: The patient presented with symptoms that may be indicative of the need for dental care, including but not limited to: - Toothache or dental pain - Sensitivity to hot, cold, or sweet stimuli - Bleeding or swollen gums - Visible plaque or calculus buildup on teeth - Discoloration or damage to existing dental restorations - General discomfort or difficulty in chewing Dental Consultation and Procedures Performed: 1. Dental Consultation and Report: Comprehensive evaluation of oral health status, including discussion of patient history, current symptoms, and treatment options. 2. Dental Care (Regime/Therapy): Implementation of a personalized dental care plan to address identified issues. 3. Removal of Supragingival Plaque and Calculus: Scaling performed using dental instruments to remove plaque and calculus from the surfaces of all teeth above the gum line. 4. Removal of Subgingival Plaque and Calculus: Root planing performed using dental instruments to remove plaque and calculus from the surfaces of all teeth below the gum line. 5. Examination of Gingivae: Assessment of gum health, including checking for signs of gingivitis or periodontitis. 6. Restoration of Tooth: Restoration of a tooth with coverage of all cusps using dental filling material to restore functionality and prevent further decay. 7. Dental Fluoride Treatment: Application of fluoride to strengthen tooth enamel and prevent cavities. 8. Oral Health Education: Patient education on proper oral hygiene practices, including brushing, flossing, and dietary recommendations. Medication Prescribed: - Sodium Fluoride 0.0272 MG/MG Oral Gel Instructions for Taking Sodium Fluoride 0.0272 MG/MG Oral Gel: - Apply a pea-sized amount of the gel to a toothbrush. - Brush teeth thoroughly for at least one minute, ensuring all tooth surfaces are covered. - Spit out the gel after brushing; do not swallow. - Avoid eating, drinking, or rinsing for at least 30 minutes after application to allow the fluoride to be fully absorbed. - Use the gel as directed by the dentist, typically once daily before bedtime. - If accidental swallowing occurs, contact a healthcare provider or poison control center immediately. Follow-Up: - Schedule a follow-up appointment in to monitor oral health and evaluate the effectiveness of the treatment plan. Physician Signature: Note: This medical note is for informational purposes only and should not be considered a substitute for professional medical advice. Always consult with a qualified healthcare provider for any health-related concerns.

============================================================

## Note 103 (undefined - 3e842f4a-f8c7-9ef2-02d0-ee1dc2d023f1)

**Note ID:** 3e842f4a-f8c7-9ef2-02d0-ee1dc2d023f1
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2025-03-15T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 54 - Sex: Female - Race: White Encounter Date: Reason for Visit: Routine check-up History of Present Illness: The patient presents for a routine check-up. No specific complaints were reported at this time. However, symptoms such as fatigue, increased thirst, and frequent urination may be associated with diabetes, which is being managed with insulin therapy. Additionally, the patient may experience symptoms of anxiety or depression, which were screened for during this visit. Medication Reconciliation: - Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension : - Dosage and Administration: Administer subcutaneously once daily, typically in the morning or as prescribed by the provider. Rotate injection sites to prevent lipodystrophy. - Instructions: Inject at least 30 minutes before a meal. Monitor blood glucose levels regularly to adjust dosing as needed. - Potential Side Effects: Hypoglycemia (low blood sugar), weight gain, injection site reactions. - Hydrochlorothiazide 25 MG Oral Tablet : - Dosage and Administration: Take one tablet orally once daily, preferably in the morning. - Instructions: Take with or without food. Avoid excessive sun exposure due to potential photosensitivity. Monitor electrolytes (e.g., potassium) as directed. - Potential Side Effects: Dizziness, dehydration, electrolyte imbalances, increased urination. Procedures Performed: - Medication reconciliation - Assessment of health and social care needs - Assessment of anxiety - Depression screening - Depression screening - Assessment of substance use - Screening for drug abuse Assessment: The patient is stable but requires ongoing management of diabetes and hypertension. Anxiety and depression screening were performed, and no immediate concerns were identified, but continued monitoring is recommended. Plan: 1. Continue current medications as prescribed. 2. Schedule follow-up in to reassess blood glucose and blood pressure control. 3. Encourage lifestyle modifications, including a balanced diet and regular exercise. 4. Refer to a mental health specialist if depressive or anxiety symptoms worsen. Provider Signature: Date:

============================================================

## Note 104 (undefined - aa8c5d19-30e2-8a3a-3e9d-6716b97c07e0)

**Note ID:** aa8c5d19-30e2-8a3a-3e9d-6716b97c07e0
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Trinity427 Hartmann983
**Date:** 2025-03-29T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Fritsch593 - Age: 54 years - Sex: Female - Race: White Encounter Date: Reason for Visit: General examination History of Present Illness: The patient presents for a general examination. No specific complaints were reported, but the encounter included a comprehensive assessment of health and social care needs, including screening for anxiety and depression. The patient was also referred for dental care procedures. Medication Reconciliation: - Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension : - Instructions: Administer subcutaneously once daily, typically before breakfast or dinner. Rotate injection sites to prevent lipodystrophy. Monitor blood glucose levels as prescribed. Do not shake vigorously; gently roll the vial between palms if cloudy. - Hydrochlorothiazide 25 MG Oral Tablet: - Instructions: Take one tablet orally once daily, preferably in the morning to minimize nighttime urination. Maintain adequate hydration and monitor electrolyte levels as needed. Assessment: - The patient was assessed for health and social care needs, with no immediate concerns noted. - Anxiety was evaluated, and screening was performed; no significant symptoms were reported. - Depression screening was conducted, and the patient did not meet criteria for major depressive disorder. - Referral for dental care was made due to . Potential Symptoms: The patient may experience symptoms related to her medications, including: - Hypoglycemia (e.g., sweating, tremors, confusion) from insulin therapy. - Hyperglycemia (e.g., increased thirst, urination, fatigue) if insulin doses are insufficient. - Electrolyte imbalances (e.g., low potassium) from Hydrochlorothiazide. - Orthostatic hypotension (dizziness upon standing) from Hydrochlorothiazide. Plan: - Continue current medications with adherence to dosing instructions. - Schedule follow-up in to reassess blood glucose control and electrolytes. - Follow up with dental provider as per referral. - Encourage monitoring for any new symptoms and to report them promptly. Provider Signature:

============================================================

## Note 105 (undefined - 4535572e-e6f6-f6d4-0408-21376bf5bb21)

**Note ID:** 4535572e-e6f6-f6d4-0408-21376bf5bb21
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2025-04-12T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593
- Age: 54
- Gender: Female
- Race: White Reason for Encounter: Check-up for Gingivitis. History of Present Illness: The patient presents today for a check-up regarding Gingivitis. Gingivitis is a common condition characterized by inflammation of the gums. Symptoms that may be caused by Gingivitis include:
- Red, swollen, or tender gums
- Bleeding gums, especially during brushing or flossing
- Bad breath (halitosis)
- Receding gums
- Loose teeth The patient has been experiencing some of these symptoms, which prompted her to seek dental care. Dental Consultation and Report: The patient underwent a comprehensive dental consultation, which included a detailed dental report. The consultation revealed signs of Gingivitis, necessitating further dental care and therapy. Dental Care (Regime/Therapy): The following procedures were performed as part of the dental care regime/therapy:
- Removal of supragingival plaque and calculus from all teeth using dental instruments.
- Removal of subgingival plaque and calculus from all teeth using dental instruments.
- Dental plain x-ray bitewing to assess the extent of dental issues.
- Examination of gingivae to evaluate the condition of the gums.
- Dental fluoride treatment to strengthen tooth enamel and reduce the risk of further dental problems.
- Oral health education to inform the patient about proper oral hygiene practices. Prescription: The patient was prescribed sodium fluoride 0.0272 MG/MG Oral Gel to aid in the prevention and treatment of Gingivitis. Instructions for Taking Sodium Fluoride 0.0272 MG/MG Oral Gel: 1. Apply a small amount of the oral gel to a toothbrush.
2. Brush your teeth thoroughly for at least one minute, ensuring that all tooth surfaces are covered.
3. Spit out the excess gel after brushing, but do not rinse your mouth with water immediately.
4. Wait for at least 30 minutes before eating, drinking, or rinsing your mouth to allow the fluoride to be fully absorbed.
5. Use the oral gel as directed by your dentist or healthcare provider, typically once daily before bedtime.
6. If you experience any unusual side effects or have concerns about the medication, contact your dentist or healthcare provider promptly. Follow-Up: The patient will be scheduled for a follow-up appointment in six months to monitor the progress of her Gingivitis and ensure that the prescribed treatment is effective. Additionally, regular dental check-ups are recommended to maintain optimal oral health. Conclusion: The patient has been provided with comprehensive dental care and therapy for Gingivitis. She has been instructed on the proper use of sodium fluoride 0.0272 MG/MG Oral Gel and educated on oral health practices. Follow-up appointments will be scheduled to monitor her condition and ensure continued improvement.

============================================================

## Note 106 (undefined - 31867b3f-e606-0b67-cb04-20d3f71008ef)

**Note ID:** 31867b3f-e606-0b67-cb04-20d3f71008ef
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2025-05-17T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 54 years - Sex: Female - Race: White Encounter Date: Reason for Visit: Routine check-up. ### History of Present Illness (HPI): The patient presents for a routine check-up. She has been prescribed insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension for diabetes management. She also takes Hydrochlorothiazide 25 MG Oral Tablet for blood pressure control. No specific complaints reported at this time. ### Review of Systems (ROS): - Endocrine: Patient reports stable blood glucose levels but may experience symptoms such as hypoglycemia (shakiness, sweating, confusion, dizziness) if insulin dosage is not properly managed. - Cardiovascular: No chest pain, palpitations, or edema reported. - Renal: No complaints of increased urination or changes in urine output. - Neurological: No dizziness or weakness reported. - Gastrointestinal: No nausea, vomiting, or abdominal pain. - Mental Health: No reported symptoms of depression or anxiety. ### Medication Reconciliation & Instructions: 1. Insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension - Dosage: - Frequency: - Instructions: - Rotate injection sites (abdomen, thighs, upper arms) to prevent lipodystrophy. - Administer 15-30 minutes before meals to prevent hypoglycemia. - Monitor blood glucose levels regularly (pre-meals and bedtime). - Signs of hypoglycemia: Shakiness, sweating, confusion, dizziness. Treat with 15g fast-acting carbohydrates (e.g., glucose tablets, juice). - Store unopened vials in the refrigerator; keep opened vials at room temperature (do not refrigerate). 2. Hydrochlorothiazide 25 MG Oral Tablet - Dosage: 25 mg orally once daily. - Instructions: - Take in the morning to avoid nighttime urination. - Ensure adequate fluid intake to prevent dehydration. - Monitor for electrolyte imbalances (e.g., low potassium—symptoms like muscle cramps or weakness). - Avoid alcohol, as it may increase dizziness. ### Procedures Performed: - Medication reconciliation. - Assessment of health and social care needs. - Depression screening (negative). - Assessment of substance use (negative). - Screening for drug abuse (negative). ### Assessment & Plan: - Assessment: Stable diabetic and hypertensive patient with no acute concerns. - Plan: - Continue current medications with proper monitoring. - Schedule follow-up in for HbA1c and blood pressure checks. - Educate patient on hypoglycemia prevention and management. - Encourage lifestyle modifications (e.g., diet, exercise) for diabetes and hypertension control. Signature:

============================================================

## Note 107 (undefined - 63fed264-8526-7e14-ec98-500a19378811)

**Note ID:** 63fed264-8526-7e14-ec98-500a19378811
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2025-06-14T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593
- Age: 54 years
- Gender: Female
- Race: White Encounter Details: - Date: - Reason for Visit: Routine Check-up Chief Complaint: The patient presents for a routine check-up. History of Present Illness: The patient is a 54-year-old white female who has been prescribed insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension and Hydrochlorothiazide 25 MG Oral Tablet. The patient has no specific complaints at this time, but routine assessments were conducted. Medication Reconciliation: - Insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension : The patient was instructed on the proper administration of this medication. The patient should take this medication subcutaneously once daily, preferably at the same time each day. The dose should be divided into 70% insulin isophane and 30% insulin regular. The patient should rotate injection sites to prevent lipodystrophy. The patient should monitor blood glucose levels regularly and adjust the dose as needed under the guidance of the healthcare provider.
- Hydrochlorothiazide 25 MG Oral Tablet: The patient should take one tablet orally once daily, preferably in the morning. The patient should ensure adequate hydration and monitor for electrolyte imbalances, such as hyponatremia or hypokalemia. The patient should also monitor blood pressure regularly. Assessment of Health and Social Care Needs: The patient's health and social care needs were assessed. No significant issues were identified at this time. Assessment of Anxiety and Depression: The patient was screened for anxiety and depression. The patient reported no symptoms of anxiety or depression. Screening for Substance Use and Drug Abuse: The patient was screened for substance use and drug abuse. The patient reported no history of substance use or drug abuse. Referral for Dental Care: The patient was referred for dental care procedure(s) to address any potential dental issues. Symptoms that may be caused by the medications: - Insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension : The patient may experience hypoglycemia (low blood sugar), which can present as sweating, tremors, confusion, or palpitations. The patient should be aware of these symptoms and have a source of glucose readily available.
- Hydrochlorothiazide 25 MG Oral Tablet: The patient may experience dizziness, lightheadedness, or dehydration due to the diuretic effects of the medication. The patient should ensure adequate fluid intake and avoid abrupt changes in posture to prevent falls. Plan: - Continue current medications as prescribed.
- Monitor blood glucose levels regularly.
- Monitor blood pressure and electrolyte levels as needed.
- Follow up with dental care for the referral.
- Schedule a follow-up appointment in to assess the patient's response to the medications and address any concerns. Physician Signature:

============================================================

## Note 108 (undefined - 96f76716-212f-07ac-1bf6-2b62e001d1b5)

**Note ID:** 96f76716-212f-07ac-1bf6-2b62e001d1b5
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2025-06-28T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 54 years - Gender: Female - Race: White Encounter Date: Reason for Encounter: Check-up for Gingivitis History of Present Illness: The patient presents for a dental check-up due to concerns regarding gingivitis. The patient reports experiencing symptoms commonly associated with gingivitis, including: - Redness and swelling of the gums - Bleeding gums, particularly during brushing or flossing - Bad breath (halitosis) - Gums that appear shiny or puffy - Mild discomfort or tenderness in the gum tissue The patient states that these symptoms prompted her to seek dental consultation and care. Dental Consultation and Report: The patient underwent a dental consultation, where a comprehensive report was generated detailing the findings of gingivitis. The report indicated the presence of plaque and calculus accumulation on both supragingival and subgingival surfaces. Dental Care (Regime/Therapy) Performed: - Removal of supragingival plaque and calculus from all teeth using dental instruments. - Removal of subgingival plaque and calculus from all teeth using dental instruments. - Examination of gingivae to assess the severity of gingivitis and rule out periodontitis. - Application of composite dental filling material to dentin of a tooth following a reported fracture. - Oral health education was provided to the patient, including proper brushing and flossing techniques, the importance of regular dental visits, and dietary recommendations to support oral health. Findings: Upon examination, the patient’s gingivae were noted to be erythematous and edematous, with areas of bleeding upon probing. Supragingival and subgingival plaque and calculus were present, consistent with the diagnosis of gingivitis. The fractured tooth was repaired with a composite filling to restore its integrity and function. Plan: 1. Continue with oral hygiene instructions provided during the visit. 2. Schedule a follow-up appointment in to assess the response to therapy and monitor gingival health. 3. Encourage the patient to maintain regular dental check-ups to prevent recurrence of gingivitis. Signature:

============================================================

## Note 109 (undefined - 3c30d797-3446-6336-081e-0437bc964f7b)

**Note ID:** 3c30d797-3446-6336-081e-0437bc964f7b
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2025-09-13T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 54 years - Sex: Female - Race: White Encounter Date: Reason for Visit: Routine check-up. ### Subjective: The patient presents for a routine check-up. She reports no acute complaints. No specific symptoms were mentioned during the encounter. However, potential symptoms related to her chronic conditions (e.g., diabetes, hypertension) may include: - Diabetes-related symptoms: Polyuria, polydipsia, fatigue, blurred vision, or unintended weight changes. - Hypertension-related symptoms: Headache, dizziness, or shortness of breath. - Other concerns: No reported symptoms of domestic abuse or substance use. ### Objective: - - Medication Reconciliation: Confirmed current medications and dosages. - Assessment of Health and Social Care Needs: Completed. - Screening for Domestic Abuse: Negative. - Assessment of Substance Use: Negative. - Alcohol Use Disorders Identification Test (AUDIT-C): Completed; no significant risk identified. - Dental Referral: Patient referred for dental care procedure(s). - Immunizations: Administered Influenza, seasonal, injectable, preservative-free. ### Plan: 1. Medications: - Insulin Isophane, Human 70 UNT/ML / Insulin, Regular, Human 30 UNT/ML Injectable Suspension : - Instructions: Administer subcutaneously once daily, preferably in the morning. Rotate injection sites (abdomen, thigh, upper arm, or buttocks) to prevent lipodystrophy. Do not shake vigorously; gently roll the vial if needed. Monitor blood glucose levels as prescribed. - Hydrochlorothiazide 25 MG Oral Tablet: - Instructions: Take one tablet orally once daily, preferably in the morning. Take with or without food. Monitor for electrolyte imbalances (e.g., potassium levels) and report symptoms like muscle cramps or weakness. Ensure adequate hydration. 2. Follow-Up: - Schedule follow-up in to reassess blood glucose and blood pressure control. - Monitor for any adverse effects from medications. 3. Referrals: - Dental care referral for procedure(s) as needed. ### Assessment: Patient is stable with well-managed diabetes and hypertension. No acute concerns identified. Immunizations updated. Provider Signature:

============================================================

## Note 110 (undefined - a3654e85-1ed2-7ed3-0cca-52c79e34a533)

**Note ID:** a3654e85-1ed2-7ed3-0cca-52c79e34a533
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Salvador46 Ayala238
**Date:** 2025-09-27T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Medical Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593
- Age: 54 years
- Gender: Female
- Race: White Date of Encounter: Reason for Encounter: Check-up for Gingivitis History of Present Illness: The patient presented today for a check-up regarding Gingivitis. She reported experiencing symptoms commonly associated with Gingivitis, including redness, swelling, and tenderness of the gums. She also mentioned occasional bleeding during brushing or flossing. The patient expressed concern about the progression of her condition and sought further evaluation and treatment. Physical Examination: - Oral Examination: Examination of the gingivae revealed generalized redness, edema, and slight bleeding upon probing. No significant periodontal pockets were noted.
- Dental X-ray (Bitewing): No significant dental caries or bone loss was observed. Procedures Performed: 1. Dental Consultation and Report: Comprehensive discussion regarding the patient's oral health status and treatment plan.
2. Dental Care (Regime/Therapy): Implementation of a personalized oral hygiene regimen to manage Gingivitis.
3. Removal of Supragingival Plaque and Calculus: Utilization of dental instruments to remove plaque and calculus from the surfaces of all teeth above the gumline.
4. Removal of Subgingival Plaque and Calculus: Utilization of dental instruments to remove plaque and calculus from the surfaces of all teeth below the gumline.
5. Dental Plain X-ray (Bitewing): Performed to assess the presence of dental caries and bone loss.
6. Examination of Gingivae: Detailed evaluation of the gum tissue for signs of inflammation and disease.
7. Dental Fluoride Treatment: Application of fluoride to strengthen tooth enamel and prevent further decay.
8. Oral Health Education: Instruction provided on proper brushing and flossing techniques, as well as the importance of regular dental visits. Medication Prescribed: - Sodium Fluoride 0.0272 MG/MG Oral Gel: Prescribed to aid in the prevention of dental caries and to promote gum health. Instructions for Taking Sodium Fluoride 0.0272 MG/MG Oral Gel: - Apply a small amount of the oral gel to a toothbrush.
- Brush teeth thoroughly for at least one minute, ensuring all tooth surfaces are covered.
- Spit out the gel after brushing; do not swallow.
- Rinse mouth with water after spitting out the gel.
- Use the oral gel as directed by the dentist, typically once daily before bedtime, after brushing with regular toothpaste.
- If swallowing difficulties are experienced, consult the dentist for alternative administration methods. Follow-Up: The patient is advised to return for a follow-up appointment in three months to assess the progress of her Gingivitis and to ensure compliance with the prescribed treatment plan. Regular dental check-ups and adherence to the recommended oral hygiene regimen are essential for maintaining optimal oral health. Signature:

============================================================

## Note 111 (undefined - 3d763994-e6d0-edd3-5eb5-eaa81685a055)

**Note ID:** 3d763994-e6d0-edd3-5eb5-eaa81685a055
**Patient ID:** 02776682-5a6b-eef6-c3d7-12d8794d68a1
**Note Type:** DocumentReference
**Provider:** Dr. Cherrie404 Conn188
**Date:** 2025-10-18T20:55:15.581-04:00
**Source:** Adelaide981_Fritsch593_02776682-5a6b-eef6-c3d7-12d8794d68a1.json

**Clinical Content:**
Emergency Department Encounter Note Patient Information: - Name: Adelaide981 Felisha640 Fritsch593 - Age: 54 years - Sex: Female - Race: White Chief Complaint: Brought to the emergency room for severe symptoms of uncontrolled diabetes mellitus. History of Present Illness: The patient was brought to the emergency department due to severe symptoms of hyperglycemia, including extreme thirst (polydipsia), frequent urination (polyuria), generalized weakness, and confusion. The patient reported a recent increase in blood glucose levels, with readings as high as 400 mg/dL. She also reported experiencing blurred vision and fatigue. The patient states she has been nonadherent to her prescribed insulin regimen and has missed multiple doses of her oral antihypertensive medication. Past Medical History: - Diabetes mellitus type 2 - Hypertension Medications at Home: 1. Insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension - Instructions: Administer subcutaneously once daily, typically in the morning, 15–30 minutes before breakfast. Rotate injection sites to prevent lipodystrophy. Mix the suspension thoroughly by gently rolling the vial between the palms before drawing up the dose. Do not shake vigorously. 2. Hydrochlorothiazide 25 MG Oral Tablet - Instructions: Take one tablet orally once daily, preferably in the morning, with or without food. Ensure adequate fluid intake and monitor for electrolyte imbalances (e.g., potassium levels). Physical Examination: - Vitals: Blood pressure 150/90 mmHg, heart rate 90 bpm, respiratory rate 18 bpm, temperature 98.6°F. - General: Alert but confused, appears dehydrated. - Skin: Dry mucous membranes, poor skin turgor. - Neurological: Mild disorientation to time and place. Assessment: The patient is presenting with severe hyperglycemia and signs of dehydration, likely due to nonadherence to her prescribed insulin regimen and antihypertensive therapy. Immediate management is required to correct hyperglycemia and address potential complications such as diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS). Plan: 1. IV Fluids: Administer normal saline IV at 125 mL/hr to correct dehydration. 2. Insulin: Start IV regular insulin drip to lower blood glucose levels, titrating per protocol. 3. Electrolytes: Check electrolytes (especially potassium) and correct as needed. 4. Education: Reinforce the importance of adherence to insulin and oral medications. Discuss proper storage and administration of insulin. 5. Follow-Up: Admit to the hospital for further management and stabilization. Procedures Performed: - Assessment of health and social care needs. Disposition: Admitted to the hospital for management of uncontrolled diabetes mellitus and dehydration. Signature:

============================================================

